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Abstract   
It is known that evolutionarily conserved pathways regulate several essential 
biological processes, such as the cell cycle, DNA replication and protein synthesis. I 
hypothesise that there exists a conserved regulatory mechanism which controls cell size 
as well. To test this proposition, I carried out two types of experiment: 
 
Bioinformatics. Development of a bioinformatics tool to predict cell size regulators, 
based on information of evolutionarily-conserved proteins which have been described 
as cell size regulators in genome-wide studies. I collected existing large-scale data from 
the literature from five evolutionarily distant organisms (A. thaliana, D. melanogaster, H. 
sapiens, S. cerevisiae and S. pombe), then looked for conserved orthologous proteins with 
conserved cell size regulatory functions. I used the eggNOG orthology database as the 
primary source for orthology information, in addition to one manually curated list by 
PomBase curators. I added biological pathway information from KEGG and functional 
data from Gene Ontology. This approach allowed me to identify a core conserved cell 
size regulatory network and based on data on three of these species I created a list of 
predicted novel cell size regulators for the remaining two organisms. I focussed on those 
orthologous groups of proteins, which have only one ortholog in all five organisms and 
further reduced the list by concentrating on those which lack pathway annotations. 20 
conserved orthologous groups matched these criteria. Some of these were tested in wet-
lab experiments. 
Additionally, I have extended this tool with the capability to find the conserved 
core of any biological function, listed in the Gene Ontology SLIM database and 
extended the list of the investigated model species to seven (A. thaliana, C. elegans, D. 
melanogaster, D. rerio, H. sapiens, S. cerevisiae and S. pombe). This bioinformatics tool is 
also able to predict novel functional annotations to Gene Ontology, based on 
orthologous group involvement in eggNOG. 
 
Wet-lab experiments. Analysis of some of the predicted cell size regulators by 
carrying out experiments on Arabidopsis thaliana and human T-Cells. 
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T-Cells. I isolated human peripheral blood T-Cells that are in a quiescent state, 
which increase in size and enter the cell cycle when stimulated via CD3/CD28. The 
quiescent T-Cells were transfected with siRNA to reduce the induction of each of the 
predicted proteins, which normally occurs as the cells respond to CD3/CD28. I 
analysed the size distribution by Flow Cytometry, measuring FSC-A values. My data 
show that reducing the induction of TCTP, a protein that plays a role in microtubule 
stabilisation, apoptosis and calcium binding, affects T-Cell size. I also show that 
reducing the expression of the MCM7 protein, a member of the mini-chromosome 
maintenance protein complex, reduced the size of T-Cells in G1 and increased their size 
in the S-phase of the cell cycle. 
Arabidopsis thaliana. I confirmed previously published data that knockout 
mutants of pfd6, a member of the prefoldin complex, produce small plants. I show that 
knock-out pfd3 mutants have a significantly smaller cell size compared with the control. 
The knock-out pfd3 mutants also have significantly different seed and silique sizes. 
Furthermore, I found that the knockout of mos14, encoding a nuclear import receptor, 
results in significantly smaller leaves. 
 
In summary, I have created a flexible bioinformatics tool that can predict novel 
cell size regulators, some of which are verified by experiments on human cells and 
Arabidopsis.  
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List of Abbreviations 
APCs Antigen-presenting cells 
ATP Adenosine triphosphate 
Cdk Cyclin-dependent kinase 
CFSE Carboxyfluorescein succinimidyl ester  
CKI Cyclin-dependent kinase inhibitor 
Col-0 Columbia type Arabidopsis plant 
CSV Comma Separated Value (File type) 
DNA Deoxyribonucleic acid 
dpg days post germination 
ENSG Ensembl Gene Identifier 
FACS Fluorescent activated cell sorters  
FBS Foetal Bovine Serum 
FITC Fluorescein Isothiocyanate  
FNP First neighbour protein (bioinformatics) 
Foxp3 forkhead box P3 
FSC Forward Scatter (Flow Cytometry) 
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase 
GO Gene Ontology Database 
GOOT Gene Ontology Orthology Tool (my tool) 
ITAM Immunoreceptor Tyrosine-based Activation Motif  
KEOPS complex Kinase, putative endopeptidase and other proteins of small size 
KO Knock-Out (gene) 
LDS Lithium Dodecyl Sulfate 
MCM complex Minichromosome maintenance protein complex  
MGG May-Grünwald Giemsa (staining) 
MHC Major histocompatibility complex 
mTOR Mammalian Target of Rapamycin  
A system level approach to identify novel cell size regulators 




NCBI The National Center for Biotechnology Information 
NK cells Natural Killer cells 
NK-T cells Natural-Killer T-Cells 
PBMCs Peripheral Blood Mononuclear Cells 
PBS Phosphate Buffered Saline 
PCR Polymerase chain reaction 
PE Phycoerythrin 
PI Propidium Iodine  
pMHC Peptides associated with major histocompatibility complex class I 
PPI Protein-protein interaction 
Rb Retinoblastoma protein 
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SGD Saccharomyces cerevisiae Genome Database  
siRNA Small interfering RNA 
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SVG Scalable Vector Graphics 
TAIR The Arabidopsis Information Resource 
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TCTP 
Synonim for TPT1, as Translationally Controlled Tumour 
Protein  
TOR  Target of Rapamycin  
TPT1 Tumour Protein, Translationally-Controlled 1  
UID Uniprot ID 
VBP1 Von Hippel-Lindau Binding Protein 1 
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”Once you eliminate the impossible, 
whatever remains, 
no matter how improbable, 
must be the truth”
Sir Arthur Conan Doyle
  
General Introduction 




1.1  Aims of PhD Dissertation  
There are cellular processes that are conserved in many species. The work in my Thesis 
addresses a related fundamental question in biology: 
 
Are there common regulators of cell size in evolutionarily distant organisms? 
 
To answer this complex question, I will collect data from the academic literature 
manually, then use a self-created bioinformatic tool to predict evolutionarily conserved 
proteins that control cell size, some of which will be tested experimentally. During the 
data collection and bioinformatic analyses will check other bioinformatic tools such as 
the Gene Ontology and eggNOG databases as additional sources of information. I test 
my predicted candidates using two distinct organisms to determine whether they 
regulate cell size. I chose human T-Cells and Arabidopsis thaliana, which are 
evolutionarily distant organisms. Analyses of these species will also determine whether 
there are common cell size regulators in in mammals and plants.  
 
The key aims of my Thesis are to: 
 
• Develop a bioinformatics tool that predicts novel groups of genes involved in cell size 
control by using system-wide, peer-reviewed studies, ortholog databases and Gene 
Ontology annotations. 
• Identify novel cell size regulator genes from some of those predicted by the 
bioinformatics tool by carrying out gene knockout experiments on the plant 
Arabidopsis thaliana. 
• Identify novel cell size regulators in Human cells by using small interfering RNA to 
reduce the expression of some of the predicted genes in human peripheral blood T-
Cells. 
• Expand the bioinformatics tool with functionality to find the conserved core of a given 
functional annotation and give novel annotations for groups of proteins in a specifically 
selected Gene Ontology annotation based on their orthological relationship.  




1.2  Cell size 
1.2.1  Cell size difference and uniformity 
In nature, cell sizes in different organisms vary enormously as do the sizes of cells within 
an organism. Despite the wide range of cell sizes, the size of individuals within each 
species is relatively uniform; this is true for overall size as well as for the dimensions and 
proportion of organs within the body. This kind of uniformity means strict control of 
cell, organ and organism size mediated through complex coordination of cellular growth 
and proliferation (Conlon & Raff, 1999; Cook & Tyers, 2007). 
 
1.2.2  Cellularity 
In unicellular species, cell size can vary by ten thousand-fold. The smallest known 
unicellular organism, Mycoplasma genitalium (Sippel et al., 2012), is around 0.1 μm in 
diameter, while the largest unicellular organisms candidate can be Acetabularia and 
Gromia sphaerica (Hammerling, 1963; Marshall et al., 2012; Matz et al., 2008), which 
are approximately 3 meters in diameter. Cell size in multicellular organisms also differs. 
The average size of an animal cell is between 10–20 μm in diameter (Guertin & 
Sabatini, 2006). In humans despite there being around 30 trillion cells in the body 
(Bianconi et al., 2013), there are around 200 cell types (Fu et al., 2017), all holds its 
own characteristic of size, which indicate precise regulatory mechanisms to control cell 
size (Guertin & Sabatini, 2006). Just to give some examples, how diverse a human cell 
can be: a human egg has a diameter of 0.1 mm, an axon of a human motoneuron can be 
over 1 meter long, while neutrophil blood cells are only 10 μm in diameter (Baserga, 
2007; Guertin & Sabatini, 2006). 
 
In a unicellular organism, the cell size determines the size of the organism; in a 
multicellular species, the combination of the number of cells and their sizes determines 
the organism size. Although in advanced multicellular organisms, cells form organs and 
the numbers of cells in the organ determines the size of that organ. However, the size 




control of organs and tissues also affect the size of cells in the organ (Edgar, 2006). 
Master hormonal regulators such as insulin/insulin-like growth factor signalling 
hormones control the growth of cells, tissues and body of Drosophila melanogaster 
(Goberdhan & Wilson, 2003). Insulin pathway defects cause cellular growth defects 
(Böhni et al., 1999), while hyperactivation of the pathway causes overgrowth 
(Weinkove et al., 1999). Hyper nutrient usage and increased number of steroid 
hormone receptors can also affect the cell growth (Edgar, 2006). 
 
Some perturbations of cell size, like a change in ploidy, can alter cell size, without 
modifying the organ size (Cook & Tyers, 2007; Jorgensen & Tyers, 2004). Generally, 
cell sizes scale with ploidy, this was shown for example in S. cerevisiae, where diploid 
cells are almost double the size of haploid cells (Weiss et al., 1975). However, this is not 
true for all the organisms. The most notable example of this is an experiment done by 
Fankhauser using salamander larvae (Fankhauser, 1945), where the ploidy was 
increased, but the size of the organs remained the same. This is the case for pentaploid 
animals that were grown under normal laboratory conditions also, where the number of 
cells was just one fifth that of the original salamanders (Fankhauser, 1945). 
 
In other cases, the size of organs can be larger, without any changes in size at the cellular 
level. To give an example, in transgenic mouse studies, where CDKN1B (encodes 
p27Kip1) deficient mice have enlarged organs due to increased cell proliferation, while 
cellular dimensions remain the same (Kiyokawa et al., 1996; Nakayama et al., 1996; 
Tumaneng et al., 2012). However, in most of the cases, cells “sense” the organ size and 
in the case of a mutation such as CDK1 mutants in Drosophila (Su & O’Farrell, 1998; 
Weigmann et al., 1997), cells decrease in size to fit the dimensions of an organ. (Cook 
& Tyers, 2007). 
  




1.2.2.1  Regulation of cell size 
Evolutionarily conserved pathways regulate several essential biological processes in cells 
such as the cell cycle engine, which affects cell proliferation (Cross et al., 2011; van den 
Heuvel & Dyson, 2008) and core processes of ribosome biogenesis (Thomson et al., 
2013). Since cell size is widely variable throughout the phylogenetic tree (Conlon & 
Raff, 1999), there could also be conserved mechanisms, which regulate cell size. These 
mechanisms, which control cell size and maintain cells within a particular size range 
have been investigated for a long time since the microscope was discovered by Robert 
Hooke (Hooke, 1665). However, the mechanisms that maintain a uniform cell size 
within a narrow range are poorly understood (Marshall et al., 2012). 
 
Maintaining the size of actively dividing cells requires strict regulation. Normally, when 
stem cells receive mitogenic stimuli, they proliferate and produce daughter cells in 
confined size distribution (Yamamoto & Mak, 2017). However, there are particular 
examples where this is not the case. For example, mechanical injury to tissue can alter 
cell size and results in cells that are transiently bigger (Kim et al., 2006). On the other 
hand, asymmetric cell division can happen in species such as C. elegans, producing 
daughter cells that are different, as is the case when segregation of the anterior-posterior 
axis takes place (Goldstein & Hird, 1996). In normal asymmetric cell division the 
components of the mother cell, other than DNA are differentially segregated to each of 
the daughter cells, resulting in daughter cells that differ in size but with the same DNA 
content (Hawkins & Garriga, 1998). 
 
The cell size in organisms generally reflects the balance between cell growth and 
division (Cook & Tyers, 2007; Ferrezuelo et al., 2012; Jorgensen & Tyers, 2004). 
Indeed these two processes maintain the size of cells in a particular range (Cook & 
Tyers, 2007; Jorgensen et al., 2004; Yamamoto et al., 2014). In this thesis I am looking 
for the conserved mechanisms that are regulating the size of eukaryotic cells. 
 




1.2.3  Checkpoints in cell size control 
Mutations or malfunctions can cause changes in growth rate that affect the cell size 
(Cook & Tyers, 2007; Rupes, 2002; Yamamoto et al., 2014). If a timer mechanism 
applies (see later in Section 1.3.2 ) and the growth rate accelerates, cells will be larger, 
while a slowing of growth may lead to smaller cells. Growth rate can directly determine 
the critical size1 of cells (Aldea et al., 2017). There exists a so-called size checkpoint or 
size threshold (Cook & Tyers, 2007). This is, in most cases, at the point of cell cycle 
commitment, in yeast termed “Start”(Hartwell et al., 1970), while in mammalian cells 
the “Restriction Point” (Pardee, 1974; Zetterberg & Larsson, 1985). These points are 
that checkpoints in the cell cycle where cells commit to cell division. Cell-size 
checkpoints are regulated by the environmental conditions (the number of nutrients in 
the media) in yeasts (Nurse et al., 1976). Cells growing at a slower rate will have a 
smaller cell size when they are maintained in nutrient-poor media, while cells 
proliferating in nutrient-rich media usually grow at a faster rate and reach a larger cell 
size (Nurse et al., 1976). If they are switched from a nutrient-poor medium to a nutrient-
rich medium (or vice-versa), the cells will adapt to the new conditions (Fantes & Nurse, 
1977; Nurse et al., 1976). This behaviour has been shown to occur in mammalian 
Schwann cells as well (Conlon & Raff, 2003). It was shown that the growth rate of cells 
is also dependent on the current size of those cells (Tzur et al., 2009). Reportedly there 
exist size thresholds, which are dynamically set by growth factor signals in mammalian 
cells (Dolznig et al., 2004; Zetterberg & Killander, 1965). However, in some cases, it 
seems to be that cell size is a simple result of factors that influence growth rate (Conlon 
& Raff, 2003). It has been argued that the signalling pathway proteins that are 
downstream of growth factor receptors, such as Akt/PKB, MTOR, cyclin D-CDK4 
and pRb, can also influence cell size (Cook & Tyers, 2007; Edgar, 2006). In Section 
1.3.3.1 , I explain in detail how TOR related proteins influence cellular growth and cell 
size. 
  
                                                   
 
1 A size that is required to be reached to proceed through one of the critical cell cycle transitions. 




1.2.4  Coordination of cell growth and cell division 
Cell size homeostasis in proliferating cells requires accurate coordination of cell division, 
such that on average each cell division is accompanied by a doubling of cell mass 
(Jorgensen & Tyers, 2004). In cells which are not undergoing mitotic cell division, such 
as neurons, the balance of general anabolic and catabolic reactions maintain cell size 
(Jorgensen & Tyers, 2004). To maintain cell size, cells must coordinate the processes of 
cell growth and the cell cycle, which depends on the model that the cells follow. If cells 
grow linearly then even with noise on the process, cell size will be maintained in a 
certain regime. Whereas if cells increase their size exponentially then larger cells can get 
larger in each cycle and small cells can get smaller in each cycle leading to a fitness loss 
(Conlon & Raff, 2003; Dolznig et al., 2004). Certain size control mechanisms are 
proposed to maintain the size of these cells in homeostasis by coupling cell cycle 
progression to reaching a critical size (see Section 1.3.2 ). These mechanisms are 
thought to be conserved and coupled processes for a long period, although studies in 
recent 20 years have proved they can be uncoupled under certain circumstances 
(Conlon et al., 2001; Lea, Orr, et al., 2003). For example in T-Cells our lab has 
identified a point, named “Commitment Point” that can uncouple the transition from 
G0 to G1 in T-Cells, thus regulate cell growth during a mitotic cycle (Lea, Orr, et al., 
2003). Our lab has described that cells need to get external signals such as CD3 and 
CD28 for 3-5 hours to commit themselves to the cell cycle (Lea, Orr, et al., 2003). If 
the signal stimulus is removed earlier, cells are going to return the G0 state, while if it 
removed later the cells going to progress in the cell cycle. This commitment point is 
dependent on the activation of CDK6/4 D Cyclin and can be inhibited by the cellular 
Cdk4/6-cyclin D inhibitor p16INK4A (see Section 3.1.2.4.3.1 ). 
 
Cell division is usually dependent on cell growth, but these processes may also be 
regulated independently (see Figure 1.2-1). Blocks to cell cycle progression do not 
necessarily prevent growth and can result in abnormally sized daughter cells (Neufeld 
& Edgart, 1998; Neufeld et al., 1998). Although direct interactions between the 
regulators of cell cycle and cell growth suggest that the two processes may be controlled 
by partially overlapping networks in metazoans (Cook & Tyers, 2007). Below I discuss 




examples of mechanisms that control cell cycle progression that are and are not 
evolutionarily conserved as well as mechanisms that regulate cell growth and to what 
extent these processes are coupled. 
 
 
Figure 1.2-1: The four possible relationships between cell division 
and cell growth. 
(A) Cell division drives growth. 
(B) Growth drives cell division. 
(C) Growth and cell division rates are controlled in parallel by a common upstream 
regulator. 
(D) Independent regulation of cell division and growth 
The figure is based on Neufeld et al. (1998). 
  




1.3  Connection between cell size and 
the cell cycle 
Different cell size regulation processes may exist in organisms in the phylogenetic tree 
separated by millions of years of evolution. Also, organisms such as yeasts and mammals 
share cell cycle regulatory machinery at the molecular level (Cook & Tyers, 2007; 
Rupes, 2002). However, there are differences in protein families regulating such 
processes, such as the cyclin-dependent kinases (CDK) (Malumbres & Barbacid, 2009; 
Risal et al., 2016), as described below. 
1.3.1  Molecular regulators of cell size in yeasts 
Two well-studied species, the budding yeast and the fission yeast, provide good genetic 
models in which to study cell-cycle and cell size control (Jorgensen et al., 2007; Rupes, 
2002). These organisms are considered to grow exponentially, thus they require an 
active size control mechanism to maintain their size in a homeostatic regime. The 
central regulation of cell size consists of two different molecular processes. Each 
organism has a control point in G1/S and G2/M cell cycle phases, but the importance of 
these points are different (Rupes, 2002; Turner et al., 2012). 
 
In fission yeast, the key regulator of cell size occurs in G2/M (Jorgensen et al., 2007; 
Marshall et al., 2012; Rupes, 2002). Here the key role is played by Cdc2 (encoded by 
the Cell Division Cycle gene CDC2), (Moreno et al., 1989; Simanis & Nurse, 1986), 
which regulates progression through the cell cycle. Cdc2 is inhibited by Wee1 (Russell 
& Nurse, 1987), which is inhibited by the complex of Cdr1/Cdr2 proteins (Martin & 
Berthelot-Grosjean, 2009; Moseley et al., 2009). A key regulator of cell size is Pom1, 
which is slowly released from the tips of the rod-shaped fission yeast cells. As the cell 
grows and elongates the relative concentration of Pom1 decreases in the cell, especially 
near the nucleus. Thus, it cannot inhibit Cdr1 anymore, which inactivates Wee1 leading 
to Cdc2 T14/Y15 dephosphorylation and Cdc2 activation of, inducing mitosis (see 
Figure 1.3-1). 





Figure 1.3-1: Cell size control in Fission yeast and Pom1 gradient 
model. 
Details of Cdc2 regulation by Pom1 are described in the text. 
The figure is reproduced from Marshall et al. (2012). 
In budding yeast, the important checkpoint is at the G1/S transition. A G1 cyclin protein 
called Cln3 regulates “Start” (Marshall et al., 2012; Rupes, 2002; Turner et al., 2012) 
by inhibiting Whi5 and thereby allowing transcription of genes required for cell cycle 
progression (de Bruin et al., 2004). The rate of protein synthesis affects the level of Cln3 
because of its high turnover rate, thereby coordinating cell growth with progression 
through the cell cycle (Marshall et al., 2012; Rupes, 2002). 
 
It seems that there is a different primary regulation in distinct yeast species. However, 
there exist common regulators that affect the regulation of cell size. A good example is 
Sch9 protein from budding yeast; it is an S6 kinase, that is activated by the 
phosphorylation of TORC1 complex, while in response it inhibits Rim15, a protein that 
controls the entry into the G0 (Pedruzzi et al., 2003). Sch9 has three different orthologs 
in fission yeast: Sck1, Sck2 and Psk1 (Nakashima et al., 2010), and recently it has been 
described one of them, Sck2 affects greatwall-endosulfine Prpk18 (Chica et al., 2016). 




1.3.2  Different concepts of cell size control 
In proliferating cells the cell size is determined by a balance between cell growth and 
cell division (Tzur et al., 2009). 
There are three models in the literature that employ different mechanisms: 
 
• Sizer model: In this case a cell actively monitors its size, then if it reaches a 
certain size (threshold size), it will divide (Facchetti et al., 2017). One widely 
known example for this concept is the Whi5-Start mechanism in budding yeast 
(Facchetti et al., 2017; Turner et al., 2012). 
 
• Timer model: In the timer model, cells are in the growth phase for a certain 
amount of time, after which they enter the cell cycle. In fission yeast the amount 
of time spent in the G2 phase is according to this timer model (Sveiczer et al., 
1996). 
 
• Adder model: The newest concept incorporates the assumption that cells add a 
constant amount of cell mass to increase size that is unrelated to the time spent 
in the cell cycle or the size of the new-born cell. A good example of this concept 
is E. coli bacteria homeostasis (Taheri-Araghi et al., 2014). 
  




1.3.3  Cell size regulatory pathways and molecules 
Numerous pathways have been described that regulate cell size. Here I give a short 
overview of three selected examples: two fundamental, cell size related pathways and 
an independent cell size regulator. As I have shown above a common example for the 
fission yeast and budding yeast from the TOR pathway, I start with TOR pathway. 
1.3.3.1  TOR pathway 
In 1991, two proteins were identified in budding yeast as they can be blocked by a 
macrolide, called rapamycin that causes immunosuppression in humans. These proteins 
were named Target of Rapamycin: TOR1 and TOR2 (Heitman et al., 1991). Later it 
was shown that these TOR proteins are involved in growth control (Kunz et al., 1993). 
Studies in yeasts have identified that these proteins form two distinct protein complexes 
(TORC1 and TORC2) (see Figure 1.3-2) and fulfil crucial roles in connecting 
metabolism with cell size regulation (Martin et al., 2004; Wullschleger et al., 2006). It 
is now known that TORs are evolutionally conserved serine/threonine kinases that are 
controlled by environmental conditions. TORs are in a signalling network and 
phosphorylate several proteins (see Figure 1.3-3) (Gonzalez & Rallis, 2017). 
 
Figure 1.3-2: TORC1 and TORC2 complexes in budding yeast. 
Diverese effects of TORC1 and TORC2 in buddying yeast. 
The figure is reproduced from Wullschleger et al. (2006). 





TORCs have various signal inputs from stress to nutrient availability and regulate 
multiple processes (Wullschleger et al., 2006). The first complex, TORC1 is responsible 
for promoting ribosome biogenesis, protein anabolism and cell proliferation, while the 
second complex TORC2 has antagonistic effects (Averous & Proud, 2006). The rate of 
ribosome biogenesis is managed by nutrient conditions and transmitted by the TOR 
pathway also via Sch9 proteins (Jorgensen & Tyers, 2004). TOR pathway has also been 
identified in mammalian species (named mTOR) (Brown et al., 1994). In mammals, 
only one mTOR protein exists compared with two protein in yeasts (Hay & Sonenberg, 
2004; Wullschleger et al., 2006). For a comparison between processes in metazoans and 
yeast see Figure 1.3-3. 
 
 
Figure 1.3-3 Representation of the major pathways regulating 
growth and division at the G1 to S phase transition in budding yeast 
and Drosophila melanogaster S2 cells. 
(A) In budding yeast, the G1/S transition and the crucial role of TOR. 
(B) G1/S transition in metazoans, similar mechanisms exist as for budding yeast, as 
described in the text.  
The figure is reproduced from Cook & Tyers, 2007. 
 




1.3.3.2  Hippo pathway 
The Hippo pathway was discovered in studies on Drosophila Melanogaster. 
Subsequently, it was shown to be a highly conserved pathway responsible for organ size 
and tissue homeostasis (Yu et al., 2015). The Hippo pathway regulates cell proliferation 
and apoptosis (Yu et al., 2015). The mechanism involves Hippo pathway members 
inhibiting YAP/TAZ to facilitate gene transcription (Figure 1.3-4). Transcription is 
regulated in part by phosphorylation of the transcriptional regulator yes-associated 
protein (YAP) (Huang et al., 2005), YAP is under the direct control of LATS1/2 (Zhao 
et al., 2010). YAP controls transcription of CCNE, which encodes the cell cycle 
regulator Cyclin E and the gene encoding the cell death inhibitor DIAP1 (Huang et al., 
2005; Nolo et al., 2006; Tapon et al., 2002; Thompson & Cohen, 2006). In 
mammalians, CTGF (connective tissue growth factor) pathway is a usual marker of the 
YAP activation (Zhao et al., 2008). Members of the Hippo pathway are directly 
affected by the modifications of the actin cytoskeleton, for e.g. by the overexpression of 
Rho GTPases (Dupont et al., 2011). Loss of function mutations in Drosophila such as 
Capulet gene directly leads to tissue overgrowth (Sansores-Garcia et al., 2011). 
 
The best-known function of Hippo pathway is to regulate tissue and organ homeostasis. 
It has been shown in Drosophila if Hippo pathway regulators such as Kibra, Mer and Ex 
or Hippo pathway kinases such as Wts and Hpo are upregulated, this leads to an 
enlargement of organs and overgrowth of wings and eyes (Halder & Johnson, 2011; 
Pan, 2010; Yu et al., 2015). Hippo pathway members affect the apico-basal polarity of 
cells, that regulates cell growth (Genevet & Tapon, 2011). Mutations of the members 
of the Hippo pathway can lead tumour development and cell transformation in mouse 
liver (Dong et al., 2007). It seems that Hippo pathway plays a fundamental role in organ 
size control in model organisms, while members of the pathway play crucial roles in the 
development tumours (Harvey et al., 2013). 
  





Figure 1.3-4: Inhibition of YAP/TAZ Transcriptional Coactivators 
by LATS1/2 
(Left) In this case, the Hippo pathway is off. The key molecule is YAP/TAZ, which 
enters the nucleus, then competes with VGLL4 for TEADs, and recruits other 
factors to facilitate gene transcription. (Right) In this case, the Hippo pathway is on. 
The YAP/TAZ complex is phosphorylated by LATS1/2 on multiple sites, resulting 
in interaction with 14-3-3 and cytoplasmic retention; phosphorylation also leads to 
YAP/TAZ poly-ubiquitination and degradation. VGLL4 interacts with TEADs 
and represses target gene transcription. 
The figure is reproduced from Yu et al. (2015). 
  




1.3.3.3  Largen protein  
In 2014 Yamamoto et al. found in human cells that the product of the PRR16 gene is 
Largen, which is a protein that regulates cell size in in vitro experiments (Yamamoto et 
al., 2014). Largen reportedly initiates the translation of specific sub-sets of mRNAs, that 
encode mitochondrial related protein functions (see Figure 1.3-5) (Yamamoto et al., 
2014). PRR16-/- transgenic mice have increased cell size and accelerated mRNA 
translation and mitochondrial function (Yamamoto et al., 2014). The Largen protein is 
an example of the fact that there are independent cell size regulators from main signalling 
size and organ control pathways (Yamamoto & Mak, 2017). 
 
Figure 1.3-5: A proposed model for the cell size control by Largen 
Mitochondria produce ATP, which is used for many cellular processes, such as 
mRNA translation. When Largen is overexpressed, cells will have more 
mitochondria and more mitochondria lead to the production of more Largen in a 
positive feedback loop. 
The figure is reproduced from Yamamoto & Mak (2017). 




1.3.3.4  Cell size regulation in my thesis 
In this chapter I have reviewed evidences that the regulation of cell size is a highly 
complex process, which involves many control molecules (Lloyd, 2013). Some proteins 
actively regulate cell size, such as MAPK dependent protein p38 (Liu et al., 2018) or 
TOR pathway member proteins (Gonzalez & Rallis, 2017). Other proteins have to be 
present for cells to increase in size and the effects of a knock-out or knock-down on cell 
size are due to secondary effects of other processes such as cell proliferation or the 
production of mitochondria (Meziane et al., 2011). 
 
In my thesis, I’m will investigate cell size regulation as a process, where a loss of the 
function of an individual protein can alter the overall size. Some of these mutants might 
be associated with perturbations in growth (e.g. defects in ribosomal proteins), while 
others might be true regulators of cell size. This second group is the main target of my 
investigations. I am aware that in multicellular organisms, tissue and body level 
compensation can affect cell size, thus I will perform cellular level analyses of cells in 
tissues of the plant Arabidopsis thaliana and individual cells in culture, using T cells 
isolated from human peripheral blood. 
  




1.4  Orthology in Biology 
The evolution of life on Earth started about 3.5 billion years ago based on the fossil 
record (Schopf et al., 2002). Some genes that occur in different species are highly 
conserved throughout the phylogenetic tree, while others are transient or specific to 
particular species (Fang et al., 2010). Each organism has a set of genes that lead to 
phenotype. These traits may be the same in different organisms, while some can be 
extremely different. For example, the CDK1 gene, which encodes Cdc2/Cdk1 is an 
evolutionarily conserved gene that regulates mitosis from yeast to humans (Malumbres 
& Barbacid, 2009). By contrast, the IFT proteins are components of cilia motor proteins 
that regulate motility of lower organisms, but these evolutionarily conserved proteins 
regulate T-cell receptor internalisation and vesicular trafficking in human T-
lymphocytes (Finetti et al., 2009; Onnis et al., 2016). A 2010 study named the 
genotype-phenotype association of gene homologues in different species "phenologs" – 
named as phenotypes related by the orthology of the associated genes in two different 
organisms (McGary et al., 2010). A particular gene deletion or duplication observed in 
various organisms was not evolutionarily conserved by accident. Instead there is a 
specific reason driven by the associated phenotype that has a selection benefit (Fang et 
al., 2010; Fitch, 2000). Gene duplication events are also key accelerators of novel 
functional gain (Magadum et al., 2013). However, new gene duplication is more likely 
to end as a pseudogene then a gene with a novel function, unless there is a positive 
selection pressure (Walsh, 1995). 
  




1.4.1  Conserved Genes 
Gene duplication and loss of function all generate genetic diversity and are processes 
that are under selection pressure. Evolutionary pressure on alternative splicing can 
create “hotspots” within a protein sequence, that are evidently selected for a specific 
function (Xing & Lee, 2005). A study by Pagani et al. (Pagani et al., 2005) showed that 
introduction of synonymous substitutions into exon 12 of CFTR led to exon skipping 
and an inactive protein for approximately one third of the substitutions tested, which 
has been proposed to be an RNA-level selection pressure (Xing & Lee, 2005). On the 
other hand, some genes are highly conserved in many organisms, which means they 
have kept the same genetic function and sequence similarity in different species. 
Examples are 18S and 28S ribosomal RNAs and the protein binding domains of ABC 
transporters (Isenbarger et al., 2008). Experimental studies showed that the primary 
sequences of 16S ribosomal RNA in prokaryotes and 12S ribosomal RNA in the 
mitochondria of eukaryotes are highly conserved (Zwieb et al., 1981). Moreover, the 
eukaryotic 18S rRNA shows only 0.1% sequence divergence between human and 
mouse (Gonzalez & Schmickel, 1986). These rRNAs are involved in a key and essential 
function of cells, i.e. translation that needs to be maintained for cells to survive and out-
compete others in the population (Isenbarger et al., 2008). There is a consensus in the 
literature that the conserved genes usually have high sequence similarity (>90%) and 
few duplication events, although detailed sequence analysis shows smaller sequence 
similarity, and higher sequence variability for some genes (Martinez-Porchas et al., 
2017). In many cases, genes encoding proteins are transient or very specific to some 
functions in some species in which deletion, neofunctionalization and/or non-
orthologous gene displacement (Koonin et al., 1996) could end up having novel 
functions (Fang et al., 2010). 
  




1.4.2  Terms used in Orthology 
The high functional similarity of proteins in different species or homologous functional 
and sequence relationships in the same species can be categorised into two classes 
(Figure 1.4-1): 
 
(1) Orthologs: are homologous genes in different species that evolved from a common 
ancestral gene by speciation (radiation). Some orthologs retain the same function 
during the course of evolution (Fang et al., 2010). Walter Fitch first described 
the term Ortholog in 1970 (Fitch, 1970). 
 
(2) Paralogs are homologous genes related by duplication within a genome and 
usually evolve new functions (Cotton, 2005). The latter definition can be 
divided into two subcategories, depending on the timeline of the speciation 
event (Heidelberg et al., 2002):  
 
a. outparalogs, if the duplication happened before speciation  
b. inparalogs, if the duplication event occurred after speciation. 





Figure 1.4-1: Orthologs and paralogs 
Orthologs are homologous genes that were created from an ancestral gene with a 
speciation event, while paralogs are homologous genes that were created with a 
duplication event. Gene A & Gene B are paralogs of each other because they were 
created by a duplication event. Gene A1 & Gene B1, as well as Gene A2 & Gene 
B2, are the same relation, while Gene A1 & Gene A2 as well as Gene B1 & Gene 
B2 are orthologs of each other.  
The figure is based on Jensen (2001). 
  




1.4.3  Orthology Databases 
Several published orthology databases exist, which are specialised at least into four 
different aspects (Jensen et al., 2008): 
 
(1) the first type cluster pairs of genes with the same biological functions (Jensen et 
al., 2008; O’Brien et al., 2005). These databases use a Bi-directional Best Hit 
(BBH) strategy, which simply means that these are the reciprocally most similar 
pair of genes in two species. A notable example of this category is InParanoid 
(O’Brien et al., 2005; Ostlund et al., 2010).  
 
(2) The second type is clustering with more species using the best hit method. The 
best example of this is type is orthoMCL database (Li et al., 2003).  
 
(3) The third type uses a clustering method of three different genomes, called 
clustered triangles of mutually consistent, genome-specific best hit genes e.g. the 
COG/KOG database (Tatusov et al., 1997). 
 
(4) While finally, the fourth type uses phylogenetic trees to identify functional 
divergence events, notably TreeFam (Li et al., 2006; Thomas et al., 2003; van 
der Heijden et al., 2007). Only one of these contain functionally annotated 
groups of genes, namely the COG/KOG database (Tatusov et al., 1997). 
 
These database concepts employ different mechanisms to identify the best possible 
orthologs in different organism. In my thesis, I investigated several orthology 
databases, then finally I used the eggNOG database (Huerta-Cepas et al., 2018; 
Jensen et al., 2008; Muller et al., 2010; Powell et al., 2012, 2014) to connect genes 
and proteins throughout the phylogenetic tree to address my overarching aim of 
identifying novel cell size regulators. 
  




1.4.4  Using Orthology Databases 
In my thesis I use several Orthology databases. Specific databases identify orthology 
either by genomic similarities or by functional similarities of proteins in different 
organisms.  
 
As of March 2018, according to the research curation website Quest for Orthologs 
(  there are more than 30 
published ortholog databases which are publicly available. During my research I tested 
most of them, but in the early phases of my PhD I used the five databases which contain 
the seven species of interest described in Chapter 2. The five databases are: 
 
(1) KOG/COG ( ) (Tatusov et al., 1997). 
Published in 1997 as the first database to use clusters of orthologs (COG) 
approach, based on their functional similarity. This database has a major 
advantage of introducing a novel "COG" concept, however it has not been 
updated since 2003 (Tatusov et al., 2003). 
 
(2) eggNOG ( ) (Huerta-Cepas et al., 2016; Jensen et al., 
2008), which uses a similar approach to find functional novel COG/KOG 
groups. eggNOG contains several subsets of orthologue relations between 
realms of the phylogenetic tree, which are collected in functional orthologue 
groups. I selected this database to use for the analyses described in my Thesis 
for the reasons described in Chapter 2.2.4.1 . 
 
(3) HomoloGene ( ) (Coordinators, 
2014). An NCBI based project that aims to find homologous proteins based on 
their sequence similarity. Closely related proteins are first matched, then they 
are placed on a phylogenetic tree that is expanded with other proteins, based 
on their genetic distance. The major disadvantage is of HomoloGene is that it 
focuses on genetic similarity rather than functional orthology. 
 




(4) inParanoid ( ) (O’Brien et al., 2005; Ostlund et 
al., 2010). An algorithm Is used to make a pairwise comparison of genes in two 
species and then creates orthologue groups. This database contains groups of 
orthologous genes, called paralogs that were created by a speciation event. This 
database is recommended if the aim is to identify pairwise orthologs. However, 
it Is not able to identify groups of ortholog. I used it in the early phase of my 
research but chose to use the eggNOG database instead (see (2) above). 
 
(5) orthoMCL ( ) (Li et al., 2003). This database 
clusters and groups orthologically related proteins by an all-against-all BLAST 
method and is based on sequence similarity. Unlike inParanoid, orthologous 
groups in this database are not limited to a pairwise comparison of two species. 
OrthoMCL has for the advantage of Identifying groups of orthologs, however 
it does not predict functional orthologs. 
 
1.4.4.1  Selected Orthology Database 
As my concept for orthological analysis was to find functional orthologs in other 
organisms that regulate cell size I decided to use a database that provides the best 
functional ortholog proteins in other organisms. The cell size attribute is a quantitative 
trait and if one protein in an ortholog group is identified as having a role in regulating 
cell size, the same attribute may also hold for other members of this ortholog group. 
After careful analyses of other databases, I decided to use eggNOG. This database is 
regularly updated and contains good quality and grouped results. Moreover, it provides 
scripts that makes it easier to handle the data. 
  




1.4.4.2  eggNOG database 
The eggNOG database (abbreviation of the evolutionary genealogy of genes: Non-
supervised Orthologous Groups) contains orthologous groups that were created by 
extending the COG algorithm with a graph-based unsupervised clustering method to 
create a genome-wide overview of orthology (Jensen et al., 2008). These clusters were 
derived by identifying common markers for the genes based on their textual 
descriptions, and annotated functional categories (Jensen et al., 2008). To create 
orthologue groups, sequences were extracted by Smith-Waterman alignments (Smith 
& Waterman, 1981), which identified the best reciprocal matches in all-against-all 
pairwise comparison. This alignment comparison data was provided by the SIMAP 
project (Kuhn et al., 2014; Powell et al., 2012). Taxonomy levels were predefined. The 
eggNOG algorithm took the basis of Clusters of Orthologous Groups (COG) in three 
realms of the phylogenetic tree: COGs (for Bacteria) (Galperin et al., 2015), KOGs (for 
Eukaryotes) (Tatusov et al., 2003), and arKOGs (for Archea) (Makarova et al., 2015). 
Every updated orthology group is benchmarked and compared with similar approaches 
in the past, such as OrthoBench (Trachana et al., 2011, 2014). Annotations were 
hierarchically consistent in nested groups. Functional annotations were made via 
KEGG pathways (Kanehisa et al., 2014), SMART/Pfam protein domains (Finn et al., 
2014, 2016), Gene Ontology (Ashburner et al., 2000; Gene Ontology Consortium, 
2015) and COG functional categories (Tatusov et al., 2003). Finally, the eggNOG 
database contained hierarchically consistent, functionally relevant orthologue groups 
for 2031 eukaryotic and prokaryotic organism (as of eggNOG latest version 4.5, 2016) 
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2.1  Introduction 
As I have described in the introduction, the regulation of cell size is a fundamental but 
barely understood attribute of biological cells (Cook & Tyers, 2007). While a researcher 
can clearly see that certain types of cells are likely to maintain the same cellular 
dimensions, it is critical to understand how cells regulate their size. Some genes are 
conserved throughout the phylogenetic tree spanning millions of years of evolution 
(Fujiwara et al., 2002). In some cases, genes are maintained during the separation of 
ancestor species to different daughter species such as in the case of S. cerevisiae and S. 
pombe, that happened 350 million years ago (Hoffman et al., 2015). For plants and 
animals, this happened much earlier, about a billion years ago (Knoll, 1992; Sipiczki, 
1995). However, it can be seen that some gene sequences are more similar in S. pombe 
and H. sapiens than in S. pombe and S. cerevisiae, from phylogenetic trees based on rRNA 
(Sipiczki, 2000). In addition, common pathways such as the TOR pathway are 
conserved and affect the size of the cells in distant organisms in a similar way (Edgar, 
2006). This is also supported by the notion that Protein-Protein Interactions (PPIs) 
between proteins belonging to a common protein complex are more conserved than 
PPIs between proteins from different complexes (Beltrao et al., 2012). 
2.1.1  Aims of my Bioinformatics studies 
In this chapter, therefore I address the question whether there are evolutionarily 
conserved genes encoding proteins which affect cell size. I use information about seven 
different species, some separated by a billion years of evolution as well those separated 
by just a few hundred million years. The species are Arabidopsis thaliana, Caenorhabditis 
elegans, Danio rerio, Drosophila melanogaster, Homo sapiens, Saccharomyces cerevisiae 
and Schizosaccharomyces pombe. I will explain the details of the data obtained from each 
organism below in this chapter. My aim is to identify which proteins hold conserved 
functions of cell size regulation. I will determine, whether by analysing conserved 
orthologous groups and dropping common growth regulators also affecting cell size I can 
propose potential cell size regulators in various organisms. 




2.1.2  Bioinformatics as a field of science 
Bioinformatics as a field can be described as “the application of computational tools to 
organize, analyze, understand, visualize and store information associated with biological 
macromolecules” (Diniz & Canduri, 2017; Luscombe et al., 2001; Pevsner, 2015). 
Another definition is “The science of collecting and analysing complex biological data such 
as genetic codes“ (Oxford Dictionary). Bioinformatics is a large and quickly expanding 
field of biology. Novel approaches, methods and databases are regularly published by 
bioinformatics researchers who can address existing biological questions from a novel 
viewpoint. 
 
2.1.2.1  Origins of Bioinformatics 
Origins of the bioinformatics field date back as far as the 1960s when DNA sequencing 
became feasible (Hagen, 2000). Large computers became common at universities in the 
USA and researchers started to use them to solve biological questions (Hagen, 2000). 
With the help of IBM’s first high-level programming language, called FORTRAN 
(formula translation), researchers were able to determine protein sequences with coded 
programs (Dayhoff & Ledley, 1962). The first major step in the direction of 
computerized data collection was made by Margaret O. Dayhoff, who published a book 
on collected protein data called Atlas of Protein Sequence and Structure first printed in 
1966 (Eck & Dayhoff, 1966). This book was cited more than 4500 times, while the 
collection of data evolved to a Protein Information Resource Database, which was the 
first online database that was publicly available (Hunt, 1983). Based on these data 
several researchers developed early program codes to analyse phylogenetic evolution 
based on cytochrome c trees (Dayhoff, 1969) and sequence searches (Doolittle, 1997). 
By the 1970s many of the techniques had developed improve the task of analysing 
proteins. Novel methods also emerged to study DNA nucleic acid sequences (Diniz & 
Canduri, 2017). 
  




2.1.2.2  Biological databases 
As biological research has evolved throughout the years, bioinformatics databases have 
appeared to store and organise large amounts of data. These databases can store, handle, 
search, share and sometimes analyse the data from a wider perspective than can be 
obtained from biological experiments on a single species. Databases can be categorized 
based on their specificity to organisms, level of molecular data, function and usage of 
source information. Specificity can be to a certain organism, a certain group of 
organisms or all organisms, while the level of molecular data can be at DNA, RNA or 
protein. The function of a given database could be just a simple collection of 
experimental data or it could provide a relation to existing data points by some 
functions, such as functional pathways or homology. As of January 2018 according to 
the journal Nucleic Acids Research there are 1,738 publicly available biological related 
databases (the list of databases can be found on 
) (Rigden & Fernández, 2018). 
 
2.1.2.2.1  Organism-specific databases 
Organism-specific databases can be found for all highly investigated model species in 
bioinformatics. For those species I focused on in my research, there was at least one 
species-specific database available. These databases usually summarize all the available 
experimental data and information for all genes and proteins inside the given species. 
(1) A. thaliana: TAIR database ( ) (Huala et al., 
2001) 
(2) C. elegans: WormBase ( ) (Van Auken et al., 2012) 
(3) D. rerio: ZFIN database ( ) (Bradford et al., 2011) 
(4) D. melanogaster: FlyBase database ( ) (St Pierre et al., 
2014) 
(5) H. sapiens: There are many specific databases. In my research, I investigated 
closely the MitoCheck / Cellular Phenotype Database 
( (Hutchins et al., 2010; 




Neumann et al., 2010), a database containing the genome-wide phenotypic 
profiling of each of the human protein-coding genes. 
(6) S. cerevisiae: Saccharomyces Genome Database 
( ) (Hirschman et al., 2006) 
(7) S. pombe: PomBase database ( ) (Wood et al., 2012) 
 
2.1.2.3  Predicting function using homology 
As I pointed out earlier in the Introduction (Section 1.4.1 ), genes can be conserved in 
many species and they can share high sequence and functional similarity (Isenbarger et 
al., 2008). The biological concept of finding common ancestors of genes has been with 
us for a long time, since the birth of bioinformatics (Pearson, 2013). Homologous 
proteins share similar molecular structures and frequently they share similar functions. 
The main issue is that sequence similarity is more predictable and countable, while 
functional similarity is less predictable. The most difficult part of the prediction is that 
one given protein can have multiple, sometimes different functions (Loewenstein et al., 
2009). 
 
Bioinformatic methods have evolved to find similar structures in different proteins 
(Pearson, 2013). Scripts have been written to find similar DNA or protein sequences in 
different organisms by pairwise or all-against-all strategies. Commonly used similarity 
search programs which search for sequence similarities of proteins include BLAST 
(Altschul et al., 1997), SSEARCH (Smith & Waterman, 1981), FASTA (Pearson & 
Lipman, 1988) and HMMER3 (Johnson et al., 2010). The main aim of these programs 
is to infer relationships between DNA sequences and to predict homologous protein 
pairs more accurately than if they were selected by chance (Pearson, 2013). The results 
obtained are mainly sequence and structural domain homologs. 
 
Methods have also evolved to find multiple sequence alignments in protein families such 
as CDD (Marchler-Bauer et al., 2007) or PROSITE (Hulo et al., 2008) or a different 
profile-hidden Markov model such as Pfam (Finn et al., 2008). As homologous proteins 




evolve, they form distinct 3D structures. Bioinformatic approaches have also arisen to 
find structure-based family signatures that classify their protein domains into families, 
such as CATH (Orengo et al., 1997) and SCOP (Murzin et al., 1995). The reasoning 
behind using these protein family models are that common domains in proteins may 
share the same function. However, predicting accurate functional orthologs is very 
complicated and it is mainly based on sequence or structural element predictions. I 
needed to use a protein functional ortholog resource and so I used the eggNOG database 
(Jensen et al., 2008), which contains functional ortholog protein groups from thousands 
of species, including the seven species of interest for my thesis.  




2.1.2.4  Gene Ontology (GO) 
Gene Ontology (GO) (Ashburner et al., 2000) database is a well-defined functional, 
bioinformatics database whose primary goal is to represent all genes and gene product 
by all related biological attribute in a structured way. The GO database can be reached 
either via APIs or via a web-based AmiGO2 tool ( ) 
(Carbon et al., 2009). GO is a part of Open Biomedical Ontologies (OBO), a research 
wide biomedical effort to collect controlled and checked vocabularies for distinct fields 
of biology and medicine. Gene Ontology started as a major bioinformatics initiative in 
2000 that addresses the following three main goals: 
 
(1) represent an up-to-date vocabulary for genes and gene products properties 
(2) annotate genes into broader and more-specific ontologies 
(3) provide a widely available, structured bioinformatics tool for gene annotation 
and annotation enrichment analysis for researchers 
2.1.2.4.1  GO terms 
Gene Ontology terms are subdivided into three ontology categories that represent three 
distinct areas of biology as below: 
(1) cellular component: ontology describes the location of the cellular component 
at the subcellular location and at the macromolecular complex level. This 
localization also includes multi-subunit enzymes and other protein complexes. 
 
(2) biological process: ontology cast a series of events or molecular functions into 
a specific biological process. The criterion for being a process: it must have a 
defined beginning and an end. Processes have hierarchical and parallel relation 
to each other. A given process can be for example a part of, a child of or a parent 
of another biological process annotation. 
 
(3) molecular function: ontology describes the distinct abilities that related to the 
annotated component. Terms can be linked to various specific activities that 
include transporting, binding, holding and transforming molecules. 





2.1.2.4.2  GO Annotations 
An annotation in the GO database always holds an “evidence code” that explains how 
that annotation came to light. Three types of evidence codes are used in GO to refer to 
the association of the term and the biological product (reviewed in 
(The Gene Ontology Consortium, 2017). I only used the first type in my experiments. 
(1) experimentally-supported annotations (EXP): These updates made by PhD-
level experts, who curate peer-reviewed scientific literature. To maintain the 
quality and consistency of the database curators met regularly and discussed 
further developments, as well as they do annotation consistency exercises. 
The Gene Ontology database can be updated from manually curated, 
experimental based sources, such as from microRNA database (Huntley et 
al., 2016) as well as from protein-protein interaction (PPI) databases such as 
IntAct (Meldal et al., 2015). 
(2) Phylogenetically-inferred annotations (IBA): There are specific phylogenetic 
approaches to expand annotations based on phylogenetic. Curators have 
developed software like PAINT (Phylogenetic Annotation Inference Tool) 
(Gaudet et al., 2011). The curators of the GO can model of gain and loss of 
function in genes at distinct branches in a given phylogenetic tree. Curators 
use this to infer novel annotation for gene families 
(The Gene Ontology Consortium, 2017). 
(3) Computationally-inferred annotations (IEA): These updates are made by 
software, and associated terms are not individually reviewed. There are three 
methods taking place to add computationally inferred annotations to the GO 
database: (1) comprehensive methods based on sequence homology, and 
group of homologous protein using InterPro2GO tool (Mitchell et al., 2015), 
a similar initiative to my approach; (2) Based on UniProt controlled 
vocabulary terms, that describes an enzymatic activity; (3) Then based on 
orthologs inferred from Ensembl gene trees, an automatic approach to 




transfer novel annotations based on one gene 1:1 orthologs in other species 
in the same taxonomic clade. 
2.1.2.4.3  Process of curation 
Gene Ontology Consortium (GOC) maintains and updates the database (Ashburner 
et al., 2000). Annotation of terms in the GO database can be either manually curated, 
based on published literature or computationally generated (Camon, 2004). Specific 
expansion of GO can be made via cross-discipline development projects that aim an 
expansion of a specific research field such as immune system, heart development, 
transcription and cell cycle (Dessimoz & Walker, 2017). GO can be updated by 
community contributors of the GO database. The majority of these contributors are 
specific research groups, who focuses on a given model organism, these are such as 
ZFIN (Bradford et al., 2011), PomBase (McDowall et al., 2015) and FlyBase 
(Tweedie et al., 2009), or on a broader view at the proteomic level like the UniProt 
database community (Huntley et al., 2015). Independent researchers can also update 
the GO by contacting the GOC and they forward the request to the appropriate 
research community. The current list of scientific communities that contributes to the 
GO database can be found on 
 
 
2.1.2.4.4  Quality control on the curation 
The GO community runs distinct quality controls to maintain the biological relevance 
and quality of the database (Poux & Gaudet, 2017). GO usually runs automated checks 
via GO annotation rulebase (
), that validates the relation between the biological content and syntactic 
in sources. In the other hand, GO consortium regularly ask researchers to independently 
annotate the same original paper to ensure the annotation is of high quality (Poux & 
Gaudet, 2017). As a third way, there are bioinformatics tools like the Reference 
Genome Project that provide a useful tool to improve annotations in line with GO 
(Gaudet et al., 2011). 
  




2.1.2.4.5  Statistics on GO database 
As of March 2018, GO contains 4,945,480 annotations (latest statistics retrieved from: 
). Most of these annotations are 
given based on similarity, not by direct experiments in each organism (Figure 2.1-1). 
Data on more and more tested organisms contain experimental evidence. Although 
annotations of less investigated organisms are mostly predicted and based on orthology. 
In the case of data on human cells, there are 294,776 non-experimental and 198,810 
experimental annotations. 
  
Annotation name Number 
similarity evidence 3,640,710 
experimental evidence 727,191 
curator inference 373,362 
author statement 149,552 
combinatorial evidence 53,578 
genomic context evidence 1,087 
Figure 2.1-1: Basic statistics of Gene Ontology 
The left chart describes the proportion of experimental and non-experimental GO 
annotation in distinct species. The chart on the right gives the evidence for these 






























































































































2.2  Materials and Methods 
2.2.1  Creating a comprehensive database of orthologous proteins 
Data on the following seven, evolutionarily distant eukaryotic species were obtained 
during this research: Arabidopsis thaliana, Caenorhabditis elegans, Danio rerio, 
Drosophila melanogaster, Homo sapiens, Saccharomyces cerevisiae and 
Schizosaccharomyces pombe. I was collecting the list of all proteins involved in cell size 
regulation in these species. 
2.2.2  Sources for existing cell size regulators 
2.2.2.1  S. cerevisiae 
I used the study by Jorgensen et al. (2002) (Jorgensen et al., 2002) as the source of 
known cell size regulator proteins in S. cerevisiae. In this study, the authors used the 
complete budding yeast knockout gene deletion collection of the 4,812 open reading 
frames (ORF) of individual genes and investigated their effects on cell size. Clusters for 
cell size distribution were established: 451 abnormally small (whi) or large (lge) mutants 
were found in 4 groups (haploid or diploid, large or small mutant). I added to this list 
the cell size regulators from the study by Moretto et al. (2013) (Moretto et al., 2013), 
which expanded the previous results by Jorgensen et al. (2002). 
2.2.2.2  S. pombe 
To collect S. pombe cell size regulator genes, an academic study performed by Hayles et 
al. (2013) was used (Hayles et al., 2013). This study focuses on creating a genome-wide 
gene deletion library of 4,843 fission yeast genes, while the authors investigated the 
effect of each deletion on cell shapes (see Table 2.2-1), I used only the size or shape 
specific attributed gene deletion candidates. I selected the terms that might represent 
changes in size based on a discussion with the first author of the original study. Plus I 
added extra 90 genes that has been described to affect cell size distribution (Graml et 
al., 2014). I will refer to these misshapen cells commonly as “size mutants” in my thesis. 




Table 2.2-1: Usage of gene attributes in S. pombe based on Hayles 
et al., 2013 
Shape form Usage in this analysis 
curved Used 
germination Not Used 
long branched Used 
long high penetrance Used 
long low penetrance Used 
misshapen essential Not Used 
misshapen viable Not Used 








2.2.2.3  H. sapiens 
To collect H. sapiens cell size related genes, the MitoCheck database 
( ) was used, which is based on the paper published in 2010 
(Neumann et al., 2010). The MitoCheck database contains the genome-wide 
phenotypic profiling of each of the human protein-coding genes in the human genome 
database. Each gene was uniquely targeted with a short interfering RNA (siRNA) 
library, and the effect on cell cycle progression was monitored by an assay using cells 
expressing a fluorescent core histone protein (Hutchins et al., 2010). Each of the cell 
lines was analysed by two-day live cell imaging of fluorescently labelled chromosomes, 
which were annotated according to 16 morphological classes (Neumann et al., 2010). 
 




MitoCheck contains information about cell size phenotypes and to build the database I 
used the “Large” phenotype class of the primary screen results from the MitoCheck 
database (small cell or small general classification were not categorized in MitoCheck 
primary screen phenotypes). 
 
2.2.2.4  D. melanogaster 
To collect D. melanogaster cell size related genes, a study published by Bjorklund et al. 
(2006) (Björklund et al., 2006) was used. These authors analysed the effect of the loss 
of function of 70% of Drosophila genes (including 90% of genes conserved in humans) 
(Björklund et al., 2006). Several properties were measured including the effect on cell 
size. I have focused on all of the genes whose loss of function affected cell size and 
merged this data with info from the Drosophila specific FlyBase database (St Pierre et 
al., 2014) on cell size defective phenotype. 
 
2.2.2.5  A. thaliana, C. elegans and D. rerio 
For three species, namely A. thaliana, C. elegans and D. rerio there are no reports 
describing genome-wide mutational analyses of cell size and growth. Therefore I used 
a biological process annotation term from Gene Ontology (GO) (Ashburner et al., 
2000), called GO:0008361 “regulation of cell size” to identify cell size regulators. 
 
This same term contained several genes I have found for other organisms, but the 
original data from those genome-wide screens included many more genes than I found 
by the same approach in the Gene Ontology database. 
  




2.2.3  Incorporation of protein-protein interaction (PPI) data 
Since conserved biological functions are mostly pathway dependent, I hypothesised 
that proteins that interact with multiple cell size regulator proteins in a given organism 
might also be involved in cell size regulation or their orthologs could play similar roles. 
Thus, I extended the database of cell size regulator proteins with neighbour proteins 
from protein-protein interaction (PPI) network. 
 
2.2.3.1  Sources for PPI network: BioGRID and IntAct 
For mapping my collected list of genes to a common UniProt identifier, UniProt.org 
Mapper tool was used (  (UniProt Consortium, 
2014) (conversations made in May 2014). In order to map general protein names the 
Ensembl Gene database, (Cunningham et al., 2014) version 77 was used via the 
BioMart tool ( ) (Kinsella et al., 2011). Each 
of the entries has only one unique UniProt identifier, while in some cases there are 
duplicates because of the concurrent appearance of the reviewed (SwissProt) and un-
reviewed (TrEMBL) identifiers. 
 
For PPI connections two PPI databases were used. First is the BioGRID database 
( ) (Stark et al., 2006), version 3.2.115 and second is the IntAct 
database ( ) (Orchard et al., 2014) version 4.1.4. Both of 
the databases contain only undirected protein-protein connections. Proteins from the 
BioGRID database proteins were mapped to UniProt IDs, while IntAct database 
primary keys already provide UniProt IDs. From BioGRID, only physical interactions 
were obtained, while from IntAct, all of the interactions were used. Finally, a database 
was established containing only those PPI connections which appear in both databases. 
  




2.2.3.2  Visualization of the network  
First neighbour proteins (FNPs) of cell size regulator proteins were added to the 
network, but only those proteins, which have at least two PPI connections (two degrees2 
connections) to known cell size control proteins (SCPs) (Figure 2.2-1). Five different 
networks were created based on the five-different species that I selected earlier (A. 
thaliana, D. melanogaster, H. sapiens, S. cerevisiae and S. pombe). 
 
Figure 2.2-1: First neighbour selection criterion. 
Protein 2, 3, 4 and 5 are proteins (nodes) encoded by known cell size control genes, 
while Protein 1 is a first neighbour protein if it is not a cell size regulator, but it has 
two protein-protein interaction (PPI) connections (edges) to cell size control 
proteins. Degree term describes how many other proteins are connected via PPI 
connection to a given protein. 
The Cytoscape network analyser program was used to visualise PPI networks and 
calculate the network statistics, (  (Shannon et al., 2003), 
used version 3.1.1). Data was subsequently exported to CSV files and ordered by 
Microsoft Excel and analysed by self-made PHP scripts (scripts are available upon 
request). 
                                                   
 
2 Degree: The degree of a node in a network means how many edges the node has. Here it means how 
many first neighbours a particular protein has in the network. 




2.2.4  Ortholog and pathway annotation databases  
2.2.4.1  Ortholog databases 
Ortholog and pathway annotation databases were used to curate ortholog relations. 
After an investigation of all resources (discussed above), three databases were selected: 
 
(1) eggNOG (Jensen et al., 2008; Powell et al., 2014) version 4.0 was used, 
(2) inParanoid (O’Brien et al., 2005; Ostlund et al., 2010) version 8.0 was used, 
(3) and a manually curated orthologous list by PomBase curators between S. pombe 
– S. cerevisiae and S. pombe – H. sapiens (retrieved from 
, in May 2014) (Wood et al., 2012) 
 
For a collection of orthologs COG (Clusters of Orthologous Groups for Eukaryotes) 
groups were used as eggNOG database provided it. I have also noted if an eggNOG 
suggested orthology relation is backed up by data from InParanoid database. 
 
2.2.4.2  Pathway databases 
Pathway enrichment from KEGG (Ogata et al., 1999) and REACTOME (Croft et al., 
2014) was added to each of the proteins in the developed database to be able to search 
for conserved pathways involved in cell size regulation. 
  




2.2.5  A database for conserved size control proteins: OrthologFinderTool 
Separate database files were created for a comprehensive database, using Microsoft 
Excel, PHP and R scripts (appropriate script files are available upon request). These 
back-end database files were put together to form a bioinformatics website. The website 
is based on Apache engine using PHP scripts in the back-end, while the front-end uses 
a JQuery JavaScript library and the table viewer is based on the DataTables JQuery 
table plugin ( ). 
 
The website can be easily handled via a form-based query page. The source code of the 
whole website can be retrieved from 
 GitHub address, where a readme document describes how to use the tool and the 
code. 
 
2.2.6  A database for conserved biological functions: GO Orthology Tool 
2.2.6.1  Gene Ontology source 
To generalise the orthology search tool I have replaces the data source of cell size 
regulators with data from the Gene Ontology Database (Ashburner et al., 2000). I used 
the generic GO_SLIM dataset, developed by the GO Consortium (retrieved from 
, on 10 November 2015) 
to reduce the number of GO terms that can describe all biological processes. This list 
contains 71 generic biological processes (for the whole list of terms see Supplementary 
Table 6.2-1). I used the proteins belonging to these 71 terms in seven species to find the 
conserved genes involved in each biological process to create a database for GO 
Ontology Tool. I created a comprehensive MySQL powered database, that includes a 
curated list of size control proteins (merged data of collected data explained earlier in 
Section 2.2.2 ), together with their eggNOG database and GO_SLIM database 
annotations. Data from seven organisms including data from different strains (A. 
thaliana, C. elegans, D. melanogaster, D. rerio, H. sapiens, S. cerevisiae and S. pombe) 
were used with the following taxon ids (Table 2.2-2). 




Table 2.2-2: Taxon ids used from Gene Ontology database 
Taxon ID Species Name 
3702 A. thaliana 
6239 C. elegans 
7227 D. melanogaster 
7955 D. rerio 
9606 H. sapiens 
4932 S. cerevisiae 
545124 S. cerevisiae 
559292 S. cerevisiae 
643680 S. cerevisiae 
721032 S. cerevisiae 
764097 S. cerevisiae 
4896 S. pombe 
 
2.2.6.2  Creating Venn Diagrams 
I drew Venn Diagrams and Edwards-Venn Diagrams based on samples with Adobe 
Illustrator software to visualise data that I put it in the cross-species database. Various 
Venn-Diagrams were produced, ranging from 2 sets to 7 sets (Figure 2.2-2) in SVG 
(Scalable Vector Graphics) format. I handled these diagrams with scripts (available 
upon request) to replace letters with relevant numbers.  
2.2.6.3  GO Orthology Tool 
The database was employed by PHP code on a website back-end, while the front-end 
was empowered by a JQuery JavaScript library and the table viewer is based on the 
DataTables JQuery table plugin ( ). The Tool handled the 
manually created Venn Diagrams to show multiple relations among species. 
 
The website can be easily handled via a form-based query page. The source code of the 
whole website can be retrieved from  
GitHub address, in parallel with a readme document. 
 





Figure 2.2-2: Venn Diagrams from 2 to 7 sets. 
These Venn Diagrams (VDs) were made by using Adobe Illustrator. Pictures were 
exported in SVG format to easily handle with algorithms. 2 set VD has 3 relations, 
3 set VD has 7 relations, 4 set VD has 15 relations, 5 set VD has 31 relations, 6 set 
VD has 63 relations, 7 set VD has 127 relations. 
 
  




2.3  Results 
2.3.1  The quest for cell size regulators – building a database 
I hypothesized that it is possible to uncover the conserved regulatory pathways and find 
novel regulators of cell size through a comprehensive overview of the known cell size 
mutants of 5 evolutionally distant species. To reach a broad and comprehensive 
overview, I created a web-based database of cell size regulators using sources as 
described in Section 2.2.2 . Using this database, the tool can predict novel affectors of 
the cell size and identify the universal core regulators of cell size. 
 
2.3.1.1  Creating a database of orthologous proteins 
2.3.1.1.1  S. cerevisiae 
To obtain budding yeast genes that are involved in the regulation of cell size, data on 
451 mutants were obtained from Jorgensen et al. (Jorgensen et al., 2002). A name and 
Saccharomyces cerevisiae Genome Database (SGD) identifier correction were performed 
using the Yeast Genome Database, which reduced the list to 445 genes. From the 
Moretto et al. study (Moretto et al., 2013), 44 new genes were added as mutations 
caused significant size differences. Among these 44 new cell size regulators 30 were 
ribosomal proteins. 
 
Overall in budding yeast 489 genes were collected with unique SGD identifiers. These 
genes were mapped to 490 unique UniProt protein identifiers (UID). From their PPI 
network, 1,072 first neighbour proteins (FNP) were added. In total, a PPI network with 
1,562 size control proteins and 5,514 connections was created (see Figure 2.3-1). 





Figure 2.3-1: Two PPI networks of S. cerevisiae 
(A) The PPI network of Size Control Proteins (SCPs) in S. cerevisiae (B) The PPI 
network of SCPs and First Neighbour Proteins (FNPs) in S. cerevisiae. Red nodes 
are SCPs, while blue nodes are FNPs. Single nodes are not displayed. Network 
visualisation was created by Cytoscape version 3.1.1. 
2.3.1.1.2  S. pombe 
To obtain a list of cell size regulators in fission yeast, 871 genes were identified from the 
Hayles et al. study (Hayles et al., 2013), while 90 new genes came from the list of 
proteins affecting cell size distribution from (Graml et al., 2014). These were merged 
into 909 genes with unique PomBase Systematic Identifiers (ORF) and then mapped to 
932 unique UIDs. From their PPI network, 74 new FNPs were added. In total the 
network of Schizosaccharomyces pombe contained 1,006 proteins with 505 connections. 
The lower number of connections is a result of the lack of systematic protein interaction 
studies on fission yeast. 
2.3.1.1.3  H. sapiens 
To obtain the list of human genes involved in controlling cell size, a query was 
performed using the MitoCheck primary screen data (Hutchins et al., 2010) for the 
‘large’ search term. This query identified 316 genes with unique Ensembl gene (ENSG) 
identifiers. These genes were mapped to 1,051 unique UIDs. From their PPI network, 
157 new FNPs were added. In total the network of human cell size related proteins 
contained 1,208 proteins with 431 connections. Unfortunately, there was no data on 
small cells, so in this case I focused only on mutants with larger cell size. 




2.3.1.1.4  D. melanogaster 
To obtain the list of Drosophila genes which control cell size, 385 genes were retrieved 
from the Björklund et al. study (Björklund et al., 2006) with unique FlyBase genome 
(FBgn) identifiers. These genes were mapped to UIDs. 
 
Also, the FlyBase database (St Pierre et al., 2014) was queried for the following terms:  
• ‘size defective’,  
• ‘increased cell size’,  
• ‘decreased cell size’ and  
• ‘body size defective’. 
These queries contained 1,574 unique UIDs in the results. Then results were merged 
with the Bjorklund study into 2,193 unique UIDs. From their PPI network, 860 new 
FNPs were added. 
 
In total the network of Drosophila cell size related proteins contained 3,053 proteins 
with 3,376 connections. 
 
2.3.1.1.5  A. thaliana 
There were no published genome-wide studies on gene mutants affecting cell size for A. 
thaliana. Therefore the Gene Ontology (GO) database (Ashburner et al., 2000) was 
used to query loss-of-function defective mutants. The GO database was queried for the 
GO term GO:0008361 ‘regulation of cell size’. 
 
As a result of the query 57 genes were obtained. From these 55 have unique The 
Arabidopsis Information Resource (TAIR) identifiers (Huala et al., 2001). TAIR 
identifiers were mapped to 68 unique UIDs. From their PPI network, only one FNP 
was added. In total the network of Arabidopsis cell size related proteins contained 69 
proteins with 4 connections. 
 




2.3.1.2  PPI network, orthologous and pathway annotation databases for 
cell regulators database 
In each of the organisms, two PPI networks were created: one restricted to known cell 
regulators and one expanded network with added FNPs. In total 10 PPI networks were 
created, then all data were exported to separate spreadsheets and merged into one 
database file per organism. To obtain orthologous proteins of these species, three 
different orthologous sources were integrated, and the biological pathway annotation 
was applied. 
 
2.3.1.3  Comprehensive Database - Ortholog Finder Tool 
I created a website for the database with a user-friendly front-end (Figure 2.3-2). The 
result of a query appears straightaway after every single query from the database file 
sources (Figure 2.3-3). The tool can be reached at the 
 web address. (Note: in Figure 2.3-3, data for 
Table 2.3-1, row B). 
 
Each results page can be downloaded as a CSV (comma separated value) file for further 
analysis.  
  





Figure 2.3-2: Ortholog Finder Tool: Front-end of the query page 
Users can select from one option for the Dataset and Function as shown, while there 
are five species available.  
 
Figure 2.3-3: Ortholog Finder Tool: Front-end of the results page 
Here I show the query/result page of a query taken on the S. cerevisiae database and 
then filtered to “tctp” term. TCTP in Drosophila is an ortholog of the TMA19 
budding yeast protein (Rinnerthaler et al., 2006) and TPT1/TCTP in human. The 
appearance of proteins in other SCP lists is always marked by a yellow background 
text. I also provide pathway enrichment from KEGG for each protein. However, in 
this given example none of the proteins had one. 




2.3.2  Selecting genes for experiments 
As one of my main aims was to find novel cell size regulators in Arabidopsis and human, 
I began by analysing the database with the idea to find proteins that are conserved in 
these organisms and also in the investigated two yeasts and in Drosophila. I was 
specifically looking for cases when the yeast and Drosophila orthologs were already 
associated with cell size regulation, but this was not shown in human and Arabidopsis. 
The resulting lists were exported from the database then systematically analysed. 
 
1. Initially, I reduced query results to those proteins, which have at least one 
orthologous protein in one of the other organisms (Table 2.3-1, row A) (e.g. a 
budding yeast protein has a fission yeast ortholog).  
2. Then to those proteins which have an ortholog in all five organisms (Table 2.3-1, 
row B). 
3. Subsequently, I reduced these lists to only include those proteins which have a 
pathway annotation (Table 2.3-1, row C) 













Size-control proteins (SCPs) 68 2193 1051 490 932 
First neighbour proteins 
(FNPs) of SCPs 
1 860 157 1072 74 
SCPs + FNPs 69 3053 1208 1562 1006 
(A) Proteins that have at least 
one orthologous protein 
24 2207 356 1398 923 
(B) Proteins that have at least 
one orthologous protein in all 
other species 
13 567 139 821 512 
(C) Proteins that have at least 
one orthologous protein in all 
5 328 76 479 294 
                                                   
 
3 Arabidopsis numbers are significantly lower because of the significantly lower amount of source data. 




other species and has 
pathway annotation 
4. Then, I merged the five lists of databases into one grand database, which I started 
to reduce further. I began to select those orthologous groups, where there was 
more than one evidence of cell size regulation. It means that out of S. cerevisiae, 
S. pombe and D. melanogaster at least two of them are either reported SCP, or 
one reported and one of them is an FNP of at least two reported SCPs. 
5. Later, ribosomal proteins were removed since perturbations of ribosomes could 
lead to changes in the rate of translation, the cellular growth rate and therefore 
cell size (Jorgensen & Tyers, 2004; Jorgensen et al., 2002). Still, they are not 
directly involved in the regulation of cell size and cell volume. These were 
removed from my analysis since they could have an indirect and common role 
in cell size regulation and their sheer number could bias subsequent analyses. 
Probably other groups of proteins could have been removed for the same 
reasoning, but no other group had such a distinct role in growth regulation. 
6. From this list, I removed protein groups that have been shown to control cell size 
in human and Arabidopsis. However, I used some of them as a positive control 
(such as PFD6). After this point the list contained proteins that were not known 
to be involved in cell size regulation either in human or Arabidopsis. 
7. Later, I developed a method to check the number of articles mentioning the 
candidate proteins and cell size. I named it “PubMed score”. It means that if 
someone puts a query into  with the name 
of the protein and species it will report the same number of academic papers as 
the “PubMed score”. Accordingly, I have removed those proteins which had a 
PubMed score of 6 or more to focus on less investigated candidate proteins. 
8. As a result, I selected about 40 proteins that I further investigated by manual 
checking. Following these checks, I created a list in which only those 
orthologous groups were considered where only one protein is present in each 
organism. 
9. The final list contained 17 proteins (Table 2.3-2) and from this list I chose 5 
proteins. I have chosen these candidates because they are known to regulate cell 




size in at least one organism and there is no information on their roles in 
controlling cell size in human and Arabidopsis. 
Table 2.3-2: Table of one-to-one ortholog proteins investigated 
The column marked "X" means the orthologous group was selected for the 
experimental test.  
 
Selected A. thaliana D. melanogaster H. sapiens S. cerevisiae S. pombe 
  ARP6  Arp6  ACTR6  ARP6  arp6  
X At1g12470  dor  VPS18  PEP3  pep3  
  At1g31780  CG1968  COG6  COG6  cog6  
  At1g42440  CG7338  TSR1  TSR1  tsr1 
  At1g69070  I(3)07882  NOP14  NOP14  nop14  
X At5g26110 Prpk TP53RK BUD32 bud32 
X At5g49510  mgr  VBP1  PAC10  pac10 
X At5g62590  Trn-SR  TNPO3  MTR10  mtr10 
  F5M6.12  CG13625  BUD13  BUD13  cwf26  
  F6I18.100 CG4554  UTP20  UTP20  utp20  
  INO80  Ino80  INO80  INO80  ino80  
  MCM23.1  CG9004  NOM1  SGD1  sgd1  
  MED31  MED31  MED31  SOH1  med31  
  MED6  MED6  MED6  MED6  med6  
  MFB13.10 Aatf  AATF  BFR2  bfr2  
  SWC4 DMAP1  DMAP1  SWC4 swc4  
X TCTP4 TCTP TCTP TMA55 tma19 
 
SCP FNP 
                                                   
 
4 This information has been revealed by a later literature review (Berkowitz et al., 2008).  








I selected TCTP/TPT1, TP53RK, VBP1, VPS18 and TNPO3 as candidates for wet-
laboratory experiments. The other candidates were dropped for various reasons, 
including that their functions were already known, the gene is crucial for cell 
maintenance (the knock-out or knock-down of the protein was lethal), and/or the 
deletion or silencing of the gene was not reported. Thus, I have selected five candidate 
proteins, which I investigated by gene deletion in Arabidopsis and by siRNA 
experiments using human T cells isolated from peripheral blood.  




2.3.2.1  Orthologs of TCTP/TPT1 
Translationally Controlled Tumour Protein (TCTP) is a highly conserved, 
multifunctional protein that is involved in several fundamental biological processes 
either in human or other species (Bommer, 2017). It has only one copy in all five species 
that I investigated, which suggest it could have a dosage related function. One copy 
means in each of the species it fulfils a specific role, and this could explain why this gene 
was not duplicated in any of these species. Moreover, it has only one copy in C. elegans 
and D. rerio as well. The homologous gene in Drosophila has been described as a cell 
size and body size defective mutant (Björklund et al., 2006), while in budding yeast it 
is an FNP protein (see Table 2.3-3) (PHO85 (YPL031C), RPN11 (YFR004W) and 
UBP3 (YER151C)). Deletion of TCTP in Arabidopsis causes reduced cell size 
(Berkowitz et al., 2008). However, I was not able to reproduce this phenotype in my 
Arabidopsis experiments (see Section 4.3.4 ). 
 
Table 2.3-3: Orthologs of the TCTP protein and current 
knowledge of its involvement in cell size regulation.  




P31265: Reduces cell size (Berkowitz et al., 
2008) 
D. melanogaster TCTP 
Q9VGS2: SCP: cell size defective,  
decreased cell size, size defective,  
body size defective 
(Björklund et al, 2006) 
H. sapiens TPT1 P13693 










2.3.2.2  Orthologs of TP53RK/Bud32 
TP53RK, also known as Bud32 and PRPK, is a transcriptional regulator and tumour 
suppressor gene that regulates the phosphorylation of TP53 on Serine 15 (Miyoshi et 
al., 2003). TP53RK protein has one homologue in all seven organisms (incl. C. elegans 
and D. rerio). The gene encodes a cell size control protein in budding yeast (Jorgensen 
et al., 2002) and Drosophila (Björklund et al., 2006). See Table 2.3-4. 
Table 2.3-4: Orthologs of the TP53RK protein and current 
knowledge of its involvement in cell size regulation. 
Species Protein name Involvement in size regulation 




Q9VRJ6: SCP: cell size defective, 
decreased cell size, size defective, body size 
defective 
(Björklund et al, 2006) 
H. sapiens TP53RK Q96S44 
S. cerevisiae BUD32 (YGR262C) 
P53323: SCP: haploid-larger 






2.3.2.3  Orthologs of VPS18/PEP3 
VPS18 (Vacuolar protein sorting-associated protein 18 homolog) protein in human 
plays an important role in the vesicle-mediated protein trafficking to the lysosome 
(Wurmser et al., 2000) and the protein is also required for vacuolar biogenesis in yeast 
(Preston et al., 1991). The protein is a part of HOPS (homotypic fusion and vacuole 
protein sorting) and CORVET (class C core vacuole/endosome tethering) complexes, 
while it controls the fusion of endomembrane (Hunter et al., 2017). VPS18 was found 
to control cell size in fission and budding yeast (Hayles et al., 2013; Jorgensen et al., 
2002), while it is an FNP in the Drosophila network. In all of the seven species analysed 
only one copy of the gene is present. 
 




2.3.2.4  Orthologs of TNPO3 
TNPO3 (Transportin 3) protein is a receptor located in the nuclear membrane where it 
is responsible for transporting serine/arginine-rich proteins such as the splicing factors 
RBM4, SFRS1 and SFRS2 (Allemand et al., 2002; Kataoka et al., 1999). TNPO3 is 
involved in HIV-1 infections, while it interacts with capsid proteins (Krishnan et al., 
2010). The TNPO3 protein ortholog in fission yeast has been identified as a cell size 
regulator (Hayles et al., 2013), while budding yeast and fly orthologs have been 
described as FNP proteins. 
 
2.3.2.5  Orthologs of VBP1/PFD3 
VBP1 (von Hippel-Lindau-binding protein) protein in humans is a component of the 
prefoldin complex and It Is also known as Prefoldin 3.The Prefoldin complex promotes 
cellular protein folding into the proper conformation and maintains homeostasis (Siegert 
et al., 2000). Apart from its involvement in the protein folding, VBP1 is a member of 
the ubiquitin protease system and stimulates protein degradation (Mousnier et al., 2007; 
Tsuchiya et al., 1996). VBP1 protein orthologs in budding yeast (Pac10) and fission 
yeast have been identified as cell size regulators (Hayles et al., 2013; Jorgensen et al., 
2002), in line with the Drosophila ortholog that has been described as an FNP protein. 
One copy of the VBP1/PFD3 gene is present in all of the species investigated and the 
same is true for genes encoding the other components of the prefoldin complex. 
  




2.3.2.6  Selection of genes of the prefoldin complex orthologs 
After carrying out the first round of gene deletion experiments on Arabidopsis I have 
identified VBP1/PFD3 as a good candidate for further research (see Section 4.3.3.1 ). 
Since this protein is a member of the prefoldin complex, I decided to investigate other 
components of this complex (see Table 2.3-5). These proteins form a heterohexameric 
molecular complex that is highly conserved in eukaryotes, including humans (Cao, 
2016). In the complex, there are two alpha (PFD3 and PFD5) and four beta subunits 
(PFD1, PFD2, PFD4 and PFD6) (Siegert et al., 2000). The prefoldins, in conjunction 
with molecular chaperonins are mainly involved in the correct folding of cellular 
proteins (Vainberg et al., 1998). 
Table 2.3-5: Members of the prefoldin complex. 
  PFD1/PFDN1 PFD2/PFDN2 PFD4/PFDN4 PFD5/PFDN5 PFD6/PFDN6 





























































2.3.2.7  Orthologs of CDC7 
In addition to the prefoldin complex, I selected another orthologous group for wet-
laboratory experiments. CDC7 in humans is a protein kinase that is important for the 
G1/S transition in the cell cycle (Montagnoli et al., 2002). The protein binds chromatin 
and interacts with MCM2 and MCM4 proteins to regulate the activity of the MCM 
hexamer DNA replication complex (Masai et al., 2006; Tsuji et al., 2006). CDC7 was 
characterised as a cell size regulator protein in the fly (Björklund et al., 2006) and fission 
yeast (Hayles et al., 2013), while in budding yeast it has been described as an FNP. 
 
Table 2.3-6: Orthologs of CDC7 and their involvement in size 
regulation. 
Species Protein name Involvement in size regulation 
A. thaliana At4g16970  Q0WPK0 
D. melanogaster Cdc7 [FBgn0028360.] 
Q9W3Y1: SCP: cell size defective, 
decreased cell size, size defective, 
body size defective 
Q8T0Q5 and Q9VJ90 
H. sapiens CDC7 O00311 
S. cerevisiae CDC7 (YDL017W) P06243: FNP 
S. pombe 
hsk1 [SPBC776.12c]  
spo4 [SPBC21C3.18] 
P50582: SCP: long high penetrance 
(Hayles et al.)  
Q9UQY9 
 
These orthologs have an evident involvement in cell cycle regulation and as Table 2.3-6 
shows they also affect cell size in some organisms. Thus, I wanted to test the effects of 
perturbations of CDC7 on cell size in human T-cells and Arabidopsis. 




2.3.3  Gene Ontology Orthology Tool (GOOT) 
Based on the orthology of proteins that are associated with a common biological process 
it Is possible to search for the conserved set of genes that could be important for a given 
biological process in selected species. Thus, I created a tool that can rank eggNOG 
orthologous groups by the conservation of GO annotated biological processes in which 
their members are involved. The same tool can also be used to identify gaps in GO 
annotations. Since, if I find that an orthologous group contains six proteins in six 
investigated species that all belong to the same GO annotation, then it is likely that a 
seventh group member from a seventh species is also involved in the same biological 
process.  
 
To fulfil these aims I built an extension of the tool called the Gene Ontology Orthology 
Tool (GOOT) to analyse the current status of gene ontology functional terms based on 
orthology. This tool shows the conserved function of proteins for a given GO term and 
gives suggestions for novel functional annotations based on data annotated for other 
species. 
 
2.3.3.1  Building up the database - sources 
To build the tool, I used external datasets from the following databases: 
(1) eggNOG database (version 4.0) was used for orthology 
(2)  GO_SLIM database was used for GO terms, which contains the list of 71 
generic biological processes 
a. The list of GO terms included are given in Supplementary Table 6.2-1 
b. The dataset was last updated on 10th August 2017. 
 
I created a website for the tool that is up and running on the web. The address of the 
website is . 
 




2.3.3.2  Using the GOOT website 
The interface of the website welcomes the user; then users can enter a query (Figure 
2.3-4). There are four options on the query page: 
 
• Selection from the 71 GO Slim terms. 
• Selection from seven organisms (A. thaliana, C. elegans, D. melanogaster, D. 
rerio, H. sapiens, S. cerevisiae and S. pombe) - multiple choices are possible. 
• Selecting from two types of Venn Diagrams (normal and Edwards-Venn 
diagram). 
• Determine a hit species threshold level between one and seven, meaning how 
many of the seven species need to have a protein from a given orthologous group 
associated with the selected GO term.  
 
The hit species threshold level means that an orthologous group needs to have an 
annotated protein in the GO in the threshold number of species. If the threshold number 
is three and we select “GO:0051726 - regulation of cell cycle” GO term, there are 103 
orthologous groups that have a protein, in at least three species annotated to this GO 
term. 45 of the orthologous groups are present in all seven organisms. Just to compare, 
if the threshold number is one as shown in Figure 2.3-5, there are 244 common 
orthologous groups of proteins that have at least one annotation to this GO term and are 
present in all seven species. The value of hit species threshold is always 1 for the Venn 
Diagrams shown in this chapter. 
 





Figure 2.3-4: Query page of the Gene Ontology Orthology Tool 
Users can select from 71 GO terms, seven species, two types of Venn diagrams and 
seven threshold levels. 
  




2.3.3.3  Results 
2.3.3.3.1  Venn Diagrams 
Once the user sends a query, the results page will load a Venn diagram of the selected 
GO term at the top of the page (Figure 2.3-5). It describes all the possible orthological 
overlaps among the selected number of species, then represents the number of common 
orthologous groups in each possible relation. Each number in the diagram means one 
single orthologous group that contain several unique proteins in species, from one 
protein to hundreds of proteins. The numbers show the orthologous groups that have at 
least one protein out of the seven species annotated in the selected GO term (the hit 
species threshold number is always 1 for Venn Diagrams).  
 
In Figure 2.3-5, I show three different Venn diagrams for the “GO:0051726 - regulation 
of cell cycle” that can be created with the tool, depending on which species are selected 
for analysis. 





Figure 2.3-5: Regulation of Cell Cycle – Venn Diagrams 
“GO:0051726 - regulation of cell cycle” GO term and three different queries: among 
seven-, among four- and among three-species. Each number denotes an orthologous 
group from eggNOG that contains proteins from the given species for each overlap. 
Only overlapping groups are displayed, species-specific orthologous groups are not. 
There are 426 orthologous groups (bottom left) where there is at least one gene from 
budding yeast, fission yeast and humans annotated to this GO term.  




2.3.3.3.2  Current Annotations based on orthology 
On the result page shown by the tool, the second section is the current knowledge 
functions of Gene Ontology annotations based on orthology. Here the tool shows a table 
of the annotated functional orthologous groups above the selected hit species threshold 
level. 
 
The table contains the following columns (see Figure 2.3-6): 
• Group: eggNOG group name that links to the related eggNOG group on the 
website of the eggNOG database 
• Average H/M: Individual Hit/Member (H/M) ratio of the species calculates 
the number of given GO annotated proteins (hit) divided by all proteins 
(member) annotated to that eggNOG orthologous group in the given species. A 
calculated average number makes an average of individual hit/member ratios of 
individual species, then divides it by the number of species present in that 
orthology group.  
 
I needed to consider this as some genes have many copies in a single organism, 
while present as a single copy in others. I did not want to penalise cases when 
the biological function might be conserved for one of the many copies in one 
species as well as in the single copies in other species. 
• Total H/M: Total Hit/Member ration is a summarized number of annotated 
proteins to that term (hit) divided by the number of all proteins (member) exist 
in the orthologous group. This measure can be misleading if there are multiple 
copies of a gene in one or two species while a few copies in others. 
• Hit species: The number of species that have at least one protein annotated to 
the given GO term. 
• Total species: The number of all species that have at least one protein in the 
orthologous group. 
• Hit species in total species: Describes the number of species that have a protein 
annotated (hit species) and the number of all species (total species) in the 
orthologous group. 




• Description: Describes the number of annotated proteins in the number of hit 
species and describes the number of all proteins in all species that belongs to this 
eggNOG orthologous group. 
• List of hit species: List of species that have a protein annotated to the given GO 
term in the orthologous group. 
 
The Average H/M ratio is able to discriminate among groups to show the most relevant 
GO functional orthologous groups. As Figure 2.3-6 shows “GO:0051726 - regulation of 
cell cycle” GO term orthologous groups ordered by Average H/M in descending order. 
We can discriminate a conserved core function of proteins where the total H/M value 
is 1 and the number of hit species equals the total number of species in the databases 
used by the tool. There are four orthologous groups (ENOG410IQA2, KOG2983, 
KOG2163 and KOG4803), with four proteins that met this criterion. Furthermore, if 
we set total H/M value to 0.9, while the hit species still equals to the total species, we 
can discriminate an additional two orthologous groups, KOG4743 and KOG1010, 
increasing the number of identified conserved orthologous groups to six. 
In general, this tool can be used to rank eggNOG groups based on their association in 
multiple organisms to a given GO term. Thus, it can be used to identify the most 
conserved genes associated with a given ontology association. 
 
 





Figure 2.3-6: Current Annotations based on Orthology 
Data for “GO:0051726 - regulation of cell cycle” GO term. The Figure shows the first 
ten rows ordered by Average H/M in descending order. It can be seen that there are 
four orthologous groups which have all of the proteins annotated with this GO term 
in all the investigated species. Hit species threshold equals 3. 
  




2.3.3.3.3  Novel GO Annotations 
The second table on the results page is the main result of the tool: it suggests 11 novel 
functional annotations based on orthology. The tool shows orthologous groups which 
have all but one hit species, Average H/M ratio 0.800 or above, and Total H/M ratio 
0.500 or above. These selected orthologous groups are shown in a table (Figure 2.3-7), 
where all the proteins are shown for all investigated species, in line with the Group 
name, Average H/M ratio and Total species numbers. In all hit species the “HIT:” tag 
and the novel functional annotation prediction the “PREDICTION:“ tag is shown. For 
the “GO:0051726 - regulation of cell cycle” GO term, 13 protein predictions from 11 
orthologous groups can be made (Figure 2.3-7 and Table 2.3-7) 
 
 
Figure 2.3-7: Novel GO Annotations based on orthology 
Data for “GO:0051726 - regulation of cell cycle” GO term. The figure shows the 11 
rows of orthologous groups where 13 novel functional annotations can be made. 
For example, here the tool predicts the Cyclin H (O17144) protein from D. 
melanogaster as the “GO:0051726 - regulation of cell cycle” GO term, based on KOG 
2496 - Cyclin H - Cell cycle control, cell division, chromosome partitioning – 
orthologous group. 
  




Table 2.3-7: Predictions for GO:0051726 - regulation of cell cycle 
Predictions based on KOG 2496 - Cyclin H - Cell cycle control, cell division, 
chromosome partitioning orthologous group. 
 









Uniprot ID of 
Predicted 
Protein 
KOG2496 7 D. melanogaster Cyclin H O17144 





KOG0794 7 H. sapiens CCNC Q7Z4L3 
KOG0596 6 D. melanogaster Mps1 A0A0B4KG66 
KOG4593 6 D. melanogaster Mad1 Q95S25 





KOG3285 6 D. melanogaster Mad2 Q9VRQ2 




KOG0835 5 D. melanogaster EG:67A9.2 Q9U1K6 
KOG2810 5 D. melanogaster Rad9 A8JNV5 
KOG3924 5 D. melanogaster gpp A0A0B4KFP4 
 
The first protein CycH (O17144) from the KOG2496 group is informative by its name, 
it was identified by similarity in eggNOG and the evidence is at the transcriptome level. 
However, it has not been annotated yet to this GO term, unlike other Cyclin H proteins 
in other organisms. 
  




2.3.3.4  GO Results for Regulation of cell size 
As I created a new tool to find novel functional annotations based on orthology, still my 
aim remained to find novel cell size regulators. The GO database contained the 
“GO:0008361 - regulation of cell size” GO term. I found that 37 individual orthologous 
groups have at least one protein annotated in a minimum of one species of the seven-
investigated species (Figure 2.3-9, top). Moreover, I found that there are 47 orthologous 
groups among my initial five species (A. thaliana, D. melanogaster, H. sapiens, S. 
cerevisiae and S. pombe) that have at least one protein annotated in at least one species 
(Figure 2.3-9, bottom right). In addition, I found that there are 70 orthologous groups 
between S. cerevisiae and S. pombe that have at least one protein annotated in at least 
one species (Figure 2.3-9, bottom left). 
2.3.3.4.1  Applying threshold levels 
 I applied hit species threshold level 2, that means a given orthologous group needs to 
have an identified functional ortholog in at least 2 species. I found that 29 orthologous 
groups have three proteins annotated in at least three species. When a threshold level of 
3 Is applied, I found that 9 orthologous groups have three proteins annotated in at least 
three species (Figure 2.3-8). 
 
 
Figure 2.3-8: GO Regulation of cell size: Current annotations 
The 9 orthologous groups that have at least three proteins annotated in at least three 
species are shown. 






Figure 2.3-9: GO Regulation of cell size: Venn Diagrams 
The diagram shows that there are more common protein groups in phylogenetically 
closer species than in more distant species. Between 2 species there are 70 common 
protein groups, while among 7 species there are only 37 groups of proteins. 
Hit species threshold is 1.  




Table 2.3-8: Number of GeneOntology annotations for the 
“GO:0008361 - regulation of cell size” GO term 
The table shows that the Gene Ontology database is updated from time to time and 
sometimes annotations are not only corrected, but also erased from the database. 
 
  
GO:0008361 - regulation of cell size 
  
 Nr of proteins, 
10th August 2017 
eggNOG groups, 
10th August 2017 
Nr of proteins, 
24th March 2018 
A.thaliana 17 11 35 
C.elegans 99 27 105 
D.melanogaster 39 20 160 
D.rerio 139 28 88 
H.sapiens 204 91 209 
S.cerevisiae 34 20 48 
S.pombe 10 10 15 
 
  




2.4  Conclusions 
In this Chapter, I explained how I built two bioinformatics tools. The first directed to 
provide predictions of proteins that regulate cell size, while the second is a generalised 
tool to identify the conserved core associated with a GO function and to give novel 
functional annotations for the Gene Ontology database. 
2.4.1  Ortholog Finder Tool results 
I created the Ortholog Finder Tool that collects cell size related information from five 
model organisms, in parallel with the collection of their orthology relations. The tool 
can show functional orthological relations in line with known cell size data information. 
I have used the tool to predict functional orthology groups for subsequent wet laboratory 
experiments. With the help of these results, I was able to select gene orthology groups 
for experimental tests in Arabidopsis and also with Human T cells. 
2.4.1.1  Results of experiments on selected proteins 
I carried out experiments to determine whether the selected proteins have a role in 
regulating cell size. These experiments were based on the hypothesis that ablating a 
protein by gene knock-out in A. thalina or reducing the induction of the protein in 
human T cells during entry into the cell cycle from quiescence by transfecting siRNA 
would affect cell size. Thus, I created an analytical method, which I named the 'one-to-
one method', which means that in all investigated species (five-species at the time: A. 
thaliana, D. melanogaster, H. sapiens, S. cerevisiae and S. pombe) the selected orthologous 
groups have to contain only a single copy of the ortholog gene. I found 17 orthology 
groups that could be further investigated experimentally (see the list of these groups in 
Table 2.3-2). I analysed this list manually and after reading the literature I selected 
TCTP/TPT1, TP53RK, VPS18/PEP3 TNPO3, and VBP1/PFD3 orthologs for 
further experiments. 
TCTP/TPT1 orthologs are highly conserved, multifunctional proteins that are involved 
in many fundamental biological processes and disorders in human and other species 
(Bommer, 2017). TCTP/TPT1 orthologs have been reported to be involved in 




mammary carcinoma (Gross et al., 1989), histamine release (MacDonald et al., 1987, 
1995) and it can serve as an anti-apoptotic protein (Li et al., 2001). While the orthologs 
of the other selected protein, TP53RK/Bud32 are known to regulate p53 by 
phosphorylation on Serine 15 (Miyoshi et al., 2003). This phosphorylation of S15 
impairs the binding of MDM2 and leads to the accumulation and activation of p53 
(Shieh et al., 1997; Tibbetts et al., 1999). Although these two proteins have a wide 
range of characterised phenotypic effects in various organisms, they have never been 
associated with cell size regulation in Humans. The following chapters (Chapters 3 and 
4) contain details of experiments designed to investigate whether TCTP and TP53RK 
have roles in regulating cell size in human T cells and In Arabidopsis. Briefly, the TCTP 
siRNA knock-down experiments on human T cells confirmed its role in cell size 
regulation. In contrast, reducing the levels of TP53RK did not. The protein encoded by 
the Tctp1 ortholog in Arabidopsis was already known to have a role in regulating cell 
size (Berkowitz et al., 2008). However, as described in Chapter 4 I was not able to 
reproduce these results. 
 
 
The VPS18/PEP3 protein is known to control the fusion of endomembranes (Hunter 
et al., 2017). VBP1/PFD3 a component of the prefoldin complex (Siegert et al., 2000), 
while TNPO3 is known to be responsible for transporting serine/arginine-rich proteins 
(Allemand et al., 2002; Kataoka et al., 1999). Although of the roles of all these proteins 
in several biological processes were investigated, they have never been reported to be 
involved in the regulation of cell size either in Human or Arabidopsis. In Chapter 4, I 
show that the PFD3 knock-out mutants have a cell size defect in Arabidopsis. Since this 
protein is a member of a conserved protein complex, I decided to expand my analysis to 
other members of this complex.  
 
Following the encouraging results on the cell size perturbing phenotype of the PFD3 
mutant in Arabidopsis, I further investigated the other members of the prefoldin complex 
(PFD1, PFD2, PFD4, PFD5 and PFD6). Prefoldin complex members are known to 
regulate the correct folding of proteins with molecular chaperonins (Vainberg et al., 




1998). Furthermore, some members have other functions, for example VBP1/PFD3 is 
a member of the ubiquitin protease system, which controls protein degradation 
(Mousnier et al., 2007; Tsuchiya et al., 1996). The PFD6 protein is known to be 
required for normal microtubule dynamics (Gu et al., 2008). Perturbation of Pfd6 also 
affects plant size as these mutant plants were shown to be smaller than a control group 
(Gu et al., 2008). Other prefoldins have not been associated with any cell or organ size 
related effects in human, while Pfd3 and Pfd5 have been described to cause a specific 
size difference in Arabidopsis (Rodríguez-Milla & Salinas, 2009). 
 
2.4.1.2  Possible further candidates 
As the list of orthologous groups for possible targets contained 17 groups (Table 2.3-2), 
I could not Investigate 12 of them in my wet-laboratory experiments. If time had 
allowed, I would have selected and investigated a few of them. For example, the 
SWC4/DMAP1 orthologous group, which is a conserved member of the NuA4 histone 
acetyltransferase complex, that has orthology from yeast to humans (Doyon et al., 
2004). DMAP1 has been reported to regulate ATM kinase activity, a survival function 
of the cells to halt the cell cycle while specific DNA damage is being repaired (Penicud 
& Behrens, 2014). These could affect cell size as controlled degradation of specific 
cyclins is Important In controlling progression through specific cell cycle phases and 
may effect cell size, which has been shown in budding yeast (Martínez-Láinez et al., 
2018). In Arabidopsis, SWC4 as a part of the SWR1 protein complex contributes to 
plant development and physiology (Bieluszewski et al., 2015) and defects or deletion of 
the gene might affect the size changes normally associated with cellular differentiation. 
  




2.4.2  The Gene Ontology Orthology Tool 
I developed the Gene Ontology Orthology Tool that collects the current Gene 
Ontology functional annotations and shows them in line with functional orthologous 
groups exported from the eggNOG database (Huerta-Cepas et al., 2016; Jensen et al., 
2008). The tool can identify the conserved core molecules of a given Gene Ontology 
term. These conserved core molecules seem to be crucial for the given pathway and 
may reveal novel insights of a regulatory mechanisms behind. In addition, the tool 
provides suggestions for novel protein functional annotations to a given GO term. These 
suggestions are purely based on my computational analysis, explained earlier in Section 
2.2 and require experimental investigation. 
 
2.4.2.1  Extension of GO annotations 
The Gene Ontology (GO) database is not complete. Research groups have already 
created tools and approaches to expand and correct current annotations 
(The Gene Ontology Consortium, 2017). GO contains terms as a universal concept of 
relation to gene function and these terms are always expanded, revised and checked. 
There are tools like TermGenie (Dietze et al., 2014) that aims to create new classes via 
a web-based interface or a GitHub tracker (
) where issues can be posted for the structure of the ontology or new 
relationship types. There are also discussions taking place between the manual curators 
and members of the consortium about further possible annotations 
(The Gene Ontology Consortium, 2017).  
 
As GO is a part of Open Biomedical Ontology (OBO) classes and using the OWL (Web 
Ontology Language), there are also regular updates from other ontologies. These 
updates include entries from PO (Plant anatomy) (Jaiswal et al., 2005), ChEBI 
(chemicals) (Degtyarenko et al., 2008) and PATO (qualities/descriptors) (Gkoutos et 
al., 2005). 
 




2.4.2.2  Novelty of GOOT 
As I described in section 2.1.2.4.4 , there are also approaches taking place in the GO 
community to expand GO based on orthological relations and homology (see Section 
2.1.2.4.2 ). To find similar functional orthologs the method needs to employ homology 
similarity search by sequence, domain or protein structure (Pearson, 2013). In the 
current approach there are approaches to expand GO based on homology, such as 
InterPro2GO (Mitchell et al., 2015). InterPro2GO is an approach to integrate the 
functional knowledge of protein families, domains and sites which are combined from a 
number of different protein signature databases, such as Gene3D, Panther, Pfam, 
PRINTS, ProSite, SMART, SUPERFAMILY and TIGRFAM, then annotate them 
into GO (Mitchell et al., 2015). These methods describe the same protein family or 
domain into a single unique entry then applies cross referencing to include other proteins 
with similar protein sequence. If the InterPro finds similar proteins with a similar 
conserved function, it suggests a mapping between the InterPro entry and a GO 
database (Mitchell et al., 2015). There are other tools such as PAINT (Gaudet et al., 
2011), which predict novel GO annotation based on phylogenetical relations such as 
sequence homology. 
 
My method is a little different, since none of the other approaches currently uses a 
functional orthology database, such as the eggNOG database (Huerta-Cepas et al., 
2016; Jensen et al., 2008) as a comprehensive source of functional annotation. eggNOG 
is a functional orthology database that groups proteins of 2031 eukaryotic and 
prokaryotic organisms into thousands of functional orthology groups (Huerta-Cepas et 
al., 2016). Using eggNOG made it easier to use the data, however it constrains my 
predictions to the current annotations in the eggNOG database. Moreover, current 
methods stick to the same taxonomic clade and they do not analyse similarities between 
mammalian and plant, whereas my tool is able to analyse proteins in Human and 
Arabidopsis. I used seven distinct, well-studied model organisms (A. thaliana, C. elegans, 
D. melanogaster, D. rerio, H. sapiens, S. cerevisiae and S. pombe) to find novel annotations 
for proteins and genes. It is for further research how far this can be expanded to other, 
less well-studied species. 




2.4.2.3  Predictions of GOOT 
2.4.2.3.1  Predicted novel annotations to GO 
The tool predicted new GO annotations for 13 proteins in 4 species for the 
“GO:0051726 - regulation of cell cycle” GO term, where the total H/M value is 0.8 or 
above and hit species is one less than the total species. These proteins usually hold an 
uncharacterized name, or a name related to a hypothesised function (as for CyclinH in 
Drosophila), but they have not been annotated to the Gene Ontology. This information 
means that these proteins have been confirmed to exist and the genes encoding these 
proteins have been sequenced but have not been annotated to a function. The tool 
described here could extend what Is known by giving suggestions for Gene Ontology 
annotation predictions. However, there could be a bias in the prediction, because my 
main source of data is the eggNOG database. If a group of proteins is in the database, 
the tool can make predictions based on that protein, but if it is not it cannot make any 
predictions. My predictions can be varied by changing the H/M values which affects 
the probability of the result. I showed that this method could work in some cases such 
as “GO:0051726 - regulation of cell cycle”. However, in other cases the currently 
available GO annotation data was not enough to identify a conserved core and give 
predictions of missing GO terms. I showed an example for the “GO:0008361 - regulation 




Human T-Cells  





3.1  Introduction 
3.1.1  Cell size attributes in human cells 
There are an at least 3.72 × 1013 cells in a human body (Bianconi et al., 2013) which 
have been classified as more than 411 different cell types (Vickaryous & Hall, 2006). 
Although these are large numbers and cells of different types are of a great variety of 
sizes, cells of the same type are similar in size. In addition, cells of a particular type 
maintain a specific range of sizes in a given tissue (Guertin & Sabatini, 2006). Therefore, 
there is a mechanism for sensing and maintaining a narrow range of cell sizes in human 
tissues. Three different parameters are controlled, namely the number of cell organelles, 
the total number of cells and their size (Marshall, 2016). 
 
Organelles such as the nucleus (Jorgensen et al., 2007), nucleolus (Neumann & Nurse, 
2007) and vacuoles (Berciano et al., 2007) scale with cells size (Chan & Marshall, 2012) 
and can affect the overall cell size. At least 5 different methods are known to control the 
size of organelles, which have been investigated by the use of organelle-specific reported 
molecules. To give some examples these are: (1) size dependent accumulation, if a 
reporter molecule binds to an organelle with which it has an affinity; (2) concentration 
gradient, a molecule in a certain part of the organelle creates a gradient depending on 
the size of the structure; (3) occupancy time, if a reporter molecule is delivered to a 
certain part of the organelle; (4) conformational change of a molecule that is dependent 
on the organelle and (5) structural scaffold (Chan & Marshall, 2012). The precise 
control of organelle size and number is important especially in Lymphocytes, but the 
overall cell size is mainly due to the size of the nucleus (Huber & Gerace, 2007). 
 
Cell size regulation is dependent on cell growth, which is the mass accumulation of 
matter, and cell proliferation (Lloyd, 2013). Coordination between cell growth and cell 
proliferation is a key factor that sustains cells size through successive cell divisions 
(Conlon & Raff, 1999). The size of a given cell type is restored in dividing cells after 
each cell division and is maintained in quiescent cells. Cell growth and progression 





through the cell cycle are coordinated in normal cells. However, these processes can be 
separated in mammalian cells with growth signals such as mTOR and PI3K (Fingar et 
al., 2002) and in human T-Lymphocytes (T-Cells) by peturbation of the regulatory 
"commitment point" (Lea, Orr, et al., 2003) or by siRNA experiments to prevent the 
induction of specific proteins normally caused by CD3/CD28 stimulation (Orr et al., 
2012). 
To test and analyse cell size changes in human cells, I picked T-Cells as a model. 
Specifically, quiescent, non-activated T-Cells which increase in size, enter the cell cycle 
and become functionally active in response to stimulation via CD3/CD28. 
3.1.2  Human T-Lymphocytes 
In my work, I have done experiments with non-activated human T-Cells isolated from 
peripheral blood. These are predominantly memory T-Cells and are CD4+ and CD8+ 
(see later for explanation). I will describe what is known about these cell populations in 
general in the sub-sections below. 
3.1.2.1  T-Cells 
T cells, also called T-Lymphocytes, are a type of white blood cell. These cells circulate 
in the bloodstream and they play a fundamental role in cell-mediated immunity. There 
are two major types of lymphocyte in a human body that determine the specificity of 
the immune response to antigens, namely T- and B-cells (Provan et al., 2004). T-Cell 
is a general term and many different subtypes of T-Cells are known, which have 
different Immune functions (Gerriets & Rathmell, 2012). T-Lymphocytes detect 
foreign substances, including infectious microorganisms as antigens and generate a 
specific immune response that can eliminate the threat from the body. T-Cells recognise 
non-self-molecules such as exogenously encoded pathogens upon ligation of clonotypic 
T cell receptors (TCR) by major histocompatibility complexes (MHCs) on antigen 
presenting cells (APCs) (Brownlie & Zamoyska, 2013). These TCR–peptide–MHC 
ligations induce an immune response against the pathogen by activation of effector 
molecules and T-Cell proliferation. The cells become effector T-Cells, and some 
become memory T-Cells (see details below) (Brownlie & Zamoyska, 2013).  





3.1.2.2  Cell Size of T-Cells 
White blood cells vary widely in shape and size when viewed by light microscopy, 
which is particularly evident after May-Grünwald-Giemsa (MGG) staining (see 
Section 3.2.12 ) and the population of lymphocytes is easily distinguishable because of 
cellular features. Most lymphocytes in the peripheral blood are non-activated and 
quiescent. These cells are oval or spherical with basophilic cytoplasm, a large spherical 
nucleus that fills up to 90% of the cell and contains condensed dark chromatin (see 
Figure 3.1-1). The usual cell size of normal, healthy lymphocytes is between 6.8 – 7.8 
µm (Kuse et al., 1985) and the cells double in size after stimulation via CD3/CD28 (see 
below). 
 
Figure 3.1-1: Isolated, unstimulated, quiescent T-Lymphocytes 
under a light microscope 
This image is of quiescent, quiescent (G0) T-Lymphocytes. These cells are oval or 
spherical with a small annulus of cytoplasm surrounding a large spherical nucleus 
containing condensed dark chromatin. 
Non-activated, quiescent T-Cells were isolated from human peripheral blood as 
described in Section 3.2.4 , immobilised onto a microscope slide by 
Cytocentrifugation and stained with MGG dye as described in Section 3.2.12 .  
I captured this image of quiescent T-Cells using light microscopy.  





3.1.2.3  Origin of T-Cells 
T-Cells originate from haematopoietic stem cells in the bone marrow, but they mature 
in the thymus, which gives them the name T-Cells (Brownlie & Zamoyska, 2013; 
Schwarz & Bhandoola, 2006). If the thymus is absent, low numbers of T-Cells are 
produced (Boyd et al., 1993). See Figure 3.1-2 on how T-Cells are produced from 
haematopoietic stem cells. 
 
Haemopoietic progenitor cells are kept in the bone marrow by interactions of cell 
surface receptors such as SDF-1 and 
  







Figure 3.1-2. Representation of haematopoiesis that illustrates the 
main lineage commitment steps. 
Hematopoietic Stem Cells are at the top of the figure. When these cells divide, 
Multipotent Progenitor Cells (MPC) are produced from one of the progenies and the 
other remains as a stem cell. The MPCs give rise to common lymphoid and common 
myeloid progenitor cells. 
Lymphoid cells: There are four mature cell types, which are produced through a 
step-wise process of lineage commitment, Plasmacytoid dendritic cells, Natural Killer 
cells, B-Cells and T-Cells. 
Myeloid cells: There are two types of progenitor cell: Granulocyte-Monocyte 
Progenitor Cells and Megakaryocytic-erythroid Progenitor Cells. These cells 
mature into seven different cell types through commitment steps to produce 
Conventional dendritic cells, Monocytes, Neutrophils, Eosinophils, Basophils, 
Megakaryocytes and Erythrocytes. 
The figure is based on Figure 1 from Famili et al., 2017.  
  





3.1.2.3.1  Subtypes of T-Cells 
Several subsets of T-Cells exist, which all have distinct functions in the body. The 
majority of human T-Cells have α and β chains that make up their TCR (αβ T-Cells) 
(Krogsgaard & Davis, 2005). Several subsets of αβ T-Cells exist that have functions, 
such as effector, helper and cytotoxic T-Cells. These T-Cells are distinguishable by the 
fact that they express different co-receptors and produce various cytokines (see Figure 
3.1-3 for details). Subsets of αβ T-Cells can be categorised into at least three different 
groups based on their function and co-receptors. The most common subsets of αβ T-
Cells are distinguished by CD4 and CD8 co-receptors. These cells have a TCR complex 
that consists of 3 different proteins: (1) the αβ TCR (2) linking co-receptor molecule 
CD4 or CD8 and (3) specific MHC molecules such as MHC class I for CD8 and MHC 
class II for CD4 on APC cells (Davis et al., 1998). In humans, there are three 
polymorphic class I genes (HLA-A, B- and -C) and four class II gene pairs (HLA-DM, -
DP, -DQ and -DR) (Ellis & Ballingall, 1999; Hughes, 1995). Lymphocytes make up 70-
90% of peripheral blood mononuclear cells (PBMC), of which 70-85% are T-Cells. 
There is approximately a 2:1 ratio of CD4+ and CD8+ T-Cells. These are the 
predominant T-Cell populations that I isolate for the work described in this chapter 
(Lea, Orr, et al., 2003). 






Figure 3.1-3. Different Subtypes of T-Cells. 
There are two major groups of T-Cells. The most common group is CD4+ T-Cells. 
Naïve T-Cells become activated by antigen presentation. Responses to specific 
interleukins (IL), interferons (IFN) and other cytokines such as Transforming 
growth factor beta (TGF-β), Tumour necrosis factor alpha (TNF-α) and Hypoxia-
inducible factor 1 alpha (HIF1α) cause differentiation to seven subtypes, namely 
Th1, Th2, Th9, Th17, Th22, Tfh and Treg. These cells are effector T-Cells, and all 
of them produce the cytokines indicated. 
The second group are CD8+ T-Cells, which consist of naïve and memory cells. 
These cells are generated to combat infections. 
The third and much smaller group is Natural Killer T-Cells, that is as heterogeneous 
group shares similar properties with Natural Killer Cells. These cells can be divided 
into three different subgroups. 
The image is based on Figure 2 from Gerriets & Rathmell, 2012, Figure 1.1 from Sun & 
Zhang, 2014 book and Figure 1 from Simoni et al., 2013.   





3.1.2.4  Activation and antigen discrimination 
Most primary T-Cells in the human circulatory system are in an unstimulated, quiescent 
(G0) state (see below). These cells remain in this quiescent state until they receive a 
specific mitogenic stimulus via their TCR. If a specific stimulus is received, T cells 
respond by activating effector functions, and they enter the growth cycle and cell cycle, 
as described below. 
3.1.2.4.1  The Quiescent state 
Quiescent T-Cells are in a non-proliferative cell cycle phase termed G0 (Takada & 
Jameson, 2009; Thomas, 2004; Yang & Chi, 2018). These quiescent T-Cells are small 
in size relative to proliferating T cells with low protein content, 2n DNA content and 
low metabolic activity (Thomas, 2004). Quiescent T-Cells can enter the cell cycle and 
divide when they receive a mitogenic stimulus, such as via the TCR and co-receptors 
such as CD28 (see below). Quiescence is different from senescence since senescent cells 
have lost their ability to respond to mitogenic stimuli and to divide (Campisi, 1996; 
Terzi et al., 2016). The quiescent state is not just a dormant state with limited activity, 
it is an actively controlled state in which cells are still capable of responding to 
stimulation and is necessary for T-Cell homeostasis (Hamilton & Jameson, 2012; Yang 
& Chi, 2012). T-Cells are thought to be kept in G0 by proteins, such as the hypo-
phosphorylation of the retinoblastoma protein family, namely pRB and p130 (reviewed 
in Thomas, 2004). Many proteins that are required for progression through the cell 
cycle, such as minichromosome maintenance proteins (MCM2 to MCM7) and Cdc6 
(Williams, Shohet, et al., 1997; Yan et al., 1998), DNA polymerase α (Nakamura et al., 
1984), ribonucleotide reductase (Mann et al., 1988) and thymidine kinase (Rittling et 
al., 1986; Wintersberger et al., 1992) are not present in quiescent T-Cells. Therefore, 
these cells do not contain many of the proteins necessary for cell proliferation (Lea, Orr, 
et al., 2003; Orr et al., 2010). These proteins are synthesised de novo when T cells are 
stimulated to enter the cell cycle by ligation of CD3 and CD28 (ibid). Peripheral blood 
T-Cells produce energy in the quiescent state by catabolic metabolism, which is 
insufficient to support the increase in size that occurs in response to stimulation via 
CD3/CD28 (Rathmell et al., 2000). When T cells are stimulated by CD3/CD28 





ligation, metabolic reprogramming occurs from oxidative phosphorylation (OXPHOS) 
to glycolysis (Allison et al., 2017; Buck et al., 2015, 2017; Fox et al., 2005; MacIver et 
al., 2013; van der Windt & Pearce, 2012). This is associated with increases in the levels 
of nutrient transporters (Orr et al., 2012), including the glucose transporter Glut1 which 
translocate to the cell surface (Wieman et al., 2007). 
 
3.1.2.4.2  Activating T-Cells 
T-Cell activation is initiated by APCs, which have MHCs bound to a peptide antigen 
on their surfaces, as described above. APCs can be dendritic cells, macrophages or B-
Cells. Immune response to foreign antigens via APCs activate heterodimeric αβ TCR 
(Krogsgaard & Davis, 2005), described above. TCR αβ heterodimer receptors are non-
covalently associated with three forms of the CD3 subunit dimers: CD3εγ, CD3εδ 
heterodimers and CD3ζζ homodimers (Call & Wucherpfennig, 2007; Ngoenkam et al., 
2017; Weiss, 1993). A specific amino acid sequence, called immunoreceptor tyrosine-
based activation motif (ITAM) can be found on the cytoplasmic side of CD3 subunits: 
CD3ε, CD3γ and CD3δ contain one ITAM, while CD3ζ contains 3 ITAMs (Brownlie 
& Zamoyska, 2013). Activation of the TCR-CD3 complex by antigen binding leads to 
intracellular signal transduction that initiates cell proliferation, increase in cell size and 
activation programmes (Brownlie & Zamoyska, 2013). 
 
3.1.2.4.2.1  CD3 / CD28 co-stimulation 
Stimulation via the TCR-CD3 receptor is not enough to trigger a full immune response, 
and in the absence of a second stimulus via a co-stimulatory receptor an abortive 
immune response is the result (Jenkins et al., 1990). In this case, the T-Cell is unable to 
produce interleukins and is not able to proliferate (Porciello & Tuosto, 2016; Schwartz, 
2003). There are two major groups of co-stimulatory proteins on the surfaces of APCs. 
First is the ligation of CD28 by B7.1/CD80 or B7.2/CD86 (Freeman et al., 1993; Gross 
et al., 1990), which both result in transcriptional activation of genes required for cell 
cycle entry and functional activation (Acuto & Michel, 2003). Gene transcription is 
activated via transcription factors such as NF-B, PU.1, E2F and others that are 





necessary for the proliferation and activation programs (Li et al., 2005; Rothenberg, 
2014). Stimulation of CD28 receptors by either B7.1/CD80 or B7.2/CD86 results in 
increased expression of the interleukin 2 receptor (IL2R) on the cell surface (Shahinian 
et al., 1993), production of interleukin 2 (IL2) (Lucas et al., 1995; Reichert et al., 2001) 
and entry into the cell cycle (Bonnevier & Mueller, 2002). Specifically, CD28 receptor 
ligation upregulates the expression of D-type cyclins and causes a reduction of cyclin-
dependent kinase inhibitors (CKI), such as p27Kip1 that enables cycle entry to be 
initiated from quiescence (Appleman et al., 2002). Cyclins control progression through 
the cell cycle as well as other cellular processes, such as transcription by initiating the 
activation of Cyclin-dependent kinases (Cdk) (Hochegger et al., 2008). CD28 co-
stimulation also activates the PI3K/mTOR signalling pathway (Mamane et al., 2006). 
mTOR is a major signalling pathway that leads to an increase in cell size, as described 
in Chapter section 1.3.3.1 Also, CD28 co-stimulation causes cytoskeletal 
rearrangement, resulting in a change of cell shape from small round cells (Figure 3.1-1) 
to larger cells with irregular shapes (Boomer & Green, 2010). 
 
The consequences of stimulation via CD3/CD28 are that T-Cells enter the cell cycle, 
become larger, i.e. enter the growth cycle that controls cell size, and induce many 
effector molecules that are responsible for T-cell functions.  
  






3.1.2.4.3  The Mitotic Cell Cycle 
The mitotic cell cycle can be divided into two separate gap phases (namely G1 and G2 
phases), which are separated by two synthesis phases (see Figure 3.1-4). Between G1 
and G2 phases, there is a cell cycle phase during which DNA is synthesized (called S-
phase), while cell division/cytokinesis occurs between G2 and G1 (called M-phase) 
(Thomas, 2004). The transitions between phases are coordinated by members of the 
Cdk family, which are activated by cyclins, as their name suggests (Hochegger et al., 
2008). Non-stimulated, quiescent cells are in the G0 phase described above, and upon 




Figure 3.1-4: The main phases of the cell cycle 
A mitotic cell cycle consists of four phases: mitosis (M phase) and DNA synthesis (S 
phase) that are separated by two gap phases called G1 and G2. Cells can exit the G1 
phase and enter a non-proliferative, quiescent state called G0. 
The figure is based on Figure 8.2 from Thomas (2004). 
  





3.1.2.4.3.1  The Commitment Point during Cell Cycle entry from quiescence 
In human cells there exist numerous control points that regulate progression through cell 
cycle phases (Charollais et al., 1994). The Thomas laboratory identified the 
“commitment point” as the point during the transition from G0 to G1 phase after which 
continued stimulation of CD3 and CD28 are no longer needed for T-Cells to progress 
into the cell cycle (Lea, Orr, et al., 2003). This study identified that T-Cells require 3-
5 hours of continuous CD3/CD28 stimulus to commit to entering the cell cycle. If the 
stimulus is stopped earlier than this, cells remain quiescent. This G0 - G1 commitment 
point requires the activation of CDK4/6 – Cyclin D since cell cycle entry is inhibited 
by adding TAT-p16INK4A, which enters the cells and inhibits both CDK4 and CDK6 
activity. Transition through the commitment point is also necessary for T cells to enter 
the growth cycle and increase in size, but transition through the commitment point is 
not required for induction of effector functions. This study showed that entry into the 
cell cycle and the growth cycle could be uncoupled from the expression of T-Cell early 
effector functions (Lea, Orr, et al., 2003). A subsequent study from the laboratory 
showed that entry into the cell cycle from quiescence and entry into the growth cycle 
could also be uncoupled (Orr et al., 2012). 
 
3.1.2.4.3.2  Checkpoints during the G1 phase 
There exists another control point during the G1 phase called the restriction point. This 
restriction point (R-point) is the point beyond which cells no longer need growth factors 
to enter the S phase of the cell cycle. Although the R-point was identified using 
fibroblasts (Pardee, 1974) an analogous control point may exist in other cell types, such 
as T-Cells (Cantrell & Smith, 1983). The restriction point in T-Cells involves 
stimulation via the IL-2 receptor. IL-2 withdrawal causes T-Cells to exit the cell cycle 
and arrest in mid/late G1. Re-stimulation with IL-2 causes re-entry into S-phase, which 
takes a shorter time than the transition into S-phase from quiescence (Cantrell & Smith, 
1984; Cantrell et al., 1988). However, in T-Cells, there is an activation-induced cell 
death program that protects against inappropriate, repeated T-Cell proliferation by 
triggering apoptosis (Rodríguez-Tarduchy & López-Rivas, 1989; Shi et al., 1990). IL-
2 control is executed in part by causing degradation of the p27kip1 cyclin-dependent 





kinase inhibitor (CKI) (Boonen et al., 1999; Moore et al., 2001). In the absence of the 
IL-2 signal, p27kip1 functions as an inhibitor of cell cycle progression as it inhibits the 
activation of the cyclin-dependent kinase Cdk2-Cyclin E (Pavletich, 1999; Sherr, 
1994). 
Various cyclin–CDK complexes are involved in progression through G1 
(Hengstschläger et al., 1999) by phosphorylating proteins such as pRb. When pRb is in 
a hypophosphorylated state, it binds and inhibits E2F transcription factors (Weinberg, 
1995). Upon phosphorylation by cdk4-Cyclin D and cdk2–Cyclin E complexes on sites 
including serine 807 and 811, it releases E2F transcription factors to activate the 
transcription of genes encoding proteins required for progression through the cell cycle 
and other cellular programmes (MacDonald & Dick, 2012; Thomas, 2004; Weinberg, 
1995). pRb is one of a family of three proteins, the others being RBL1 (p107) and RBL2 
(p130). Both of these proteins control the progression of cells into the cell cycle by 
inhibiting E2F activity (Cobrinik, 2005) and there is evidence that the main complex 
in quiescent haemopoietic cells, including T-Cells is p130-E2F4-DP1 (Thomas et al., 
1998; Williams, Linch, et al., 1997).  
 
3.1.2.4.3.3  The function of Cyclins, CDKs and CKIs 
The Cyclin family are a conserved group of proteins which are fundamentally involved 
in regulating the cell cycle. Cyclins were originally discovered as proteins that are 
synthesised and degraded cyclically as cells progress through the cell cycle (Evans et al., 
1983). Cyclins are subunits of CDK holoenzyme5 (cyclin-dependent kinase) complexes 
which regulate cell cycle checkpoints by phosphorylating specific target proteins on 
Serines and Threonines (Reviewed in Goodman, 2008). To date, more than 20 cyclins 
and cdks have been discovered in higher eukaryotic cells, many with unknown 
functions (Goodman, 2008; Kalra et al., 2017). 
 
The discovery of cyclins and CDKs were major scientific breakthroughs that were 
celebrated by the Nobel prize in 2001 awarded to Tim Hunt, Paul Nurse and Leland 
                                                   
 
5 Holoenzyme is a biochemically active molecular complex that is formed of an enzyme and a coenzyme. 





Hartwell. Hartwell found genetic mutants of yeast that affect the cell cycle, which he 
termed cell division cycle (CDC) mutants. He identified CDC28, which affects 
progression through G1 and G2/M in S. cerevisiae (Hartwell et al., 1970). Later Paul 
Nurse identified the cdc2 gene, a homologue that controls mitosis in another yeast, S. 
pombe (Nurse & Thuriaux, 1980). The regulatory mechanisms involving CDC28/Cdc2 
are conserved in all eukaryotes (Lee & Nurse, 1987). Cdc2 (known as Cdk1 in higher 
eukaryotes) is the only cyclin-dependent kinase that is required in mice and CDK1-/- 
mice are not viable as no cell division takes place (reviewed in Malumbres & Barbacid, 
(2009)). 
 
The literature currently categorizes the cyclins to two groups based on their 
involvement in regulating the cell cycle. There are G1/S cyclins, such as the D-type 
cyclins which regulate CDK4/6 (Sherr & Roberts, 1999) and E-type cyclins which 
regulate CDK2 (Sherr & Roberts, 1995)(Ajchenbaum et al., 1993). The amount of 
Cyclin-D3 is increased significantly in T-Cells that have encountered a mitogen 
stimulus, which suggest that this cyclin may also have a role in responding to external 
stimuli that cause procession into the cell cycle from quiescence (Lea, Orr, et al., 2003). 
The second group are G2/M cyclins, which include B-type cyclins which regulate 
CDK1 (Porter & Donoghue, 2003). 
 
Cdk activity is under the control of cyclin-dependent kinase inhibitors (CKIs). Two 
major groups of CKIs can be categorised. The first group is INK4: p16INK4A, p15INK4B, 
p18INK4c and p19INK4D, which are inhibitors of Cdk4 and Cdk6 (Jeffrey et al., 2000). 
The second group of CKIs are Cip/Kip proteins, and members of this group are p21Cip1, 
p27Kip1 and p57Kip2. These enzymes are known to inhibit cdk2 complexes (Vidal & 
Koff, 2000). However, depending on the stoichiometry, p21Cip1 can either stimulate or 
inhibit Cdk2-Cyclin E/A activity and CKIs also have roles in other cellular functions 
such as apoptosis, transcription and cell fate (Besson et al., 2008). 
 





3.1.3  Regulation of the size of human cells 
As I have stated above T-Cells are under rigorous regulation and cell size is controlled 
within a narrow range. The growth of T-Cells (Blastogenesis) is regulated by mTOR 
pathways both in the quiescent state via Tsc1 (Yang et al., 2011) and in an activated 
state (Fingar et al., 2002; Terada et al., 1995). Indeed, a study suggests that 
development of T-Cells can be tracked by cellular size, which is regulated by mTOR 
activity (Pollizzi et al., 2015). 
 
3.1.3.1  Reported cell size regulators 
There are many known cell size regulators of T-Cells, some of them are related to the 
mTOR pathways, while some of them are independent of mTOR. Two examples are 
the Cytotoxic T lymphocyte antigen-4 (CTLA-4), an inhibitor of T-Cell responses 
which regulates the size of CD4+ T-Cells during an early phase of activation (Kuhns et 
al., 2000). Studies suggest that CTLA-4 is connected to the Akt/mTOR pathways 
(Karman et al., 2012). Another mTOR independent (Miluzio et al., 2016) example is 
eIF6 (Orr et al., 2012). The eIF6 protein regulates 60S ribosome biogenesis and my 
laboratory showed that reducing the induction of eIF6 in T-Cells during the G0 to G1 
transition with siRNA results in cell cycle entry at a reduced cell size (Orr et al., 2012). 
  





3.1.3.2  The quest for novel cell size regulators 
Silencing or reducing the expression of a given gene can be achieved by using CRISPR-
Cas9, ribozymes, DNAzymes, antisense oligodeoxynucleotides (ASO) or small 
interfering RNA (siRNA). The siRNA process is reviewed by Scherer and Rossi (2003) 
(Scherer & Rossi, 2003). To find novel cell size regulators, I followed an siRNA-
mediated "knock-down" method that was published previously by our laboratory (Lea, 
Buggins, et al., 2003; Orr et al., 2010, 2012). As described above, quiescent T-Cells do 
not contain many proteins that are essential for progression through the cell cycle and 
other cellular processes, or these proteins are expressed at very low levels. CD3/CD28 
stimulation induces the genes encoding these proteins that are required for progression 
through the cell cycle. The Thomas laboratory showed that 100% of quiescent T cells 
can be transfected with siRNA (Lea, Buggins, et al., 2003) and this method could be 
used to reduce the induction of specific mRNA and hence the protein encoded, which 
would normally occur in response to CD3/CD28 stimulation (Orr et al., 2010, 2012).  





3.1.4  Predicted cell size regulator proteins 
As I showed in the previous Chapter, a distinct group of proteins have been identified 
that are potentially capable of regulating the size of human cells (see in Chapter 2.3 ). I 
selected TCTP/TPT1, TP53RK, VBP1, VPS18 and TNPO3 as candidates for 
experiments with human T-Cells, together with the prefoldin complex protein VBP1 
(von Hippel-Lindau binding protein 1). The DNA replication protein MCM7 is also 
included in the screen as a technical control for the effectiveness of siRNA transfection 
and siRNA-mediated reduction of the induction of Mcm7, which normally occurs in 
response to CD3/CD28 stimulation (Orr et al., 2010). 
 
3.1.4.1  TCTP protein in human  
Translationally Controlled Tumour Protein (TCTP) is a highly conserved, 
multifunctional protein that is involved in many fundamental biological processes and 
disorders either in human or other species (Bommer, 2017). The protein is located in 
the cytosol (Sanchez et al., 1997) and the nucleus (Cheng et al., 2012) of cells. It is 
encoded by the Tumour Protein, Translationally-Controlled 1 (TPT1) gene that is 
located on Chromosome 13 between 13q12 – q1413 (MacDonald et al., 1999). 
 
3.1.4.1.1  The history of the TCTP protein 
The TCTP protein was first identified more than 30 years ago as Q23 in the serum-
stimulated Swiss 3T3 mouse cell line (Thomas et al., 1981), then a year later in mouse 
sarcoma ascites cells as P21 (Yenofsky et al., 1982). The mouse cDNA was cloned and 
sequenced in 1988 (Chitpatima et al., 1988). At the time, the function of the protein 
was unknown, and naming was inconsistent in the literature, merely based on its 
measured molecular weight. In human, the protein was first discovered in Ehrlich ascites 
tumour cells as P23 (Benndorf et al., 1988). A year later the protein was named as 
“Translationally Controlled Human Tumor Protein” (Gross et al., 1989) based on the fact 
that the synthesis of the protein is under translational control in the ascites tumour cell 
line (Böhm et al., 1989) and the human cDNA was cloned from human mammary 





carcinoma cells (Gross et al., 1989). TCTP is a protein that has a wide range of effects, 
including histamine release (named Histamine-releasing factor (HRF)) (MacDonald et 
al., 1987, 1995) and as an anti-apoptotic protein (fortilin) (Li et al., 2001). Since early 
2000 the naming has been consistent in all species where the protein or its homologues 
are present (Bommer, 2017). TCTP is the protein name, and TPT1 is the commonly 
used as gene name (Thiele et al., 2000), with the exception of yeast, where the gene 
symbol is YKL056c, and the protein name is TMA 19 (Fleischer et al., 2006). 
3.1.4.1.2  Conserved protein 
Studies show that the sequence of TCTP is evolutionarily conserved in eukaryotes 
(Hinojosa-Moya et al., 2008; Thayanithy & Venugopal, 2005; Yubero et al., 
2009)(Hinojosa-Moya et al., 2008). The TCTP protein is expressed in all eukaryotic 
cells and tissues where it has been investigated (Bommer, 2017; Hinojosa-Moya et al., 
2008; Thiele et al., 2000), although the level of expression is significantly lower in 
terminally differentiated tissues (Bommer & Thiele, 2004). TCTP seems to be an 
essential protein in mammalian early development, as TPT1-/- is embryonic lethal in 
mice (Chen et al., 2007; Koide et al., 2009; Susini et al., 2008) 
3.1.4.1.3  The TPT1 gene, mRNA and 3D structure 
The structure of the TPT1 gene of 4000 nucleotides was first characterised in rabbit and 
has six exons, and five introns (Thiele et al., 1998) and the human TPT1 gene is similar 
(Andree et al., 2006). The transcription of the gene results in two different mRNAs, 
both in rabbit (Thiele et al., 2000) and human cells (Andree et al., 2006), while the open 
reading frame of the mammalian mRNA encodes a protein of 172 amino acids (Thiele 
et al., 2000). The 3D structure of the yeast protein was first characterised, and this 
revealed similarity with the Mss4/Dss5 protein family (guanine nucleotide-free 
chaperones) (Thaw et al., 2001). The characterisation of the human structure revealed 
a folded core region in line with a long flexible loop (Feng et al., 2007; Susini et al., 
2008). The 3D structure of the human protein has eleven β-strands with three α-helixes 
(Figure 3.1-5).  







Figure 3.1-5: 3D structure of human TCTP protein 
Two major secondary structure elements of the protein can be recognised: a β 
stranded core domain that consists of eleven β strands from three different β sheets, 
with three α-helixes, a more extended pair of them at the front and a shorter one at 
the back. These connect to a flexible loop region (thin lines). An α-helical hairpin 
connects the two α-helixes. 
The Figure was taken with Protein Data Bank 3D Structure viewer using EMBL-
EBI website ( ).  
Source PDB id: 1yz1 (Susini et al., 2008) 
  





3.1.4.1.4  Function of TCTP 
3.1.4.1.4.1  Chaperonin functions of TCTP and ion homeostasis 
TCTP functions as a heat shock protein with chaperonin like activity (Gnanasekar et 
al., 2009; Mak et al., 2007) and conserved members of the HSP70 family interact with 
TCTP (Li et al., 2016). The protein has a role in sensing and repairing DNA damage 
(Zhang et al., 2012). TCTP also binds Ca2+ and plays a substantial role in maintaining 
ion homeostasis (Haghighat & Ruben, 1992). 
 
3.1.4.1.4.2  TCTP and Apoptosis 
Another key function of TCTP is its anti-apoptotic activity (Bommer, 2017). Anti-
apoptotic proteins from the Bcl2 family cooperatively interact with TCTP (Liu et al., 
2005; Zhang et al., 2002) and TCTP is thought to prevent apoptosis by counteracting 
the pro-apoptotic activity of Bax (Susini et al., 2008). TCTP also prevents p53-
mediated apoptosis by stimulating its degradation (Amson et al., 2012; Chen et al., 
2011; Rho et al., 2011).  
 
3.1.4.1.4.3  TCTP in mitosis and meiosis 
The TCTP protein has been shown to locate to microtubules during the cell cycle 
(Gachet et al., 1999) and the protein plays a role in binding to the mitotic spindle poles 
(Bazile et al., 2009; Jaglarz et al., 2012). TCTP also has a function in stabilizing 
microtubules during meiosis (Tani et al., 2007). 
 
3.1.4.1.4.4  TCTP and cell growth 
It has been revealed that TCTP protein levels are transcriptionally regulated via PI3-
Kinase / mTOR pathways in Drosophila (Hsu et al., 2007) and human cells (Dong et 
al., 2009). However this finding has been challenged (Wang et al., 2008). The protein 
reportedly has a direct effect on cell growth (Bommer et al., 2015). In the other hand, 
TCTP binds to one of the cytoplasmic domains of the Na, K-ATPase, that results in the 
activation of Src kinase that triggers the PI3K/Akt and Ras/Raf/ERK pathways (Jung 
et al., 2011). 
 





3.1.4.1.5  TPT1 and cancer 
3.1.4.1.5.1  TCTP role in cancer cells 
Despite the name transitional tumour control protein, the finding that TCTP proteins 
are linked to cancer was made only late in 2009 (Telerman & Amson, 2009). TCTP 
protein levels are overexpressed in human tumours and cancer cells, while they have 
also been shown to downregulate tumour suppressor genes, such as p53 (Acunzo et al., 
2014; Telerman & Amson, 2009). It has been shown that TCTP is also capable of 
promoting the transition from epithelial cells to mesenchymal cells, that is a fundamental 
step in invasive cancer (Bae et al., 2015). While a study also reported that reducing the 
expression of the TCTP protein inhibits the proliferation and invasion of LoVo colon 
cancer cells (Chu et al., 2011; Ma et al., 2010) 
 
3.1.4.1.5.2  TCTP: Cell growth in cancer 
It has been reported that TCTP actively induces proliferation and cell growth in early 
stages of colorectal cancer at the adenoma stage (Bommer et al., 2017; Xiao et al., 2016) 
and it is known to be upregulated through the PI3K/Akt pathway (Zhang et al., 2009). 
 
3.1.4.1.5.3  TCTP: Mitosis in cancer 
Mitotic functions of TCTP were investigated using hepatocellular carcinoma cells. The 
studies found that overexpression of TCTP occurs as a result of CHD1L oncogene 
activity (CHD1L is a chromatin helicase) and the number of defects during mitosis 
increased (Chan et al., 2012). 
 
3.1.4.1.5.4  TCTP and chemoresistance  
The connection between chemoresistance and the TCTP protein was studied in non-
Hodgkin lymphomas (He et al., 2015). Results of work on breast cancer showed that 
phospho-TCTP levels are an indicator of the mitotic activity of cancer cells that are 
resistant to treatment (Lucibello et al., 2015). 





3.1.4.1.6  TCTP and cell size 
TCTP has been reported to bind to a member of the TOR pathway called Rheb6 in 
Drosophila, which leads to the regulation of cell number, cell size and cell growth (Hsu 
et al., 2007), and cell development (Hong & Choi, 2013). Reports of experiments using 
diabetic mouse cells also stated that TCTP expression is elevated in glomerular cells, 
plus the reduction of cell size in podocytes can be seen after the reducing the expression 
of the TCTP protein (Kim et al., 2012).  
 
The TCTP protein has many cellular functions, as described above and it is unclear 
whether TCTP has a direct effect on cell growth. It may regulate cell size indirectly 
since it is a chaperonin molecule, which is responsible for the correct folding of a number 
of cellular proteins (Gnanasekar et al., 2009; Mak et al., 2007) (see Section 3.3.4.2.2 
below). 
3.1.4.2  TP53RK protein in humans 
TP53RK, also known as PRPK (p53 related protein kinase) is a highly conserved 20 
kDa protein kinase (Miyoshi et al., 2003). The TP53RK protein was first characterised 
in budding yeast as YGR262c (Stocchetto et al., 1997), then later in human IL-2 
activated cytotoxic T-Cells (Abe et al., 2001). The protein was shown to regulate p53 
by phosphorylation on Serine 15 (Miyoshi et al., 2003). Phosphorylation of S15 impairs 
the binding of MDM2 and leads to the accumulation and activation of p53 (Shieh et al., 
1997; Tibbetts et al., 1999).  
3.1.4.2.1  p53 protein 
The p53 protein is a well-known tumour suppressor protein (Levine, 1997). The 
expression levels of p53 are controlled by MDM2, an E3 ubiquitin ligase (Hu et al., 
2012) that causes the degradation of p53 (Haupt et al., 1997; Honda et al., 1997). It is 
                                                   
 
6 Rheb, Ras homolog enriched in brain, is a small GTP-binding protein that is the target of the mTORC1 
complex and leads to a phosphorylation cascade that results in cell growth and proliferation (Mazhab-
Jafari et al., 2012). 





possible to inhibit the connection by phosphorylating sites at the N-terminus of p53, 
such as S15 (Nakamura et al., 2000). In addition to TP53RK, p53 can be 
phosphorylated by numerous proteins including checkpoint kinases (Hirao et al., 2000; 
Shieh et al., 2000), DNA dependent kinases (Lees-Miller et al., 1992), mitogen-
activated protein kinases (Milne et al., 1994) and casein kinase 1 (Sakaguchi et al., 
2000). 
3.1.4.2.2  Serine 15 sites of p53 
The serine 15 site of p53 is very important for its regulation (Loughery et al., 2014). 
This site is phosphorylated by ATM and ATR protein kinases in response to DNA 
damage (Meek, 2009) and substitution of S15 causes p53 to lose the ability to respond 
to DNA damage and to activate transcription (Loughery et al., 2014). Activation of 
transcription by phospho-S15-p53 is thought to be due in part to induction of the 
histone lysine acetyltransferase activities of p300 and CBP proteins (Dornan & Hupp, 
2001). However, the N-terminal domain of p53 is also phosphorylated on other sites, 
such as Serines 6, 9, 20, 33, 37, 46, and Threonine 18 that are involved to some extent 
in stabilization, MDM2 binding and transcription (Ashcroft et al., 1999; Sakaguchi et 
al., 1998). 
3.1.4.2.3   Regulation of TP53RK 
TP53RK is under the regulation of the Akt/PKB protein kinase (Facchin et al., 2007). 
Also, TP53RK is regulated and inhibited by CGI-121, a TP53RK binding protein in 
yeast (Miyoshi et al., 2003). 
3.1.4.2.4  KEOPS multiprotein complex 
Two independent laboratories have described a group of proteins that are highly 
conserved and responsible for telomerase maintenance, transcriptional regulation and 
the modification of tRNA (Srinivasan et al., 2011). One termed it the KEOPS complex 
(kinase, putative endopeptidase and other proteins of small size) (Downey et al., 2006). 
Another named It the EKC complex (Endopeptidase-like Kinase Chromatin-
associated) (Kisseleva-Romanova et al., 2006), but KEOPS is the most commonly used 
name in the literature. The KEOPS complex consists of five proteins: LAGE3 (Pcc1p 





in yeast), OSGEP (Kae1p in yeast), TP53RK (Bud32p in yeast) and TPRKB (Cgi121p 
in yeast). A recent study has revealed that reducing the expression of TP53RK slows 
down the migration of human podocytes, but also accelerates cytoskeletal defects 
(Braun et al., 2017). Moreover, a gene defect affecting any member of the KEOPS 
complex results in Galloway–Mowat syndrome, primary microcephaly with nephrotic 
syndrome (SRNS) (Braun et al., 2017). 
 
3.1.4.2.5  TP53RK and cancer 
TP53RK mutants have been reported to occur in cancer as they restrain the pro-
apoptotic activity of the protein after mitotic stress. A screen showed that reducing the 
TP53RK protein may sensitise cancer cells to taxanes (Peterson et al., 2010). 
 
3.1.4.2.6  Properties of the TP53RK homologue in the mouse 
The TP53RK homologue gene Trp53rkb in the mouse has been knocked-out (White et 
al., 2013) and there was no difference in the percentage or phenotypes of white blood 
Trp53rkb-/- cells at six weeks or at 16 weeks (see Figure 3.1-6 for details). However, the 
effects of the knockout on sizes of white blood cells was not measured. 
 
3.1.4.2.7  TP53RK protein and cell size  
TP53RK is a part of KEOPS complex, as described above and it is highly conserved in 
multiple species. TP53RK was reported as a cell size regulator in fission yeast (Hayles 
et al., 2013) and a body size defective protein in Drosophila (Björklund et al., 2006). 
Furthermore, it was reported recently that the protein is required for PI3K/TOR 
pathway dependent growth in Drosophila (Ibar et al., 2013). This information suggests 
TP53RK may regulate cell size in more species, such as humans. 
 






Figure 3.1-6: Phenotype analysis of mouse TP53RK knock out cells 
The data shows the effects of mouse Trp53rkb-/- as compared with the normal 
population. The phenotypes of peripheral white blood cells show a normal 
distribution of percentage and number (colour code: blue = normal; red = different) 
Source:  (White et al., 2013) 





3.1.4.3  Prefoldin group in human cells 
3.1.4.3.1  Protein folding and chaperones 
Protein folding is an active molecular process whereby proteins gain their final 
multidimensional conformation required for functional activity (Anfinsen, 1973). 
Molecular chaperonins modulate, assist and stabilise a range of proteins to acquire the 
necessary conformation (Hartl, 1996). Chaperonins play a role in protein folding, 
protein assembly, trafficking and degradation that is necessary for development (Hartl 
et al., 2011). Chaperonins can be categorised into two distinct categories based on their 
different functions: group I proteins are present in eubacteria and eukaryotic organelles, 
while group II proteins are present in archaea and eukaryotic cytosol (Yébenes et al., 
2011). 
 
Prefoldins are group II chaperonins which fold newly synthesised polypeptide chains, 
including actins and tubulins (Geissler et al., 1998; Vainberg et al., 1998) and play a 
fundamental role in the maintenance of cellular homeostasis (Martín-Benito et al., 2007; 
Siegert et al., 2000). Prefoldins bind proteins as they are translated then transport them 
to the chaperone Tric/CCT with the help of HSP70 and HSP40 (Geissler et al., 1998; 
Hartl & Hayer-Hartl, 2002). In eukaryotes, prefoldins form a jellyfish-like 
heterohexameric protein complex, that consist of six conserved subunits: two α subunits 
and four β subunits (Siegert et al., 2000). α subunits are PFD3 (commonly named 
VBP1, gene name PFDN3) and PFD5, while β subunits are PFD1, PFD2, PFD4 and 
PFD6 (Siegert et al., 2000). This unified structure determines the substrate specificity 
of prefoldins (Abe et al., 2013). Studies have revealed that prefoldins play a crucial role 
in the cytoskeletal maintenance and cell growth and deletion of individual prefoldin 
genes slow growth and cause cytoskeletal defects (Geissler et al., 1998; Siegers et al., 
1999). Another study suggests that prefoldins play a modifier role by recognising 
misfolded proteins and reducing cellular toxicity. An example is the recognition of 
added aggregates of the Huntington protein (Abe et al., 2013; Tashiro et al., 2013). 





3.1.4.3.2  Individual members of the prefoldin family 
Prefoldin proteins have an individual role in addition to their function as part of a protein 
complex. PFDN1 knock-out mice have cerebellar atrophy (Cao et al., 2008). PFDN5-/- 
mice (commonly named as MM-1 α) also have this phenotype in addition to male 
infertility and the death of Purkinje cells (Lee et al., 2011). The MM-1 α/PFD5 protein 
is a tumour suppressor and inhibits the function of c-MYC (Mori et al., 1998) that results 
in the inhibition of cell transformation and cell movement (Fujioka et al., 2001). The 
PFD2 protein controls the expression of nutrition-related genes by forming a large 
protein complex with URI and RPB5 (Abe et al., 2013; Gstaiger et al., 2003). 
VBP1/PFD3 (von Hippel-Lindau-binding protein 1) is the member of the ubiquitin 
protease system which causes protein degradation (Mousnier et al., 2007; Tsuchiya et 
al., 1996). VBP1/PFD3 also plays a role in virus replication during HIV-1 infection 
(Mousnier et al., 2007). 
 
3.1.4.3.3  Prefoldins and the cell size 
Some of the prefoldins reportedly affect cell size of budding yeast (Hayles et al., 2013). 
However, systematic screening has not been carried out to determine whether they also 
regulate the size of human cells. Therefore, I picked VBP1/PFD3, PFD2, PFD5 and 
PFD6 to test (see Results section 3.3.4 ). 
  





3.1.4.4  The MCM7 protein 
Eukaryotic DNA replication is rigorously controlled since mistakes cause genomic 
instability and lead to diseases such as cancer. The pre-replicative complex (Pre-RC) 
plays a fundamental role in the initiation of DNA replication. Members of this complex 
include the origin recognition proteins (ORC), CDC6, CDC7, CDT1 and the mini-
chromosomal maintenance proteins (MCMs) (Zheng et al., 2017). The latter consists 
of six homologous proteins that form a hetero-hexamer structure. MCM proteins and 
the complex are highly conserved in plants as well as in humans (Nieduszynski et al., 
2005). Once the MCM helicase proteins form the structure at DNA replication sites, 
the replication of DNA starts (Blow & Hodgson, 2002), subject to strict control. The 
mechanisms involved are beyond the scope of this introduction but are reviewed in 
(Riera et al., 2017). 
 
3.1.4.4.1  Genomic instability in human T-Cells 
Work from my laboratory using human peripheral blood T cells reported that reducing 
MCM levels results in genomic instability, with increased levels of centromere 
separation, premature chromatid separation and severe chromosome defects including 
chromosome loss, gain and translocations (Orr et al., 2010). Reducing MCM levels with 
siRNA in T cells stimulated via CD3/CD28 to enter the cell cycle from G0 results in a 
reduction in the percentage of cells in S-phase and an increase in cells in G2 (Orr et al., 
2010). The absolute abundance of individual MCM proteins has been quantified and in 
quiescent (G0 phase) cells there are low numbers of MCM proteins compared with 
proliferating cells (Orr et al., 2010; Stoeber et al., 2001). Detecting cells containing high 
levels of MCM protein expression has been proposed as a means of identifying abnormal 
proliferating cells in cancers such as cervical and bladder cancers (Dudderidge et al., 
2010; Williams et al., 1998). 





3.2  Materials and Methods 
3.2.1  Testing using human T-cells 
The human experiments were carried out exclusively on peripheral blood T-Cells. 
These T-Cells were isolated from a leukocyte cone of a normal single, healthy, 
anonymous donor (obtained from the National Health Service Blood and Transplant 
Service (NHSBT), Tooting, London, United Kingdom) with ethical consent. 
 
3.2.2  Location 
Experiments with human T-Cells were carried out in the Rayne Institute, Department 
of Haematological Medicine at the Denmark Hill Campus of King’s College London, 
United Kingdom. All the experimental methods that are explained below are based on 
published literature and common laboratory usage. 
 
3.2.3  Reagents 
All materials were purchased from Sigma-Aldrich unless it is otherwise stated. PBS 
tablets were bought from Oxiod, while methanol and ethanol were bought from Fisher 
Scientific. 
  





3.2.3.1  General reagents 
Table 3.2-1. List of general laboratory reagents  
Reagent name Provider 
1.5 ml microcentrifuge ‘Eppendorf’ tubes StarLabs 
ECL-Plus Chemiluminescence detection kit GE Healthcare 
Hybond C-Extra membrane GE Healthcare 
Hyperfilm – ECL GE Healthcare 
Novex Sharp Pre-Stained Protein Standard 
(Western Blot Marker) 
InVitrogen 
NuPAGE 4-12% (w/v) polyacrylamide 
BisTris gels 
InVitrogen 
NuPAGE LDS sample buffer (4x) InVitrogen 
NuPAGE Running Buffer InVitrogen 
NuPAGE Transfer Buffer InVitrogen 
Saran Wrap  Commercially available from Sainsbury's 
Skimmed milk powder Commercially available, Marvel 
Trizol InVitrogen 
Whatman 3MM paper VWR International Ltd 
 





3.2.3.2  Tissue culture reagents and equipment 
Table 3.2-2. List of tissue culture reagents and equipment 
Reagent name Provider 
15 ml and 50 ml (Falcon) centrifuge tubes VWR International Ltd 
15 ml Pipettes VWR International Ltd 
6 well plates (TPT plates were used for 
siRNA transfections) 
VWR International Ltd 
Anti CD3/CD28 immunomagnetic beads InVitrogen 
Foetal calf serum (FCS) InVitrogen 
Hematopoietic Media (X-VIVO) InVitrogen 
Histoplaque 1077 InVitrogen 
Human serum Invitrogen 
Human T-Cell Nucleofection Kit  
(including Transfection Buffer) 
Lonza 
siRNA Dharmacon or SIGMA (see Table 3.2-9) 
T Cell Negative Isolation Kit InVitrogen 
Vented tissue culture flasks VWR International Ltd 
 





3.2.3.3  Enzymes, Solutions and Buffers 
Table 3.2-3. List of enzymes, solutions and buffers 
Reagent name Provider 
SDS lysis buffer (4x) 
125 mM Tris-HCl pH 6.8, 4% (w/v) SDS, 
40% (v/v) Glycerol, 200 mM DTT 
Cell cycle stain 
40μg/ml Propidium Iodide, 5μg/ml 
Fluorescein isothiocyanate and 1μg/ml of 
RNase A in PBS 
MES SDS Running Buffer for Western Blots 
  
50mM MES, 50mM Tris, 0.1% (w/v) SDS, 
1mM EDTA, pH 7.3 
MES SDS Transfer Buffer for Western Blots 
25mM Bicine, 25mM Bis-Tris, 1mM EDTA, 
pH 7.2 plus 20% (v/v) Methanol 
Phosphate Buffered Saline (PBS) 
1 tablet (phosphate buffer, potassium 
chloride 0.02% (w/v), sodium chloride 
0.8%(w/v)) dissolved per 100ml of H2O 
Primary antibody incubation buffer 
3% (w/v) BSA, PBS, 0.05% (v/v) Tween-
20 
RNase A 10 mg/ml in dH20 
Secondary antibody incubation buffer 
10% (w/v) Non-fat dried milk, PBS, 0.05% 
(v/v) Tween-20 
Western Blot blocking solution (PBST) 
10% (w/v) Non-fat dried milk, PBS, 0.05% 
(v/v) Tween-20 
Western Blot wash buffer PBS, 0.05% (v/v) Tween-20 
 





3.2.3.4  Equipment 
Table 3.2-4. List of major equipment 
Name Provider 
Azure C300 chemiluminescent imager Azure Biosystems 
Becton Dickinson FACS Caliber Canto II - 
Flow cytometer 
BD Biosciences 
Cellometer Auto T4 Cell Counter Nexcelom Bioscience 
FlowJo Software (version 9) Flow Jo Inc 
Light microscope  
with lens 4x-10x-40x-100x 
Nikon 
Nucleofector 2b Device Lonza 
 
3.2.4  Isolation of Quiescent T-Cells  
Quiescent T-Cells were isolated from a single-donor leukocyte cone from a healthy, 
human donor. The cone was delivered in the morning to the laboratory; then the 
following protocol was followed. 
 
The white cells in the leukocyte cone were diluted 1:1 with Phosphate Buffered Saline 
(PBS) (Dulbecco) and gently pipetted into 50 ml tubes. These diluted cells were layered 
over an equal volume of Histopaque 1077 (Sigma) in 50ml (Falcon) centrifuge tubes, 
then centrifuged for 30 minutes at 560 × Gmax with no brake. Thereafter, PBMCs that 
form a layer at the Histopaque/PBS interface was removed with a Pasteur pipette and 
resuspended in 50 ml PBS, then centrifuged at 400 × Gmax for 10 minutes. The 
remaining platelets were removed by resuspending the cell pellet in 50 ml PBS with the 





addition of 2% (v/v) Foetal Bovine Serum (FBS) (Sigma) and centrifugation at 200 × 
Gmax. This process was carried out three times. 
 
After the third wash, the numbers of live and dead cells were determined by manual 
counting. A small aliquot of PBMC were mixed with 0.4% (w/v) Trypan blue solution 
(Sigma) (1:1 (v/v) ratio) and visualised using a light microscope (Nikon) and live/dead 
cell numbers were determined by counting non-stained/blue cells using a Neubauer 
Improved counting chamber (0.0025 mm2 resolution). A full leukocyte cone yielded 
around 1 billion (1 × 109) PBMC. For my experiments, I usually used 2.5-5 × 108 PBMC 
from which to isolate T-Cells. 
 
Non-activated, quiescent T-Cells were isolated from the PBMC by negative selection 
using the T-Cell Negative Isolation Kit (Invitrogen). The following antibodies are 
present in the kit: anti-CD14, anti-CD16 (a and b), anti-CD56 and CD235a. I also 
supplemented the kit with anti-HLA class II (DR and DP) to remove any activated T-
Cells. The antibodies were incubated with the PBMCs at 4oC for 20 mins with constant 
rolling. The T-Cells were collected by centrifugation at 400 × Gmax for 8 mins and then 
washed twice with room temperature PBS, 2% (v/v) FCS and centrifugation at 400 × 
Gmax for 8 mins. The pelleted cells were then resuspended in 50 ml PBS, 2% (v/v) FCS 
and were incubated with anti-immunoglobulin-conjugated magnetic beads (Invitrogen) 
for 20 minutes at room temperature with constant rolling. Vigorous pipetting with a 5 
ml pipette dispersed bead clumps. Cells other than non-activated T-Cells bind to the 
beads and were removed using a magnetic tube holder (Invitrogen). In the supernatant, 
the unbound cells are a mixture of CD4+ and CD8+ quiescent T-Cells. Bead removal 
was repeated if it was necessary after microscopic inspection. The non-activated, 
quiescent T-Cells were then seeded in X-VIVO media (Invitrogen) at 1-4 × 106 
cells/ml, then kept in a tissue-culture incubator in a fully humidified 5% CO2 
atmosphere at 37oC until further use. Experiments with isolated T-Cells were started 
within 24 hours of the isolation. 
 





Each full T-Cell isolation kit typically yielded 1.25 - 2.5 × 108 non-activated T cells. 
For those individual experiments that I have performed. I typically used ¼ or ½ of a full 
negative isolation kit. After that, typically I used between 75 – 150 million (1 × 106) T-
Cells for my experiments. 
3.2.5   Stimulation of quiescent (G0) T-Cells  
In my experiments, T-Cell stimulation was needed, and the quiescent T-Cells were 
stimulated by the addition of Dynabeads Human T-Activator CD3/CD28 magnetic 
beads (ThermoFisher Scientific) at 0.5 bead/cell (10 μl beads/1 × 106 cells). 
 
Before using the magnetic beads, they were washed with sterile PBS three times, twice 
with 20 μl PBS, then with 10 μl PBS per 10 μl beads. Beads were isolated from each 
wash step by using a magnetic tube holder, according to the manufacturer's protocol 
(Invitrogen). 
 
3.2.6  Quantifying the percentage of cells in each cell cycle phase 
Flow cytometric analysis was used to analyse the cell cycle profile of a population of T-
Cells. 2 × 105 cell samples were taken at the time points indicated in the Results section. 
The cells were petted by centrifugation at 200 × Gmax., then fixed in 400 μl of 70% (v/v) 
ethanol at -20oC. Then the samples were transferred to Fluorescence Activated Cell 
Sorter (FACS) tubes, and the fixed cells were centrifuged at 400 × Gmax for 8 minutes. 
The supernatant was discarded. The cell pellet was resuspended in 400 μl Fluorescein 
Isothiocyanate (FITC) / Propidium Iodine (PI) cell cycle stain (40 μg /ml PI, 5 μg /ml 
FITC, 1 μg / ml RNase 1, sterile PBS) and incubated for 30 minutes at 37oC. 
Subsequently, flow cytometric analysis was performed using a Becton Dickinson FACS 
Caliber Canto II machine. At least 10,000 events were recorded by the machine for 
each target population (raw version of Figure 3.2-1 part C). 
 





To analyse cell cycle data, I used Flow Jo software (version 10.0.7r2, 
) to display two-dimensional dot plots and density plots of flow 
cytometric data with different scatter and emission properties. 
 
By plotting FSC-A (Forward Scatter - Area) against SSC-A (Side Scatter - Area) the 
healthy T-Cell population was selected (lymphocyte electronic "gate") (see Figure 3.2-1 
part A). Then, by plotting Compensated-PE-A (Phycoerythrin – Area, detected the 
emission of red florescent Propidium Iodine, Exmax 495 nm / Emmax 565 nm) against 
PE-W (Side Scatter - Width) doublets were eliminated from the analysis (see Figure 
3.2-1 part B). Single cells were selected in this population of Compensated-FITC 
(Exmax 495 nm / Emmax 520 nm) plotted against Compensated-PI (see Figure 3.2-1 
part C) and electronic "gates" were applied to quantify the numbers of cells in each cell 
cycle phase according to DNA (PI-stained) and protein (FITC-stained) content: G0, 
G1, S-phase, G2/M and Sub G0/Apoptotic cells.  
 
This method to discriminate single, healthy T-Cells in the sample is based on the 
method published earlier by Thomas laboratory (Lea, Buggins, et al., 2003).  
 
The distribution of T-Cells in the gates described above was calculated then CSV 
(comma separated value) files of single cells (selected population in Figure 3.2-1 part 
B), and all cell cycle phases (Figure 3.2-1 part C) were exported for further data 
analysis. 
  







Figure 3.2-1: Density plots of CD3/CD28 stimulated T-Cells.  
T-Cells were stimulated, then a sample was taken 72h after CD3/CD28 stimulation. 
The cells were fixed, stained with PI/FITC and analysed by flow cytometry, as 
described in the text. Each dot on the plots depicts a two-parameter display of data 
for a single cell (the parameters for each plot are shown on the X- and Y-axes, as 
detailed below). The data of cells in the area (electronic "gate") in panel (A) are 
analysed in (B), and the cells in the electronic gate in (B) are analysed in (C).  
Part A: SSC-A was plotted against FSC-A to select healthy T-Cells. 
Part B: This is a sub-population of Part A. Compensated PE-A was plotted against 
PE-W to select and analyse single cells. Cell doublets were eliminated from further 
analysis as they are outside the electronic gate. 
Part C: This is a sub-population of Part B. Gates for individual cell cycle phases are 
shown, and the number of cells in each gate is calculated 
In this given example, the distribution of cells is as follows:  
(1) Sub G0/Apoptotic cells 3.73%, 
(2)  G0 - G1 combined phases: 61.2 %,  
(3) S-phase: 26.7 % and 
(4) G2/M phase: 8.24 %. 
  





3.2.6.1  Analysis of Flow Cytometric Data 
CSV files containing FACS data, such as FSC, SSC, FITC, PE, Time and Event 
number were exported and analysed using FlowJo software. After that, a script written 
in PHP programming language using PHPExcel extension 
( ) was used to individually clear, trim and 
concatenate different experiments and time points to two single XLSX excel file sheets. 
Table 3.2-5 indicates which data source was used in the Excel files.  
 
Two different export files were made: 
 
• one for each experiment and time points comparing control experiment side by 
side, 
• one for each time point comparing all experiments that were performed in 
parallel from the same donor. 
 
Table 3.2-5: List of elements of FlowJo CSV export files 
Name Area Height Width 
Forward Scatter (FSC) Used not used not used 
Side Scatter (SSC) Used not used not used 
Fluorescein Isothiocyanate 
(FITC) 
not used not used not used 
Compensated - FITC Used n/a n/a 
Phycoerythrin (PE) not used not used not used 
Compensated - PE Used n/a n/a 





3.2.6.1.1  Processing exported CSV files with Microsoft Excel 
XLSX files were processed in Microsoft® Excel for Mac (version 15) software. The 
raw data was separated from the sheets analysed; then a statistical calculation was made 
to display the basic statistics of data: 
• Number of events incorporated in each phase, 
• Minimum value, 
• Maximum value, 
• Average (Arithmetic mean), 
• Standard deviation 
• Standard error and 
• Coefficient of Variation values. 
 
Distribution of all events at a given time point was calculated, and histograms are 
presented as bar and line charts. I used 4 fluorescent light channel values as described in 
Table 3.2-6 binned for histogram analysis. These values and results were compared to 
the control population using f-test and Student’s t-test. 
 
Table 3.2-6: List of bins and ranges for histograms 
Name Binmin Binmax Bin size 
FSC A 42,000 180,000 2,000 
SSC-A 10,000 240,000 5,000 
Compensated - FITC A 10,000 240,000 5,000 
Compensated - PE A 32,000 110,000 2,000 





3.2.6.1.2  Flow Chart of the analysis method 
 
Figure 3.2-2: Flow Chart of the methods used to analyse the Flow 
Cytometric Data 
(1) FACS data were first analysed, gated in FlowJo software, then exported to 
individual CSV files for single cells and cell cycle phases: G0, G1, S-phase, 
G2/M and Sub G0/Apoptotic cells.  
(2) Data CSV files were trimmed, cleared and concatenated with PHP code using 
the phpExcel extension, then exported to XLSX files. 
(3) Basic statistics and charts were created for FSC-A, SSC-A, Compensated 
FITC-A and Compensated PE-A. 
(4) Then 5,000 events were randomly selected with the RANDBETWEEN() 
function; two randomisation methods were introduced. Finally, line and bar 
charts were created. 
  





3.2.6.1.3  Normalisation and randomisation 
To compare individual experiments with a different number of events and from different 
donors, normalisation and randomisation were introduced. Using Microsoft® Excel for 
Mac (version 15) software, 5,000 events were selected at random (with 
RANDBETWEEN() function) for each set of data being compared (including at least 
one control siRNA experiment), while two normalisation methods were used: 
 
(1) Each set of data points were divided by the mean of the control population of 







• where n = 5,000, the number of randomly selected events 
• x, individual values of FACS data for experimental data  
• y, as individual values of FACS data for control(s) 
 
(2) The second normalisation method Involves division by square root means of the 







• where n = 5,000, the number of randomly selected events 
• x, individual values of FACS data for experimental data 
• y, individual values of FACS data for control data 
  





3.2.6.2  CD3 purity test 
CD3 is only expressed on the surface of T-cells and not on other cell types in the blood, 
and so the percentage of cells that express CD3 in any given population can be used to 
determine the percentage of T-Cells present. Therefore, the CD3 analysis was used to 
determine the purity of T-Cells isolated by negative selection. The method used a CD3 
APC-H7 antibody (BD Bioscience) and was carried out within 1h of isolation. 2 × 104 
cells were removed from the isolated T-Cell population into each of two round-
bottomed FACS tubes, then each cell sample was washed with 50 ml sterile PBS and 
centrifuged at 200 × Gmax for 5 minutes. The supernatant was poured off (approximately 
100 μl PBS is left in each tube after pouring off the bulk of the supernatant), and 5 μl of 
CD3 APC-H7 antibody was added to one of the two tubes. The samples were 
incubated for 15 minutes in the fridge (temperature 5o C). T-Cell samples were 
centrifuged again at 200 × Gmax for 5 minutes, then 200 μl sterile PBS was added and 
flow cytometric analysis was performed using a Becton Dickinson FACS Caliber Canto 
II machine. The emission of the CD3 APC-H7, APC-H7-A (Exmax 650 nm/Emmax785 
nm) antibody was plotted against SSC-A to determinate the purity of T-Cells present 
in the sample (+CD3 APC-H7 versus no antibody control). 
 
3.2.7  Culturing T-Cells  
The non-activated, quiescent (G0) T-Cells isolated by negative selection were cultured 
at 1 - 4 × 106 cells/ml in X-VIVO media with 2% (v/v) FBS. Cells proliferate in 
response to CD3/CD28 stimulation and once proliferating cell numbers double every 
23h (Lea, Orr, et al., 2003). The proliferating cells were kept in the range 5 × 105 to 1 × 
106 by the addition of cell culture medium, as necessary. 
 
3.2.8  Protein lysates and western blotting 
1 × 106 cells were pelleted at 200 × Gmax for 5 mins and then lysed in SDS buffer solution 
or NuPAGE LDS sample buffer solution (ThermoFisher Scientific - Invitrogen) (see 
above; 50 μl per 1 × 106 cells). 10 μl of each protein sample was loaded onto each lane 





of a 4-12% (w/v) polyacrylamide Bis-Tris gel (ThermoFisher Scientific - Invitrogen), 
and 10 μl of Novex Protein Standards (ThermoFisher Scientific - Invitrogen) was also 
run in an appropriate lane.  
 
Proteins were separated by gel electrophoresis at 200 V / 120 mA for 1 h (1 × running 
buffer: 50 mM MES, 50 mM Tris, 1 mM EDTA, 0.1% (w/v) SDS, pH 7.3). The 
proteins separated by electrophoresis in the gel were transferred by electroblotting at 25 
V / 160 mA for 1.5 h onto a nitrocellulose membrane (Hybond C Extra, GE Healthcare) 
(1 × transfer buffer: 25mM Tris-HCl, 25 mM bicine, 1 mM EDTA, pH 7.3, 20% (v/v) 
methanol). The remaining binding sites on the nitrocellulose membrane were blocked 
by incubation in PBS, 10% (w/v) non-fat dried milk (skimmed milk powder, Marvel) 
for 30 mins at room temperature. Before antibody probing, the blot was washed quickly 
three times with 100-200 ml PBS, 0.05% (v/v) Tween-20. 
 
3.2.9  Antibody probing 
Primary antibodies were typically used at dilutions of 1:1000 in PBS, 3% (w/v) BSA, 
0.01% (w/v) NaN3. The final concentrations of primary antibodies were between 0.1 - 
1 μg/ml. The blots were incubated in primary antibodies overnight, using 50 ml tubes 
and 5 ml primary antibody solution. Subsequently, the membranes were washed 3 × 5 
mins in 100ml PBS, 0.05% (v/v) Tween-20 and incubated in the appropriate secondary 
antibody for 30 mins. Then the blots were washed three times in 100 ml PBS, 0.05% 
(v/v) Tween-20 and protein bands were detected using the ECL-Plus detection system 
(GE Healthcare). Blots were wrapped in Saran Wrap and exposed to X-ray film 
(Hyperfilm–ECL, GE Healthcare) for various periods of time and developed using a 
Compact X4 X-Ray Developer (Konica-Minolta) (until January 2016). After that, 
chemiluminescent images were acquired using a digital scanner (Azure C300 
chemiluminescent digital imager). 
 
I used the following primary antibodies stated in Table 3.2-7. 
  





3.2.9.1  Primary Antibodies used for Western Blotting 




Dilution Species Manufacturer 
C14orf166 ab49342 1:1000  Rabbit Abcam 
eIF6 #3263 1:1000 Rabbit 
New England 
Biolabs 
GAPDH ab8245 1:1000 Mouse Abcam 
Histone H3 #4499 1:500 Rabbit  
 Cell 
Signalling 
MCM4 AHP840 1:1000 Goat Bio-Rad 
MCM7 DCS-141 1:1000 Mouse Sigma 
p107 (C-18) sc-318 1:500  Rabbit 
 Santa-Cruz 
Biotechnology 
p130 sc-317 1:500  Rabbit 
 Santa-Cruz 
Biotechnology 
p53 sc-6243 1:1000  Rabbit 
 Santa-Cruz 
Biotechnology 
PFDN2 ab206691 1:1000  Rabbit Abcam 
PFDN2 ab156146 1:1000 Rabbit Abcam 
PFDN5 sc-19843 1:1000 Goat 
Santa-Cruz 
Biotechnology 
PFDN5 ab129116 1:1000 Rabbit Abcam 





PFDN6 sc-376733 1:1000 Mouse 
Santa-Cruz 
Biotechnology 
pRB ab39689 1:1000 Rabbit Abcam 
phospho-RB 
(S805/S811) 





#9286 1:1000 Mouse  
 Cell 
Signalling 
TNPO3 ab109386 1:1000  Rabbit Abcam 
TP53RK sc-85846 1:1000 Goat 
Santa-Cruz 
Biotechnology 
TPT1 / TCTP #5128 1:1000 Rabbit Cell Signalling 
VBP1 #19837 1:1000 Mouse  
 Cell 
Signalling 
VPS18 ab178689 1:1000 Rabbit Abcam 
 
3.2.9.2  HRP-Conjugated Secondary Antibodies used for Western Blotting 



























3.2.10  T-Cell transfections with siRNA 
Quiescent, non-stimulated T-Cells were transfected within 24 hours of isolation. The 
selected amount of quiescent, non-stimulated T-Cells was centrifuged at 200 × Gmax for 
5 minutes, and the supernatant was discarded. To transfect T-Cells a Nucleofector® 
device and Nucleofection solutions (Lonza) were used. The siRNA used for each target 
was either a pool of four siRNA (Dharmacon, GE-Healthcare) or custom-made single 
siRNA (Sigma), based on published sequences. 5 nmol of the Dharmacon siRNA was 
diluted with 50 µl RNase-free water to 500 µmolar concentration. For the custom-made 
siRNA, 10 nmol was diluted with 100 µl RNase-free water to 500 µmolar concentration. 
From both, 5 µl siRNA per 5 million (1 × 106) T-Cells was added to the cell pellet with 
100 µl Nucleofection reagent (Human T-Cell Nucleofector Kit, Lonza, cat # VPA-
1002). Then, the T-Cell/siRNA mix was transfected to a cuvette and Nucleofection 
was carried out using an Amaxa Nucleofector 2B device (Lonza) using programme U-
014. Transfected cells were collected gently with a micropipette then gently transferred 
to pre-warmed X-VIVO media and left for 24-72 hours to recover at 37o C in the tissue-
culture incubator. The viable T-Cells were then counted manually using a Neubauer 
Improved cell counting chamber (0.0025 mm2 resolution) in the presence of 0.4% (w/v) 
Trypan blue solution (Sigma)) (1:1 (v/v) ratio) and visualised using a light microscope 
(Nikon). Typically, ~35-40% of the original population survived the Nucleofection 
procedure. To stimulate the transfected cells, Dynabeads Human T-Activator 
CD3/CD28 magnetic beads were added to the culture media at 0.5 bead/cell (10 μl 
beads/1 × 106 cells).  





3.2.10.1  siRNA sequences 
Table 3.2-9: List of siRNA sequences  
These sequences were ordered from Dharmacon and used as stated in the table: 
(1) used as SMARTpool mix or 
(2) used as SMARTpool mix and individual sequences  
(for TPT1 only) 
The SMARTpool mix contains all four of the related targeting sequences. 

































































SMARTpool MCM4 GAUGUUAGUUCACCACUGA 





















































































































































SMARTpool VBP1 GGGCUAAUGUAAUGCUUGA 
 
 
3.2.10.2  Custom-made siRNA sequences 
Table 3.2-10: List of custom-made siRNA sequences for PFDN2 
and PFDN5.  
These sequences were published and used in the literature by two different 
publications by a research group from Hokkaido University, Japan (Abe et al., 2013; 
Miyazawa et al., 2011) 
Protein 
Name 
Producer Sense Sequence Antisense Sequence 
PFDN2 Sigma GUCUGAACGUGCUGAACAAGA UUGUUCAGCACGUUCAGACAG 
PFDN5 Sigma GCCUAGUGAUCGAUACACUGA AGUGUAUCGAUCACUAGGCUG 
 
  





3.2.11  Analysing and counting T-Cells with a Cellometer 
The analysis was carried out to analyse the viability and measure the cell size profile of 
a population of T-Cells pre and post CD3/CD28 stimulation, as described in the Results 
section. 
 
1 × 105 T-Cell samples were taken, then centrifuged at 200 × Gmax for 5 minutes. 
Subsequently, the supernatant was discarded, and the cell pellet was resuspended in 10 
µl sterile PBS. Samples were mixed with 0.4% (w/v) Trypan blue solution (Sigma) (1:1 
(v/v) ratio), thereafter 10 µl was pipetted into SD100 Slides (Nexelcom Biosciences). 
Slides were analysed with a Cellometer Auto T4 Cell Counter (Nexelcom Bioscience), 
then data was exported to CSV files for further analysis. 
 
3.2.12  Analysis of cell size profiles by light microscopy 
To analyse cell sizes of T-Cell populations, samples of 5 × 104 cells were taken, then 
centrifuged at 200 × Gmax for 5 minutes. Subsequently, the supernatant was discarded, 
and the cell pellet was gently resuspended in 20 µl sterile PBS. The samples were 
immobilised onto poly-lysine microscopic slides using a Shandon Cytospin 4 
(ThermoFisher Scientific) machine. After the cytospin had finished, the slides were 
taken to King’s College Hospital NHS Trust Foundation, Department of Haematology 
to stain them with May-Grünwald Giemsa (MGG) dye. This dye stain cells so that the 
sub-cellular structures are visible by light microscopy. Digital light microscope (Nikon) 
images were acquired, and cell sizes were analysed using NIS-Elements software. 
 
  





3.3  Results 
3.3.1  T-Cells: entry into the Cell Cycle from the quiescent state 
Peripheral blood T-Cells remain in a quiescent state in the circulation until they 
encounter a mitogenic stimulus (Thomas, 2004). Quiescent T-Cells are small and have 
2n DNA content (Ibid). In response to CD3/CD28 stimulation (Surh & Sprent, 2008) 
they activate effector functions, enter the growth cycle and become bigger and they 
enter the cell cycle and divide (Lea, Orr, et al., 2003).  
 
In my experiments I used the DNA replication protein MCM7 as a positive control for 
cell cycle regulation. This protein is not present or present at low levels in quiescent T 
cells and is induced in response to CD3/CD28 stimulation (Lea, Orr, et al., 2003). I also 
used the ribosome biogenesis protein, eIF6 as a positive control. It is also induced in 
response to CD3/CD28 and reducing the induction of eIF6 by transfecting quiescent T 
cells with siRNA prior to CD3/CD28 stimulation affects cell size (Orr et al., 2012). 
  





3.3.1.1  Stimulation of quiescent T-Cells 
3.3.1.1.1  CD3 purity test 
Primary, quiescent, non-activated T-Cells were isolated from peripheral blood PBMCs 
by negative selection. The purity was checked by determining the percentage of cells 
expressing CD3 on their surface (CD3 APC H7 antibody, Figure 3.3-1). Panel B shows 
cells stained with the CD3 APC H7 antibody and panel A shows the no-antibody 
control (used to set the negative electronic "gate"). The Figure (Panel B) shows an 
analysis of a typical T-Cell isolate in which approximately 96.4% of the cells express 
CD3 (98.8%-2.4%). Since the negative gate (no antibody control, Panel A) is 
conservatively set at approximately 2%, I conclude that the sample contains pure T-
Cells. This type of analysis was carried out on every T cell isolate used in my study. 
 
 
Figure 3.3-1: CD3 purity test of isolated quiescent T-Cells 
Quiescent, non-stimulated T-Cells were isolated from a healthy human donor. 
Analysis to check T-Cell purity was carried out by analysing the percentage of cells 
expressing CD3 on their surface: 
(A)  T-Cells incubated without CD3 APC-H7 antibody. This is the negative 
control. 
(B) T-Cells incubated with CD3 APC-H7 antibody. 
Samples were analysed by flow cytometry, and the percentage of cells in each sector 
(electronic "gate") is shown.  





3.3.1.1.2  Cell cycle analyses by flow cytometry 
T-Cells isolated as described above were stimulated with CD3/CD28 beads. Samples 
were taken at different time points after adding the beads to the cell culture media: 0, 
24, 48 and 72h post stimulation. Cell samples were fixed and stained at each time point 
with PI (for total DNA content) and FITC (for protein content), then analysed by Flow 
Cytometry. The method quantifies the DNA and protein content of each cell, as 
described in (Lea, Orr, et al., 2003). The data are shown in Figure 3.3-2 A and the 
percentage of cells in each cell cycle phase are quantified in B. In parallel, Western-Blot 
samples were taken to check the phosphorylation of the retinoblastoma protein, which 
becomes phosphorylated on S807/811 in response to CD3/CD28 stimulation (Lea, 
Orr, et al., 2003) (Figure 3.3-2 C). 
 
In Figure 3.3-2 A there are three rows of flow cytometry data arranged into four 
columns for samples collected at each of the four different time points (0, 24, 48 and 72h 
post stimulation). In the first row, flow cytometry data is shown, as FSC-A (Forward 
Scatter - Area) plotted against SSC-A (Side Scatter - Area). Debris in the media was 
excluded from analyses by setting an electronic gate that includes only the lymphocyte 
population. Then single cells were selected by gating Compensated-PE-A 
(Phycoerythrin – Area) against PE-W (Side Scatter - Width), shown in the second row. 
Compensated-FITC (protein content on the y-axis) was plotted against Compensated-
PI (DNA content on the x-axis) for this population, shown in the third row. Electronic 
gates were set to quantify the percentage of cells in each cell cycle phase: G0, G1, S-
phase, G2/M and Sub G0/Apoptotic cells. The percentages for this experiment are 
shown in B. The data show that initially, 99.30% of cells are in a quiescent state and 
fewer than 1% in S or G2/M phases. At 24h post stimulation, cells have not started to 
replicate DNA (0.93% reached S phase and 0.24% G2/M phases). T-Cells do not 
respond synchronously to CD3/CD28 stimulation and the leading front of CD3/CD28 
stimulated cells enter S-phase approximately 35h post stimulation and 23.60% are in S 
phase and 6.86% G2/M phases 48h post stimulation. By 72h, 33.80% are in S phase 
and 11.10% G2/M phases 72h. Note that there is a difference in the protein content of 
T cells stimulated with CD3/CD28 for 24h, as compared with the 0h pre-stimulation 





sample of quiescent (G0) cells. Previous work by the laboratory (Lea, Orr, et al., 2003) 
showed that T-Cells become committed to entering the cell cycle and growth cycle 2-
5h post stimulation and at 24h post-stimulation the leading front of cells are in late G1 
and are larger than those in G0. The kinetics of entry into the cell cycle and the growth 
cycle from quiescence in response to CD3/CD28 shown here agrees with work 
published previously by our laboratory (Lea, Orr, et al., 2003). 
 
The retinoblastoma protein (pRb) is hypo-phosphorylated in quiescent cells and 
becomes phosphorylated on many different sites, including Serine 807 and 811 in 
response to CD3/CD28 stimulation (Lea, Orr, et al., 2003; Thomas et al., 1998). 
Phosphorylation at S807/811 in T-Cells is detectable by western blotting by 16h post-
stimulation. The phosphorylation state of pRb in the T-Cell samples described above 
was analysed by Western blotting and the data (Figure 3.3-2 C) show that 
phosphorylation of S807/811 is not detectable in unstimulated T-Cells and becomes 
detectable in the samples stimulated for 24h and longer with CD3/CD28, consistent 
with previously published data. 
 
The main objective of the project is to analyse the effects of specific proteins on cell size. 
To do that, I tested several methods for measuring the sizes of T-Cells. 










Time 0h 24h 48h 72h 
G0-G1 99.30% 98.40% 69.60% 55.30% 
S 0.25% 0.93% 23.60% 33.80% 
G2-M 0.31% 0.24% 6.86% 11.10% 
 
Figure 3.3-2: Cell cycle analyses and western blot analyses of 
CD3/CD28-stimulated T-Cells 
(A) T-Cells were stimulated with CD3/CD28 beads. Samples were taken at times 
shown after CD3/CD28 stimulation: 0, 24, 48 and 72h. The samples were fixed, 
stained with PI (DNA content) and FITC (protein content) and analysed by flow 
cytometry. In all-time points shown single, T-Lymphocytes were analysed by 
setting the appropriate electronic gates. 
(B) The percentage of cells in each cell cycle phase for each sample is shown. 
(C) Western blot of phospho-pRb(S807/811) and GAPDH7 (used as the loading 
control). 
                                                   
 
7 Glyceraldehyde 3-phosphate dehydrogenase, an enzyme that is constitutively expressed and 
considered as a housekeeping protein. 





3.3.1.1.3  Cell size measurements by Flow Cytometry 
The flow cytometer measures the way the laser light reflects from each cell as it passes 
through the beam. The forward scatter (FSC-A) measurement correlates well with cell 
size (Miettinen & Björklund, 2016). A previous study by my laboratory showed that 
this measurement increases as T-Cells increase in size as they progress through the G1 
phase of the cell cycle in response to CD3/CD28 stimulation (Orr et al., 2012). 
Therefore, I used the FSC-A data from my flow cytometry analyses shown in Figure 
3.3-2 to determine how this measurement changes with time after CD3/CD28 
stimulation. To do this, I used FSC-A data extracted for cells in all phases of the cell 
cycle and the histogram of the distribution shows that pre-stimulation (0h) the quiescent 
cells have a small, tight FSC-A distribution and this increases with time after 
CD3/CD28 stimulation up to 48h post stimulation. Some T-Cells have divided 72h 
post stimulation (Lea, Buggins, et al., 2003) and the size profile is smaller for this sample 
(Figure 3.3-3). The mean and range of FSC-A for each sample are shown in Table 1.3-1 
and discussed In Section 3.3.1.2.1 below. Exact size data can be obtained from the 
FSC-A measurement if a reference standard, such as 10 µm polystyrene microparticles 
are analysed in the same experiment (Yurinskaya et al., 2017). However, this reference 
was published too late for most of my analyses and I did not used a reference sample for 
FSC-A in my study. 
 
Further to analysing the FSC-A intensity values, I checked the protein content of cells 
stained with FITC (FITC-A intensity values) (Orr et al., 2012). In Figure 3.3-4, I show 
the distribution of protein content of T-Cells pre and post stimulation via CD3/CD28. 
The FITC values increase when the T-Cells are stimulated with CD3/CD28 beads in 
line with the increase in FSC-A values, in agreement with previously published work 
by my laboratory (ibid).  
 
In further siRNA experiments described in this Chapter used this method to analyse the 
sizes of T-Cells in different cell cycle phases as they progress from quiescence into the 
first cell cycle. In my cultures, almost all the T-Cells analysed have not divided (Lea, 
Orr, et al., 2003) and see Section 3.2.6.2 However, the method of analysing FSC-A or 





FITC content is limited for analysing actively dividing T-Cells as it does not distinguish 
between cells that have divided one, twice or more times. This could be important as 
T-Cells have a limited capacity to divide and once they reach the Hayflick number of 
cell divisions (Hayflick, 1965) they enter replicative senescence and cannot divide 
further (Perillo et al., 1989). There may be cell size differences between actively 
dividing cells having undergone different numbers of cell divisions and those entering 
replicative senescence. To overcome this, it might be possible to develop a method that 
also incorporates a dye such as CFSE or other cell permeable dyes which my laboratory 
has used to analyse the division of T-Cells(Kordasti et al., 2016; Lea, Buggins, et al., 
2003). However, because I only analysed T-Cells that are predominantly in the first cell 
cycle it was not necessary to develop such a method. 
 
Figure 3.3-3: Histogram chart of the distribution of cell sizes, based 
on flow cytometry data 
FSC-A intensity values are plotted on the x-axis, while the y-axis shows the relative 
distribution of T-Cells at the time-points shown. These data are derived from 
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Figure 3.3-4: Histogram chart of the distribution of protein content, 
based on flow cytometry data 
FITC-A intensity values are plotted on the x-axis, while the y-axis shows the 
relative distribution of T-Cells at the time-points shown. These data are derived 
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3.3.1.1.4  Cell size measurements by other methods 
In addition to FSC-A measurements, I also tested two other methods for measuring cell 
size: automated Cellometer and manual light microscopy analyses of MGG-stained 
cells. 
3.3.1.1.4.1  Cellometer analyses 
Samples of T-Cells were cultured as described for Figure 3.3-3, stained with Trypan 
blue and analysed using an automated Cellometer. The Cellometer is an automated 
image analyser which automatically recognises, counts and measures the diameter of 
cells. Images of the cells analysed by this method are shown in Figure 3.3-5 and the cell 
measurements are quantified below. Note that quiescent T-Cells are single cells, but 
CD3/CD28 stimulation results in the expression of adhesion molecules that are 
important for immune responses and which cause activated T-Cells to form clumps 
(Bierer & Burakoff, 1988; Dustin, 2001). By 24h post CD3/CD28 stimulation and 
subsequently the Cellometer images obtained show that T-Cells have formed clumps. 
The T-Cells which form clumps are the cells that have been stimulated with 
CD3/CD28 and therefore those most important for my analyses. This clumping 
therefore complicates analyses of cell size and the Cellometer was not able to distinguish 
individual cells, and I could not adequately disaggregate the clumps into single cells by 
manual pipetting with a p1000 Gilson pipette (the method used routinely in the 
laboratory). It might be possible to disaggregate clumps of cells by using a protease such 
as Trypsin. However, there is a risk of causing cell death and such a method has not 
been developed in the laboratory. 
 
3.3.1.1.4.2  Light Microscopy analyses 
Samples of T-Cells (as described for Figure 3.3-3) were taken at the time points shown 
and immobilised on microscope slides by Cytocentrifugation. The immobilised cells 
were fixed and stained with May-Grünwald Giemsa (MGG) stain, which enables 
individual cells to be visualised and analysed under light microscopy (Figure 3.3-6). 
Cell numbers and measurements of cell sizes were carried out of these images using 
ImageJ software, and these data are described below. 
 






Figure 3.3-5: Cellometer images of CD3/CD28-stimulated T-Cells 
T-Cells were stimulated as described for Figure 3.3-2 and analysed using an 
automated Cellometer, using standard settings.  
 
Figure 3.3-6: Light microscopy images of MGG-stained T-Cells 
T-Cells were stimulated as described for Figure 3.3-2; samples were taken at times 
shown after stimulation, immobilised on microscope slides and stained with MGG 
stain. The cells were visualised under light microscopy, and cell numbers and 
measurements of cell size were performed manually with ImageJ software. Small 
orange spheres are the CD3/CD28 beads used to stimulate the T-Cells. 





3.3.1.2  Comparing different methods for analysing cell size 
As described above, three different approaches were used to count and measure the size 
of non-stimulated and CD3/CD28-stimulated T-Cells. The data obtained in each case 
was used to compare and select the best method for further use. 
 
3.3.1.2.1  Flow Cytometry Data – Forward Scatter Area 
I acquired FSC-A data, as described above and basic statistics of the flow cytometry. 
These data show that quiescent cells (0h) have a small, tight FSC-A distribution and 
the mean and range of FSC-A values increase after CD3/CD28 stimulation. Cells 
double in size during each cell cycle so that the size of cells in the population are 
maintained after each cell division. As described in the Introduction Section 3.1.2.4.1  
quiescent T-Cells increase in size but not DNA content by 24h post CD3/CD28 
stimulation as they enter G1 and start to enter S-phase by 30-48h. Cell cycle entry is 
not synchronous, and this results in a heterogeneity of cell sizes post stimulation, as 
discussed in (Orr et al., 2012). By 24h, <1% of T-Cells have divided, which increases 
to 16.4% by 48h. 36% have divided once, and 1% have divided twice at 72h (Lea, Orr, 
et al., 2003). Work published previously by our laboratory also showed that FSC-A 
increases in line with the increase in protein content of T-Cells as they enter G1 (Orr et 
al., 2012) and my data are consistent with the increase in cell size that occurs as T-Cell 
enter and progress through the cell cycle. 
  





3.3.1.2.2  Cellometer data 
Automated Cellometer images were analysed using standard settings and the data are 
shown in Table 3.3-2. The average sizes of cells at individual time points did not change 
with time post CD3/CD28 stimulation and remained at approximately 12 µm. Also, the 
standard deviation and coefficient of variation values were very high, and the cell 
numbers counted in the same amount of each sample varied from 1.6 to 4 thousand. T-
Cells significantly increase in size as they progress through the cell cycle. The 
Cellometer data did not reflect this change. As it can be seen on Figure 3.3-5, it is likely 
that the analyses are simply of single cells that have not yet responded to CD3/CD28 
stimulation since the stimulated, activated T-Cells form large clumps, as described 
above that I could not adequately disaggregate. Therefore, the Cellometer was not used 
in further studies in my Thesis. 
3.3.1.2.3  Analysis data of MGG staining 
Images were analysed using the oval selection tool of ImageJ software, which was used 
to analyse pictures taken from MGG stained slides. Standard settings were used, and 
the data are shown in Table 3.3-3. I obtained very similar results to those using the 
Cellometer: the average sizes of cells at individual time points did not change with time 
post CD3/CD28 stimulation and remained at approximately 13 µm. In addition, the 
standard deviation and coefficient of variation values were very high. 
 
The cell numbers counted in the same amount of each sample varied from 120 to 150, 
which is low as compared with the 10,000 cells analysed by flow cytometry. This is a 
manual counting method with software quantification, but there is high variability 
because of the differences between fields of the cell samples. T-Cells increase in size as 
they progress into and through the cell cycle, which is apparent when different fields of 
cells are viewed, but the manual measurement of cell sizes on the MGG slides did not 
reflect this phenomenon. Since it would be very time-consuming to quantify multiple 
fields of cells to obtain representative data of sufficient numbers of cells, I did not use 
this method in further analyses. 

















G0 7,504.00 42,498.90 140,255.09 53,597.45 12,507.87 23.34% 4.29 
24h 6,944.00 42,498.90 151,918.20 67,267.85 15,946.23 23.71% 4.22 
48h 7,555.00 42,505.20 151,651.80 88,872.34 18,687.35 21.03% 4.76 
72h 8,067.00 42,597.00 151,824.59 85,391.81 15,812.08 18.52% 5.40 
Average 7,517.50 42,525.00 148,912.42 73,782.36 15,738.38 21.65% 4.66 
 
 














G0 1,882.00 4.74 µm 39.65 µm 11.32 µm 5.09 µm 107.29% 0.93 
24h 1,675.00 4.11 µm 38.13 µm 12.74 µm 5.25 µm 127.67% 0.78 
48h 3,432.00 4.11 µm 39.01 µm 12.00 µm 4.53 µm 110.18% 0.91 
72h 3,963.00 4.11 µm 39.83 µm 11.97 µm 4.73 µm 115.01% 0.87 
Average 2,738.00 4.27 µm 39.16 µm 12.01 µm 4.90 µm 115.04% 0.87 
 





Table 3.3-3: Basic statistics of cell size, based on the analysis of 













G0 149.00 6.22 µm 35.76 µm 12.99 µm 6.38 µm 102.58% 0.97 
24h 153.00 4.27 µm 33.56 µm 13.76 µm 5.92 µm 138.75% 0.72 
48h 141.00 4.74 µm 37.65 µm 13.17 µm 5.65 µm 119.22% 0.84 
72h 120.00 5.43 µm 38.33 µm 13.39 µm 5.87 µm 108.13% 0.92 
Average 140.75 5.17 µm 36.33 µm 13.33 µm 5.96 µm 117.17% 0.86 
 
  





3.3.2  Expression of the individual proteins predicted by Bioinformatics 
analyses in quiescent and CD3/CD28-stimulated T cells.  
In Chapter 2, I used Bioinformatics analyses of other species to predict proteins that 
may regulate the size of human cells. To be able to carry out experiments using human 
T-Cells, the proteins must be expressed and be detectable in this cell type. The 
expression of each of the proteins was analysed in samples of quiescent as well as 
CD3/CD28 stimulated T-Cells by western blotting (Figure 3.3-7). I selected the 
proteins based on the bioinformatic analysis I described earlier, and the selection criteria 
are discussed in Chapter 2, section 2.3.2 . 
 
The figure shows western blotting data of three different individual T-Cell isolates and 
in each case the kinetics of cell cycle entry was checked (one experiment is shown in 
panel A). 
 
In panel B, I analysed the expression of the TP53RK protein kinase, which 
phosphorylates p53 on serine 15. The data show that TP53RK is not expressed in 
quiescent T-Cells but is induced in CD3/CD28-stimulated cells. p53 is also induced by 
CD3/CD28 (unpublished data from our laboratory) and the western blot shows that 
p53 is induced and phosphorylated on S15. The expression of the DNA replication 
protein MCM7 was analysed as a control since it is induced during cell cycle entry (Orr 
et al., 2010). 
 
I analysed the expression levels of the prefoldin proteins, PFD2, VBP1/PFD3 and 
PFD5 and TCTP (Figure 3.3-7 C and D). Moreover, I checked the expression of a 
known cell size regulator, eIF6 as published previously by my laboratory (Orr et al., 
2012), as well as Mcm7. All proteins are expressed in stimulated T-Cells, while they are 
only present in quiescent cells at low or undetectable levels. The data show that 
TP53RK, Prefoldin proteins and TCTP are all expressed in human T-Cells after 
stimulation with CD3/CD28 beads and are clearly detectable by western blotting. 
 
  








Figure 3.3-7: Expression of individual proteins in quiescent and 
CD3/CD28 stimulated T-Cells 
Quiescent T-Cells were Isolated and stimulated with CD3/CD28 for the time-
points shown. Samples were prepared for cell cycle analyses and western blotting as 
described in Sections 3.2.8 (A) Cell cycle analysis: cells were fixed and stained with 
PI and FITC, and the percentage of cells in each cell cycle phase was determined 
by flow cytometry. A representative of the n=3 T cell isolates used for experiments 
shown in this figure. (B) Western blot of TP53RK. The blot was also probed for 
p53, phospho-p53(S15) and Mcm7. (C) Western blot of VBP1 PFD2, PFD5, eIF6 
and (D) TPT1, VBP1 and MCM7. For each blot, sample loading was checked 
either by analysing the expression of Histone H3 or GAPDH.  





3.3.3  Reducing the induction levels of individual proteins in T cells with 
siRNA. 
The experiments in the last section show that the proteins predicted as potential cell size 
regulators by my Bioinformatics analysis, namely TP53, the prefoldin proteins and 
TCTP, are all expressed at low or undetectable levels in quiescent T-Cells and are 
induced when the T-Cells are stimulated via CD3/CD28. In previous experiments in 
our laboratory, the effects of reducing the levels of specific proteins were determined by 
transfecting quiescent T-Cells with siRNA and then stimulating with CD3/CD28 (Orr 
et al., 2010, 2012). The presence of siRNA in the cells prevented the induction of the 
specific protein that would normally occur in response to CD3/CD28 stimulation. I 
intended using the same method in my experiments on cell size by determining whether 
preventing the induction of the protein of interest changes the percentage of cells in 
individual cell cycle phases and/or affects cell size. 
3.3.3.1  Reducing expression of MCM complex proteins 
Before Investigating the effects of reducing the expression of the proteins predicted by 
my Bioinformatic analyses, I repeated some of the siRNA experiments that have been 
published previously by my laboratory, namely reducing the expression of the MCM 
proteins Mcm4 and Mcm7 (Orr et al., 2010).  
 
I isolated non-activated peripheral blood T-Cells, checked their quiescence as 
described in section 3.2.6.2 , then transfected these cells with MCM4 and MCM7 
siGENOME SMARTpool siRNAs by Nucleofection (as described in section 3.2.10 ). 
All T-Cells in the population take up the siRNA (Lea, Buggins, et al., 2003). The 
transfected, quiescent T cells were cultured without stimulation for 3 days to allow them 
to recover and for low levels of Mcm7 (and Mcm4) in the quiescent cells to reduce, then 
stimulated with CD3/CD28 beads for 72 h. Both Mcm4 and Mcm7 siRNA 
transfections were carried out with duplicate or triplicate isolates of T-Cells. Samples 
were collected for western blotting, to determine whether the siRNA transfection had 
reduced Mcm4 and Mcm7 expression and for cell cycle analyses, to determine the 
percentage of cells in each cell cycle phase. Western blot results (Figure 3.3-8 panel B) 





show that transfection with MCM4 siRNA reduces the expression of Mcm4 protein 
compared with the control siRNA. Similarly, transfection with MCM7 siRNA reduces 
Mcm7 protein expression. Differences in Mcm4 (and Mcm7) expression between 
samples of control-siRNA and MCM4-siRNA transfected cells were determined by 
scanning the images and quantification with ImageJ software. Transfection of MCM4 
siRNA reduced Mcm4 protein expression by approximately 50% and MCM7 siRNA 
reduced Mcm7 protein expression by 85% or more, compared with T-Cells transfected 
with non-targeting control siRNA. These data show that the T-Cells were transfected 
with the siRNA and that the siRNA reduced the CD3/CD28-stimulated induction of 
Mcm4 or Mcm7, as published previously (Orr et al., 2010). 
 
To determine the effects on the cell cycle of transfecting T-Cells with MCM4 or 
MCM7 siRNA, the percentage of cells in each cell cycle phase was determined by flow 
cytometry (Figure 3.3-8 panel A). The data show that reducing Mcm4 or Mcm7 
reduces the percentage of cells in S-phase, the same percentage are in G2/M and more 
remain in G0/G1. These data are consistent with (Orr et al., 2010). The cells in G2/M 
are probably due to cell cycle arrest in G2 as cells exit S-phase with DNA damage (ibid), 
although this was not investigated in my study. 
  







Figure 3.3-8: Transfection of T-Cells with MCM4 and MCM7 
siRNA 
Non-activated, quiescent T-Cells were transfected with MCM4 siRNA, MCM7 
siRNA or non-targeting control siRNA and stimulated with CD3/CD28 for 72h. 
Samples were taken for cell cycle analyses by flow cytometry and for western 
blotting, to determine the expression of Mcm4 and Mcm7 proteins. 
(A) Samples were fixed, stained with PI and FITC and the percentage of cells in 
each cell cycle phase was determined by flow cytometry.  
(B) Western blots of T-Cells transfected with the siRNAs indicated were probed for 
the expression of Mcm4 or Mcm7 proteins. For both siRNA experiments, blots were 
also probed for GAPDH and Histone H3 as a loading control. 
  





3.3.3.2  Reducing the expression of proteins of interest 
3.3.3.2.1  Western Blotting 
In the section above, I showed that I could reduce the expression of two proteins in T-
Cells, namely Mcm4 and Mcm7 by transfecting siRNA and that this resulted in changes 
in cell cycle progression. Therefore, I tested whether I could use the same siRNA 
approach to reduce expression levels of proteins that were predicted by my 
bioinformatic analysis (Chapter 2.3.2 ). I carried out experiments with SMARTpool 
siRNA for TCTP, TP53RK and VBP1. Western blots of these experiments are shown 
in Figure 3.3-9 panel A. The TCTP and VBP1 siRNA reduced the expressions of Tctp 
and Vbp1 proteins respectively to very low or undetectable levels. The reduction in 
Tctp was to a consistently low level, but the reduction of Vbp1 was variable. In contrast, 
TP53RK siRNA did not reduce Tp53rk protein expression in five independent 
experiments. Experiments were also carried out with twice the amount of TP53RK 
siRNA, but Tp53rk levels were not reduced and therefore, I dropped this protein from 
further analyses. I also carried out experiments transfecting T-Cells with PFD2 and 
PFD5 siRNA SmartPools, but again the levels of these proteins were not reduced. I also 
tested custom siRNAs based on sequences published by a research group from 
Hokkaido University (Abe et al., 2013) and I also used a different antibody (see Section 
3.2.9.1 ) to detect the expression levels of both proteins. However, neither the 
SmartPools nor the published siRNA caused a reduction of Pfd2 or Pfd5 protein 
expression (Figure 3.3-9 panel C). In these experiments, siRNA to MCM7 and EIF6 
(reported by (Orr et al., 2012)) both caused a reduction in the corresponding proteins. 
 






Figure 3.3-9: T-Cell transfections of Prefoldins, VBP1 and 
TP53RK siRNA. 
The siRNA to the targets shown in the Figure were transfected into T-Cells as for 
Figure 1.3-7. Western blots were carried out for: (A) TP53RK, TCTP, and VBP1; 
(B) TCTP, VBP1, PFD2, PFD3, eIF6 and MCM7; (C) VBP1, PFD2 and PFD5 
and (D) PFD6. SMARTpool siRNA were used in each case, except experiments 
shown in Panel C where "SIG" indicates that custom siRNA was used. DHA: 
SMARTpool. Blots were also probed for Histone H3, which was used as a loading 
control.  





Based on Arabidopsis experiment carried out in parallel (see Chapter 4, Section 4.3.2.6 
) in which the PFD6 gene knockout resulted in smaller plants, slower speed of growth 
and shorter roots, I tested whether PFD6 siRNA could be used to reduce the Pfd6 
protein in human T-Cells. The Pfd6 protein is induced by stimulating quiescent T cells 
with CD3/CD28 (Figure 3.3-9 panel D), however transfecting PFD6 siRNA into 
quiescent T cells did not reduce the Induction of the protein caused by CD3/CD28 
stimulation, either using the standard amount of siRNA used in most experiments in the 
laboratory (Figure 3.3-9 panel D) or using twice this amount (data not shown). Most 
siRNA pools used to prevent the induction of many different targets in our laboratory 
have been effective, but one siRNA pool used to reduce the induction of Cdc6 in 
another project in the laboratory did not work (Dr Orr, pers. comm.). The possible 
reason behind the failure to reduce the levels of induction of TP53RK, PFD2, PFD5 or 
PFD6 could be that the siRNA sequences in the SMARTpool used in these experiments 
were not effective or that they are degraded too quickly to be effective. This might be 
remedied by re-transfection with more siRNA after a set time in culture, but this was 
not tested. 
  





3.3.4  Effects of reduction of individual proteins in siRNA experiments  
3.3.4.1  Cell cycle analysis by flow cytometry 
In the previous section, I showed experiments in which siRNA could be used to reduce 
the induction of TCTP, VBP1 and eIF6 in human T-Cells. I determined whether 
reducing the expression of these proteins affected entry into the cell cycle by flow 
cytometry. Reducing TCTP, VBP1 or eIF6 did not cause a consistent, reproducible 
change in the percentages of cells in individual cell cycle phases as compared with T-
Cells transfected with control siRNA. The difference in the % of cells in S-phase in 
(Figure 3.3-10) was not observed in all experiments. In contrast, Mcm7 siRNA reduced 
the percentage of cells in S-phase, as shown above (see Table 3.3-4). 
 
Table 3.3-4: Distribution of cells in cell cycle phases after 
transfection with siRNA: TPT1, VBP1, eIF6 and MCM7 
Cell Cycle 
phase 
CTRL TPT1 VBP1 eIF6 MCM7 
Sub G0 0.25% 0.46% 0.37% 0.36% 0.38% 
G0 36.10% 32.60% 32.80% 37.40% 55.40% 
G1 19.60% 27.40% 28.20% 24.10% 13.00% 
S 34.30% 31.80% 30.50% 30.30% 21.60% 
G2-M 9.01% 6.81% 7.05% 6.68% 7.72% 
  







Figure 3.3-10: Cell cycle profile of T-Cells transfected with TPT1, 
VBP1, and eIF6 siRNA 
T-Cell transfections with TPT1, VBP1 and eIF6 siRNA as well as non-targeting 
control siRNA were carried out and the percentage of cells in each cell cycle phase 
was determined by flow cytometry of PI and FITC stained cells.   





3.3.4.2  Analysing the cell size  
3.3.4.2.1  Identifying which siRNA reduces TCTP 
In previous work by the laboratory to reduce the levels of Mcm7 and eIF6 using siRNA, 
each of the four siRNA in the SMARTpool was tested to determine whether more than 
one was responsible for causing the reduction. In my work, I carried out experiments to 
test this for the TCTP SMARTpool, which I used in the experiments described above. 
I determined whether more than one siRNA in the pool caused a reduction of the Tctp 
protein. Each of the four siRNA was tested by transfection T-Cells, using the 
experimental protocol used for Figure 3.3-8The levels of the Tctp protein were 
determined by western blotting and the data are shown in Figure 3.3-11. The same 
dosage of siRNA was used in all the experiments. The individual TCTP siRNA 05 and 
16 both caused a reduction of Tctp protein, whereas siRNA 01 and 06 had less of an 
effect. Therefore, since the effects of the pool are caused by more than one siRNA, the 
SMARTpool was used in further experiments. 
 
 
Figure 3.3-11: Efficiency of individual siRNA strands. 
T-Cells were transfected with single TCTP siRNAs corresponding to each of the 
four siRNAs in the SMARTpool used in Figure 3.3-10. These siRNAs are 01, 05, 
06 and 16. The experiment was carried out according to the method used for Figure 
1.3-13, and the levels of Tctp protein were determined by western blotting. 
GAPDH was also detected on the blot and is used as the loading control. 





3.3.4.2.2  TCTP protein and cell size 
I investigated whether reducing the expression of the TCTP protein affects the size of 
human T-Cells, based on forward scatter data exported from flow cytometry analyses 
(Figure 3.3-12. In each experiment, the TCTP siRNA caused a reduction of Tctp 
protein, as determined by western blotting (data not shown). I extracted the mean FSC-
A data for T-Cells transfected with control and TCTP siRNA (see Figure 3.3-13). The 
distribution of cell size is wider in cells transfected with TCTP siRNA as compared with 
the control. In four of the six independent experiments, cells had higher FSC-A mean 
values than the control, while in two cases the mean values were smaller (Figure 3.3-14). 
It is possible that these differences are due to differences in the percentages of T-Cells 
in cell cycle phases in each experiment. To determine whether this is the case I extracted 
FSC-A data of individual cell cycle phases (Figure 3.3-15). Furthermore, I added 
histogram charts for the relative protein content (FITC staining), as compared with the 
control population of cells (Figure 3.3-16). The data show that there are significant 
differences (< 0.05) in FSC-A values between control and TCTP knock-down 
population based on Student’s t-Test and the cells in G0/G1 are significantly smaller. I 
used the Student’s t-test to compare the distribution of different populations. Although 
Kolmogorov-Smirnov (K-S test) also showed that there are significant differences 
between the control and TCTP data. As these tests show significance, reducing Tctp 
protein expression in T-Cells entering the cell cycle from quiescence has a statistically 
significant effect on cell size. However, differences in cell size shown here are small and 
more experiments need to be done to determine whether this change in size is time-
dependent as previous experiments in the laboratory have shown that cells transfected 
with eIF6 siRNA revert to a normal size at later time-points and earlier time-points 
might be informative for TCTP siRNA experiments. Also, further experiments are 
needed to determine whether such differences are biologically significant by 
investigating the precise cellular mechanism. 
  






Figure 3.3-12: TCTP: Distribution in the size of single cells. 
T-Cells were transfected with control or TCTP siRNA as described for Figure 1.3-
13 and the FSC-A values for cells in each population were analysed by flow 
cytometry. This distribution is a normalization result of the six independent 
experiments. 
 
Figure 3.3-13: TCTP: Comparing mean values for six different, 
individual experiments. 
The figure shows the mean of the FSC-A data from six individual siRNA 


















































































































TCTP: Mean of 6 individual experiments
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Figure 3.3-14: Comparing distributions of control cells and cells 
transfected with TCTP siRNA 
FSC-A values for single T-Cells from each of the six TCTP and control siRNA 
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Figure 3.3-15: TCTP and control siRNA: Distribution of cell sizes 
in individual cell cycle phases. 
See text for details. These results are based on the normalization of FSC-A values 





































































































































































































































































































Figure 3.3-16: TCTP and control siRNA: Relative protein content 
FITC-A intensity values, which represents the protein content, for single T-Cells 


































































































Relative distribution of protein content
CTRL TCTP





3.3.4.2.3  VBP1 protein and cell size 
VBP1 is a component of the Prefoldin complex and I was able to reduce the expression 
of Vbp1 by transfecting siRNA into T-Cells (see Figure 3.3-17). First, I analysed 
whether reducing the levels of Vbp1 affects the FSC-A values for single cells (Figure 
3.3-17), or for cells in individual cell cycle phases (Figure 3.3-18). The data show that 
reducing the expression of Vbp1 does not significantly affect the FSC-A values of T-
Cells in any cell cycle phase. Furthermore, I analysed the protein content (FITC-A 
values) of these experiments and the relative distribution is shown in Figure 3.3-19. The 
FSC-A data obtained for the Vbp1 knockdown experiments are not statistically 
different from the control based on the Student’s t-test, indicating that reducing Vbp1 
expression does not affect the size of human T-Cells. 
 
However, there is an apparent difference in the FITC-A (cellular protein content) 
values for T-Cells transfected with control and VBP1 siRNA (Figure 3.3-19). The 
reason behind this could be that VBP1 knock-down changes the cellular protein 
expression levels but cell size Is not significantly affected. Given that FSC-A and FITC-
A parameters agree under normal conditions post CD3/CD28 stimulation (Orr et al., 
2012) further experiments are now required to determine whether cell size and protein 
content can be dissociated by reducing Vbp1 expression with siRNA. 
  






Figure 3.3-17: T-Cells transfected with VBP1 or control siRNA: 
Distribution of cell size 
See text for the details. These results are based on the normalization of FSC-A 
values of six independent experiment. The normalized distribution of cell size 
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Figure 3.3-18: T-Cells transfected with VBP1 or control siRNA: 
Distribution of cell size in individual cell cycle phases 








































































































































































































































































































Figure 3.3-19: VBP1 and control siRNA: Relative protein content 
FITC-A intensity values, which represents the protein content, for single T-Cells 

































































































Relative distribution of protein content
CTRL VBP1





3.3.4.2.4  MCM7 protein and cell size 
I always used MCM7 siRNA as a technical control for each transfection experiment, 
and I also determined the FSC-A profiles recorded by flow cytometry. FSC-A or other 
measures of cell size had not been analysed in previous work published by my laboratory 
(Orr et al., 2010). Figure 3.3-20 shows normalised data of 15 individual, independent 
experiments using T-Cells Isolated from different donors. 9 of these experiments were 
carried out previously by Dr Stephen Orr for work published in (Orr et al., 2010). The 
data shows that the FSC-A size distribution of cells transfected with MCM7 siRNA, in 
which Mcm7 protein is reduced is smaller. The data are quantified in Figure 3.3-21. I 
found that FSC-A mean values of individual cells are statistically lower in T-Cells 
transfected with MCM7 siRNA as compared with non-targeting control siRNA, except 
for two experiments (#12 and #13). A graph of the relative protein content (FITC-A 
staining) of cells transfected with Mcm7 siRNA was also statistically different from the 
control (Figure 3.3-23.). 
 
Because of the difference observed in FSC-A values, I also investigated the FSC-A of 
cells in individual cell cycle phases based on the gating I used in flow cytometry analyses 
(Figure 3.3-22). I found that in G0/G1 phases, cells transfected with MCM7 siRNA 
have smaller FSC-A values than the control and the distribution of FSC-A values is 
sharper. The distribution range in S phase is much wider and the mean FSC-A is higher 
when Mcm7 is reduced than in control-siRNA transfected cells. Cells in G2/M have 
FSC-A values that are similar to the control. These data show that reducing Mcm7 
causes a reduction in the FSC-A of cells in G0/G1 and an increase in S-phase. 
Alterations in FSC-A distributions are consistent with the expression of Mcm7 affecting 
cell size of human T-Cells. The biological relevance of this results is while the MCM 
complex is responsible for initiating DNA replication in late G1 phase, "licensing" cells 
to enter S-phase (Blow & Hodgson, 2002; Oehlmann et al., 2004) it means that 
inhibiting one of the members can also significantly reduce cell size. However, MCM 
proteins also form complexes with RNA-Polymerase II and may have a role in 
transcription (Holland et al., 2002; Yankulov et al., 1999). Reducing Mcm7 may 
therefore affect the expression of specific genes and affect cell size Indirectly.   






Figure 3.3-20: T-Cells transfected with MCM7 or control siRNA: 
Distribution of cell size in single T-Cells 
See the text for details. This distribution is a normalization of FSC-A values from of 
15 independent experiments. 
 
 
Figure 3.3-21: MCM7 and control siRNA transfected T-Cells: 

















































































































FSC-A: Mean of 15 individual experiments 
CTRL MCM7








Figure 3.3-22: T-Cells transfected with MCM7 or control siRNA: 
Distribution of cell size in individual cell cycle phases 








































































































































































































































































































Figure 3.3-23: MCM7 and control siRNA: Relative protein content 
FITC-A intensity values, which represents the protein content, for single T-Cells 
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3.4  Discussion 
3.4.1  T-Cell- entry to the cell cycle 
In this chapter, I described experiments I carried out using human peripheral blood T-
Cells. I showed that non-stimulated, quiescent T-Cells could enter the cell cycle after 
mitogenic stimulation via CD3/CD28 cell surface receptors. My results clearly show 
that T-Cells enter and progress through the cell cycle with kinetics similar to that 
published previously by our laboratory (Lea, Orr, et al., 2003), double their DNA 
content (judged by PI staining) and increase their protein content (judged by FITC 
staining) as described in (Thomas, 2004). Moreover, I showed that the pRB protein is 
hypo-phosphorylated in quiescent cells and is phosphorylated on serine 807 and serine 
811 in response to CD3/CD28 stimulation, consistent with the cell cycle transition from 
G0 to G1 phase (Lea, Orr, et al., 2003; Ren & Rollins, 2004). The distribution of cells 
in different cell cycle phases are also in line with the literature as 99% of the T-Cells did 
not enter S phase until 24-48h post CD3/CD28 stimulation. This agrees with the 
published literature as CFSE8 staining experiments carried out by my laboratory 
showed that by 24h post stimulation 1% of cells divide once, by 48h this increases to 
16.4%, and finally 72h post stimulation 36% of cells have divided once and 1% twice 
(Lea, Orr, et al., 2003).  
 
The cell size of the human T-Cells is conserved between 7 and 10 μm in diameter. 
Predominantly memory T-Cells have a strict characteristic in size. T-Cells follows a 
quantititative regime of cell size as they experience CD3/CD28 stimulation: they 
double they size during the mitosis then halves after the division.  
                                                   
 
8 Carboxyfluorescein succinimidyl ester is a cell staining dye, that is used to label and track cell proliferation. 
The CFSE per cell halves as a consequence of each cell division. 





3.4.1.1  Using flow cytometry to measure cell size  
The method to measure cell properties such as cell size and volume by flow cytometry 
is commonly used in the literature (Brown & Wittwer, 2000). A parameter known as 
forward scatter area (FSC-A) is usually used to determine cell size, but a recent study 
also reported the use of FSC-W and side scatter area (SSC-A) (Tzur et al., 2011). 
Studies by my laboratory have used FSC-A and protein content (FITC staining) to 
measure cell size (Orr et al., 2012) and a recent study also confirmed that there is a high 
correlation between forward scatter area and cell size (Miettinen & Björklund, 2016). I 
tested whether the FSC-A and FITC-A of T-Cells stimulated with CD3/CD28 
changes with time post CD3/CD28 stimulation. My data show that this does occur and 
is consistent with the increase in cell size known to occur as cells progress through the 
cell cycle. 
 
Studies by other research groups have also confirmed that using forward scatter data to 
measure cell size is an appropriate method. Researchers used flow cytometry data to 
measure cell size of human stem cells (Machado et al., 2013), human epithelial cells (De 
Paiva et al., 2006) and other organisms such as E. coli (López-Amorós et al., 1994). 
While there are many different flow cytometry machines available in my department 
and others, others have shown that there could be a significant difference between 
machines (Standerholen et al., 2014). Therefore, it is important to use the same machine 
for a study, which is what I was able to do for the work presented in this Thesis. The 
way in which electronic "gates" are set and how experiments are carried out and 
analysed can affect the data obtained. To reduce experimental variability, all of the 
human T-Cell experiments presented in this thesis were carried-out by me using the 
same FACS machine and I used the same techniques and the protocols that my 
laboratory published previously (Lea, Orr, et al., 2003). I ensured technical 
reproducibility by using positive controls in each experiment and electronic 
compensation and setting electronic gates were according to standard methods used by 
the laboratory. 
 





3.4.1.2  Using a Cellometer to measure cell size 
It has been reported that a Cellometer is a good way to measure cell size, which has 
been used in assays of adipocytes (Lee et al., 2012), stem cells (Lo Surdo & Bauer, 
2012) and cells producing recombinant adeno-associated virus (Cecchini et al., 2011). 
I measured the size of T-Cells using Nexcelom slides and the automated Cellometer. 
The T-Cells were in a quiescent state before I added CD3/CD28 beads to stimulate 
them to enter and progress through the cell cycle. However, cell size measurement data 
of T-Cells generated by the Cellometer were inconsistent and unreliable and did not 
increase with time after CD3/CD28 stimulation. The expression of cellular adhesion 
molecules on the surface of T-Cells increases in response to CD3/CD28 stimulation, 
which results in the formation of large clumps of cells that are difficult to disaggregate 
completely. The inconsistency in the values determined by the Cellometer may be 
caused by it not being able to distinguish individual T-Cells in clumps. Because of the 
inconsistency and the fact that the Cellometer may exclude the CD3/CD28-activated, 
larger cells, which are the cells responding to mitogenic stimulation, I did not use the 
Cellometer to analyse cell size in my siRNA transfection experiments. 
 
3.4.2  siRNA experiments- TP53RK and Prefoldins 
As I showed in Results section 3.3.3.2 , I was not able to reduce the expression of 
TP53RK or the Prefoldin proteins PFD2, PFD5 or PFD6 using SmartPools of four 
siRNA. I ordered custom single siRNA sequences for PFD2 and PFD5 based on (Abe 
et al., 2013) and I tested different antibodies recognising epitopes in different domains 
of the proteins. None of the siRNAs tested caused a reduction in the expression of the 
protein encoded by the target mRNA, so I excluded TP53RK, PFD2 and PFD5 from 
further analysis. A PFD6 siRNA SMARTpool was tested late during my PhD and 
therefore I was not able to test custom siRNA or other antibodies. It is not clear why 
the siRNA to each of these targets did not cause a reduction in protein expression since 
MCM7 siRNA, which was used as a technical control for the Nucleofection method in 
most experiments, caused a reduction of Mcm7 protein. Only a few siRNA experiments 
in the laboratory have been unsuccessful, notably CDC6 siRNA (unpublished). Further 





work into TP53RK and Prefoldin mRNA expression and turnover in T-Cells would 
need to be done before further siRNAs to these targets are tried. Experiments in the 
laboratory have also shown that certain siRNAs are degraded more quickly than others. 
For example, TP73 siRNA was degraded in T-Cells from 48h post CD3/CD28 
stimulation and the p73 protein increased to control levels after that (Chronis et al. - 
in preparation). Therefore, TP53RK and Prefoldin siRNA turnover in T-Cells may also 
be a factor, and different siRNA sequences and other methods (see Chapter 5) would 
have to be investigated. 
 
3.4.2.1.1  VBP1 and cell size 
VBP1 is one of the two alpha-subunits of the prefoldin complex (Martín-Benito et al., 
2007). The data showed that unlike in other organisms reducing the expression of VBP1 
has no effect on the size or cell cycle entry of the T-Cells analysed in my experiments. 
I repeated experiments more than six times, and there were no significant differences. 
Many of the other prefoldin complex members have been reported to regulate cell size 
in other organisms (Gu et al., 2008; Jorgensen et al., 2002; Rodríguez-Milla & Salinas, 
2009). In human T-Cells, the reduction of VBP1 may not affect cell size because of 
functional compensation. There are many examples of functional compensation in 
human cells by members of a protein family. Examples of this for proteins involved in 
the cell cycle are the CDKs, apart from Cdc2/CDK1 (Malumbres & Barbacid, 2009). 
The RBL2 (encodes p130) knockout is compensated by other members of the pRb in 
murine T-Cells (Mulligan et al., 1998). Compensation has also been shown to occur in 
cancer cells in which somatic mutations inactivate specific genes with no functional 
effect (Cereda et al., 2016). It is possible that the reduction of Vbp1 in human T-Cells 
is compensated by other members of the family. In another project in the laboratory, 
the Prefoldin protein complex has been isolated by biochemical fractionation and in-
line mass spectrometry analyses of the proteins present (Orr et al. - in preparation). It 
would be interesting to determine the effect of reducing Vbp1 on components of this 
complex and protein folding (Sahlan et al., 2018). 





3.4.2.2  TCTP 
I showed that reducing TCTP in human T-Cells with siRNA has an effect on cell size. 
However more experiments need to investigate the underlying mechanisms and the 
biological significance and whether the mechanism directly or indirectly has an effect 
on cell size. TCTP is a conserved protein in many species (Hinojosa-Moya et al., 2008) 
and it has been associated with many different functions in human cells, including cell 
stress responses, anti-apoptotic activity, promoting cell growth and division moreover, 
it is also released from immune cells and has a role in cytokine release (Bommer, 2017). 
TCTP regulates cell size in Drosophila melanogaster (Hsu et al., 2007) and it is important 
for regulating the development of organ size and growth (Hong & Choi, 2013). 
Moreover, the gene knock-out has been reported to reduce cell size in Arabidopsis 
(Berkowitz et al., 2008). These effects could be because the TCTP protein has a 
microtubule-stabilising activity in a cell cycle-dependent manner (Gachet et al., 1999). 
Finally, as the name suggests, the protein plays a role in the development of carcinomas 
(Gross et al., 1989). The functions of TCTP in apoptosis and cell proliferation are 
important in this context, but it may also be involved in invasion and metastasis during 
the later stages of cancer progression (Bommer, 2017). 
 
3.4.3  MCM7 results 
Mcm7 is a member of the Minichromosome Maintenance Complex (MCM), which 
forms the DNA helicase is essential for replication during S-phase (Zhai & Tye, 2017; 
Zhai et al., 2017). It was shown previously by my laboratory that reducing Mcm7 (or 
Mcm4) levels in T-Cells during cell cycle entry from quiescence caused genomic 
Instability, DNA damage and affected cell cycle progression (Orr et al., 2010). Because 
of this previous work, I used siRNA to reduce Mcm7 expression in T-Cells as a technical 
control for my studies of other proteins. However, the effect of reducing Mcm7 on cell 
size was not investigated in work by Orr et al. and so I analysed the effect of reducing 
Mcm7 alongside my other experimental samples. Analyses of T-Cell size in different 
cell cycle phases in my experiments showed that the sizes of cells in G0/G1 is reduced 
and increases in S-phase when the Mcm7 expression is reduced with siRNA. To 





determine whether my results agree with those produced earlier by Dr Orr, I obtained 
flow cytometry data from him for nine experiments use in (Orr et al., 2010). Analysis of 
his data confirmed my results. The effect of reducing Mcm7 on cell size could either be 
a specific effect of Mcm7 or as a component of the MCM complex. Therefore, I also 
carried out a limited number of siRNA knock-down experiments for Mcm4. Based on 
two individual experiments, reducing Mcm4 also affected cell size in a similar manner, 
which suggests a role for Mcm7, Mcm4 and possibly the whole MCM complex in the 
regulation of cell size. Further replicate experiments would need to be done to 
investigate this, including reducing each of the MCM proteins individually using siRNA 
used previously in the laboratory (Orr et al., 2010). The increase of cell size in S-phase 
cause by reducing Mcm7 could be due to the effects on DNA replication, including fork 
collapse and subsequent DNA repair increasing the time cells take to complete S-phase 
(ibid). However, this does not account for the reduction of cell size in G1. The MCM 
proteins also bind to RNA Polymerase II and have roles in other functions, including 
transcription (Forsburg, 2004). It is possible that reducing Mcm7 (or Mcm4) affects the 
transcription of genes that are required for cell growth. To this end, I isolated RNA from 
T-Cells transfected with siRNA before they entered S-phase. These RNAs will be 
sequenced to determine whether reducing the induction of Mcm7 during G1 affects the 
transcription of specific genes in T-Cells and if these are likely to affect processes 
involved in growth, such as ribosome biogenesis. 
  





3.4.4  Conclusions 
The results that I obtained during my PhD suggest that the expression level of TCTP 
in T-Cells could be a possible regulator of cell size. The Tctp protein is a multifunctional 
protein that has several distinct functions including involvement in apoptosis and as a 
chaperonin protein and an effect on cell size could be indirectly due to one or more of 
these mechanisms. 
 
I have also shown that reducing the expression of Mcm7, a technical control in my 
experiments, affects cell size, which could be due to a role in DNA replication and/or 
transcription.  
 
In summary, I have identified two proteins that are possibly important for regulating cell 
size of human T-Cells in specific cell cycle phases. More experiments need to be done 





Arabidopsis thaliana  





4.1  Introduction 
4.1.1  General Background of Arabidopsis thaliana 
Arabidopsis thaliana is a flowering plant small in size that is a widely used as a model 
organism in plant biology. Arabidopsis is a multicellular eukaryote plant with a relatively 
small genome of about 135 megabase pairs (Mbp) with 5 chromosomes that were fully 
sequenced in 2000 (The Arabidopsis Genome Initiative, 2000). 
4.1.1.1  Biology of Arabidopsis 
Arabidopsis thaliana plant is a member of the mustard family (Brassicaceae or 
Cruciferae) and can be found in landsides in the Northern hemisphere including most 
of Europe, Asia and North America. There are several ecotypes growing in nature, but 
only two wild-type accessions are used in scientific research: Columbia (or Col-0) and 
Landsberg (Ler) ecotypes. The Figure 4.1-1 shows for a Col-0 plant, marked with the 
basic features at 14 days post germination (dpg). 
 
Arabidopsis plant is a relatively short-lived plant with a life cycle of six weeks from seed 
to seed. It starts with seed germination, then the formation of rosette leaves, followed 
by the bolting of the main stem, then it starts to flower, and the seeds mature inside the 
seed pod called silique. The average size of a plant is between 10 to 30 centimetres, 
while the diameter of rosette leaves is between 2 to 10 cm, both depending on growth 
conditions. Flowers are usually around 2 cm long, and the sexual reproduction occurs 
by self-pollination. Leaves are covered with small hair structure called trichomes. 
Leaves come in a specific order following a growth in spiral that can be counted by 
selecting the oldest leaf (leaf #1), then counting clockwise towards the right direction. 
The plants are starting to bolt about 3 weeks after germination then they follow linear 
growth diagram. A mature plant produces around 5000 seeds in total. Roots have a 
simple structure with a main root growing following gravity and several lateral branches 
that emerge laterally (reviewed in Meinke, 1998). 






Figure 4.1-1: Schematic picture of Arabidopsis plant 
On the left of the figure, a schematic drawing of an Arabidopsis plant can be seen in 
line with a picture taken 14 days post germination (dpg). On this figure I name four 









(1) roots  
(2) rosette leaves 
(3) flower ramp 
(4) siliques and 
(5) flowers 
 





4.1.1.2  Use as a model organism 
Arabidopsis plant is a model plant of choice allowing the researchers to examine all 
aspects of plant development and physiology while enabling the use of sophisticated 
genomic approaches thanks to the small genome. Furthermore, the research using 
Arabidopsis leads to breakthrough discoveries that are applied to important crops 
(Meinke, 1998; Provart et al., 2016). Arabidopsis thaliana research is important to 
understand the role of genes using forward or reverse genetics by the relatively easy 
generation of knock-out or knock-down plant mutants. As of 2014, only 12% of the 
genes have an experimentally assigned function in Arabidopsis. The vast majority of 
assigned functions to other gene are potential and based only on sequence similarity 
assignments (Rhee & Mutwil, 2014). 
 
4.1.1.2.1  T-DNA mutants 
A method emerged in the late 1990s using genome-wide random T-DNA insertions to 
disrupt gene function (O’Malley et al., 2015). This was achieved using a soil bacteria 
called Agrobacterium tumefaciens to integrate a transfer plasmid called T-DNA in the 
coding regions, promoters or UTRs of genes in the Arabidopsis thaliana genome 
(O’Malley & Ecker, 2010; Tzfira et al., 2004). The most used protocol to generate T-
DNA mutants is using the floral dip protocol that consists in simply dipping the flowers 
into an Agrobacterium solution (Clough & Bent, 1998). In this way, mutant seed banks 
were created and open to Arabidopsis researchers. There are two large repositories: The 
European Arabidopsis Stock Centre (NASC:  and the 
Arabidopsis Biological Resource Center (ABRC: ). There are 
also bioinformatic tools ( ) that help the 
researchers to visualise the sequence spanning the T-DNA insertions and to further 
design the PCR primers to check for homozygous plants (O’Malley et al., 2015). 
  





4.1.2  Size Control in Arabidopsis 
Over millions of years even closely related species have adopted specific, hugely 
different organ sizes (Mizukami, 2001) that suggest there are specific size control 
mechanisms taking place in plants (Czesnick & Lenhard, 2015). The development of 
plant starts with the growing embryo where basic structures of the plant are established. 
Later the shoot apical meristem (SAM) is formed, this makes the basis of further 
development of several structures like leaves and flowers. The SAM cells are very 
similar and functionally equivalent to stem cells in animals, while it consists of 
pluripotent cells (Aichinger et al., 2012). These cells can grow and specifies in different 
structures they form primordiums for organs such as leaf primordium for organ 
development (Tsukaya, 2013). After forming primordium cells, expansion begins, it is 
primarily driven by cell-wall modifications accompanied by increasing turgor pressure 
because of water uptake into the vacuoles (Schopfer, 2006). Several ways affecting and 
controlling the development of individual leaves, but the final size of a leaf is critically 
influenced by the duration of cell proliferation (Czesnick & Lenhard, 2015). For the 
first part, the primordium cell number increases through division, then they start to 
arrest at the distal tip (Donnelly et al., 1999). This arrest continues and are controlled 
by several regulator molecules as it can be seen on Figure 4.1-2. These factors are either 
control the proliferation or the duration of cell expansion to reach the tightly regulated 
final size of a leaf. 






Figure 4.1-2: Main genetic factors that are controlling the growth 
of plants  
The duration of cell proliferation and the extent time of post mitotic cell expansion 
determine the final size of leaf. Both of these growth phases are tightly regulated by 
a number of growth-promoting and growth-inhibiting factors 
This figure is reproduced from Czesnick & Lenhard (2015) paper. 
 
As the regulation of a leaf is affected by many factors, several defects can happen, that 
not necessarily produces a different phenotype. In flowering plants, there is a 
phenomenon called “compensation”, which has been observed where a cell proliferation 
defect in developing leaf primordia triggers excessive cell expansion (Horiguchi & 
Tsukaya, 2011). The earliest study describing a compensation was by Haber in 1962 
(Haber, 1962). In this study they describe a leaf development using gamma-irradiated 
wheat grains where the overall leaf development reduced and compensated with larger 
cells comparing to the control population of cells (Haber, 1962). Novel studies includes 





similar findings of compensation for mutants that has a defect in positive regulators of 
cell proliferation, such as AINTEGUMENTA (Mizukami & Fischer, 2000), the 
manipulation of cell cycle proteins such as CDKA1 (Hemerly et al., 1995) and KRP2 
(KIP-related protein 2) (De Veylder, 2001). 
 
Other common phenotype of compensation is when smaller cell size appears in smaller 
organs, this called more and smaller cells (msc) phenotype first described in 2009 (Usami 
et al., 2009). The overall organ size is reduced, while the number of cells increased. 
According to the study, it seems that msc genes are not directly involved in the 
regulation of cell proliferation (Usami et al., 2009). 
 
The third version of compensation when the compensating cell size can clearly hide the 
defective organ size. This is the case for ant- and an3-induced compensations 
(Horiguchi & Tsukaya, 2011). The overall cell number is significantly fewer, but cell 
size is larger compared to the wild-type cells (Horiguchi et al., 2005; Mizukami & 
Fischer, 2000). The actual result of these compensations is the increased proliferation 
(Mizukami and Fischer, 2000; Horiguchi et al., 2005). In these cases, the cause of 
compensation is clearly defective cell proliferation (Horiguchi & Tsukaya, 2011; 
Mizukami & Fischer, 2000). However it is interesting to see in growth regulating factor 
5 defective plants decrease cell number in the leaves, but fail to induce the same 
compensation despite it is a close interactor partner of an3 (Horiguchi & Tsukaya, 2011; 
Narita et al., 2004). 
 
As we can see, the cell size can compensate the organ or the plant size with increased 
proliferation. Because of these possible processes, I’m going to show that I investigated 
and measured the plant sizes in several dimensions not just the cell size. 
  





4.1.3  Screening of cell size regulators 
As I have reported in Section 2.3.2 earlier, that I have selected the Arabidopsis ortholog 
proteins of human TCTP, TP53RK, TNPO3, VPS18, CDC7 and the prefoldin group 
for screening of cell size regulators. 
4.1.3.1  TCTP  
4.1.3.1.1  In Plants 
Translationally Controlled Tumour Protein (TCTP) is a known highly conserved, 
multifunctional protein that has been described to be involved in many fundamental 
biological processes and disorders either in human or other species (Bommer, 2017). 
Homologs of TCTP were identified in numerous plant species such as pea (Woo & 
Hawes, 1997), oil palm (Masura et al., 2011), rubber tree (Li et al., 2013) and rice 
(Wang et al., 2015) as well as in Arabidopsis (Berkowitz et al., 2008; Betsch et al., 2017; 
Schmid et al., 2005). In plants, TCTP is consist of 167-168 highly conserved sequence 
of amino acids, that are identical more than 70% in each plant organisms (Gutiérrez-
Galeano et al., 2014). 
 
4.1.3.1.2  In Arabidopsis 
Arabidopsis homolog of TCTP protein, called AtTCTP, shows as high conserved 
amino acid similarity to human, Drosophila and yeast homolog of TCTP as 53.6%, 
56%, and 62% (Betsch et al., 2017; Hinojosa-Moya et al., 2013; Thayanithy & 
Venugopal, 2005). TCTP protein showed to have a major role in the coordination of 
organ size and shape (Day & Lawrence, 2000). AtTCTP protein seems to be essential 
for the development of the final plant, while knock-out plants showed embryo lethality 
(Brioudes et al., 2010). TCTP mutant plants showed delayed development compared 
to wild-type plants (Brioudes et al., 2010). Silencing of the TCTP slowed down the 
vegetative development, while altered root development – shortened primary root 
length, and decreased lateral root formation by size and number (Berkowitz et al., 
2008). Most crucially, TCTP mutants showed to have a decrease in cell size (Berkowitz 





et al., 2008). TCTP seems to be involved in tumorigenesis in plants as well. However, 
it rarely manifests as physiological disorders (Doonan & Sablowski, 2010).  
 
4.1.3.2  TP53RK (At1g12470) ortholog protein  
At5g26110, the ortholog of human TP53RK protein, has not been fully characterised 
yet in Arabidopsis. It is currently known the TP53RK homolog protein in Arabidopsis 
holds an autophosphorylation activity (Nemoto et al., 2011). While it has also been 
described At5g26110 is one of the 72 calcium-dependent protein kinases that play a 
fundamental role in plant growth and plant development (Mittal et al., 2017). 
4.1.3.3  Mos14 
Mos14 (At5g62600), the ortholog of human TNPO3, was first characterised as a 
putative protein with similarity to transportin-SR protein (Bollman, 2003; Schlueter et 
al., 2003). Later the gene was described as a coding region of the Transportin-SR 
protein, a member of the importin-beta superfamily that imports serine-arginine rich 
proteins to the nucleus (Xu et al., 2011). MOS14 seems to be important in the proper 
slicing of genes that are important in plant immunity function (Xu et al., 2011). Mos14 
defective mutants showed to affect siRNA accumulation, transcriptional gene silencing 
and DNA methylation (Zhang et al., 2013). 
4.1.3.4  VPS18 (At1g12470) ortholog protein  
At1g12470, the ortholog protein of human VPS18 was identified in 2003 with the 
analysis of the vacuolar formation in Arabidopsis (Rojo et al., 2003). Functional analysis 
later confirmed, it contains a conserved RING domain such as its human counterpart 
(Stone et al., 2005). VPS18 ortholog in Arabidopsis is also a part of CORVET-specific, 
and HOPS-specific subunits, and plays a pivotal role in vacuolar cellular trafficking 
(Takemoto et al., 2018).  





4.1.3.5  CDC7 (At4g16970) ortholog protein 
At4g16970, the ortholog of human CDC7 protein, has been not fully characterised yet 
in Arabidopsis. The only published information is that the respective protein is a 
serine/threonine protein kinase categorised as Putative casein kinase II, with 
autophosphorylation activity (Nemoto et al., 2011). 
4.1.3.6  The Prefoldin Group 
Proteins in the prefoldin group have been identified in Arabidopsis in 2001 (Hill & 
Hemmingsen, 2001). Prefoldins are molecular co-chaperonins which are highly 
conserved from Archaea to Eukaryotes. (Martín-Benito et al., 2002; Rodríguez-Milla 
& Salinas, 2009). Prefoldins have reportedly coevolved with TCP-1 (also known as 
TCP-ring complex or TriC), actin and microtubules (Gu et al., 2008; Leroux & Hartl, 
2000) as a name in yeast Genes Involved in Microtubule biogenesis (GIM) suggest 
(Rodríguez-Milla & Salinas, 2009). Prefoldins have two α subunits Pfd3 and Pfd5, while 
four β subunits (Pfd1, Pfd2, Pfd4 and Pfd6) (Siegert et al., 2000). Prefoldin proteins are 
present only in one copy in A. thaliana, while prefoldins show higher similarities to other 
prefoldins in other species than other subunits in Arabidopsis (Hill & Hemmingsen, 
2001). Prefoldins seems to affect the orientation of microtubules (Locascio et al., 2013). 
 
4.1.3.6.1  The function of alpha subunits (Pfd3 and Pfd5) 
Arabidopsis T-DNA mutants show that α subunits of the Prefoldin complex, Pfd3 and 
Pfd5 mutants, have significantly less α- and β-tubulins compared to the control Col-0 
plants (Rodríguez-Milla & Salinas, 2009). It has been described that the location of Pfd5 
in Arabidopsis can be regulated by light-sensitive - phytohormones gibberellins via 
DELLA proteins (Dixit, 2013; Locascio et al., 2013). Gibberellins transmit signals to 
the nuclear-localised DELLA proteins, a protein family of nuclear growth-restraining 
proteins (Achard et al., 2007), then these proteins can hold or release Pfd5 proteins 
(Dixit, 2013; Locascio et al., 2013). Nuclear localisation of PFD heterohexamer 
complex can limit microtubule stabilising effect and as a consequence can hinder plant 
growth and development (Locascio et al., 2013). Pfd3 and Pfd5 T-DNA mutants 





showed alterations in the microtubule organisation and an essential role in salt stress 
tolerance (Rodríguez-Milla & Salinas, 2009). Pfd3 and Pfd5 mutants showed slightly 
darker colour, slower growth rate and smaller plants (Rodríguez-Milla & Salinas, 2009). 
Moreover, at cellular level Pfd3 and Pfd5 mutants showed alterations in the size and 
shape of pavement cells of the cotyledons (Rodríguez-Milla & Salinas, 2009). Pfd3 and 
Pfd5 mutants showed a slower growth rate of root development under experimental long 
day conditions (Rodríguez-Milla & Salinas, 2009). 
 
Molecular evidence of Pfd3, Pfd4 and Pfd5 mutants show that PFDs negatively regulate 
HY5 transcription factor (Perea-Resa et al., 2017). HY5 a bZIP transcription factor that 
has a fundamental role in photomorphogenesis (Lau & Deng, 2010; Oyama et al., 1997), 
while it induces the biosynthesis of several genes that are needed for cold acclimation 
response (Schulz et al., 2015). Prefoldins interact with HY5 under cold conditions, 
while they are triggering their degradation via ubiquitination and attenuation of 
anthocyanin biosynthesis that results in the initiation of cold acclimation (Perea-Resa 
et al., 2017). 
 
4.1.3.6.2  The function of beta subunits (Pfd1, Pfd2, Pfd4 and Pfd6) 
Pfd6 T-DNA mutants in Arabidopsis showed a series of visible defects and alterations 
(Gu et al., 2008). Pfd6 mutants showed to have defects in cell division and cortical array 
organisation, while they show alteration in microtubule organisation and 
hypersensitivity to oryzalin (Gu et al., 2008). Pfd6 mutants in Arabidopsis showed no 
interchangeable functions with other β subunits of the PFD complex such as Pfd4 (Gu 
et al., 2008).  





4.2  Materials and Methods 
4.2.1  Plant material and growth conditions 
Experiments with Arabidopsis thaliana plants were performed in the greenhouses of the 
research and innovation centre at the Fondazione Edmund Mach in San Michele all’ 
Adige, Italy. Plants were grown and handled with the help of research assistants, and I 
performed all subsequent analyses by myself. 
 
Arabidopsis experiments presented in this work were performed using wild-type and 
mutant plants in the Columbia (Col-0) genetic background. The GABI and SALK T-
DNA insertion mutant lines listed in Table 4.2-1. were obtained from the Nottingham 
Arabidopsis Stock Centre ( ). Arabidopsis lines were either 
cultivated on GS90 soil (Manna Italia) or sterile half-strength Murashige and Skoog (½ 
MS) medium (Duchefa). Plants were grown at 22°C under long day conditions 
consisting in 16h of light at an intensity of 100 μmol m-2 s-1 light and 8h of the dark. 
4.2.2  Genotyping of Arabidopsis T-DNA insertion mutants. 
Except for the EMS mutant pfd6, all T-DNA insertion homozygous mutant lines were 
obtained by screening the segregating T3 lines by PCR for the presence of the T-DNA 
insert using the primers indicated in Table 4.2-2. The PCR was performed using the 2 
× PCR Super Master Mix (obtained from biotool.com) following the manufacturer’s 
conditions on a Veriti thermal cycler (Applied Biosystems). The PCR cycle consisted 
on a denaturation step at 94°C for 5 min followed by 35 cycles of 94°C for 30 seconds, 
55°C for 30 seconds, 72°C for 30 sec and a final elongation step of 5 min at 72°C. The 
lines were considered homozygous if a PCR product was found using the primer 
combination T-DNA left border/genomic specific primer but not detected when using 
primers spanning the T-DNA insertion 
  





Table 4.2-1: GABI and SALK T-DNA insertion mutant lines 
 
Arabdidopsis 
 locus id  
Primer name in 
human 
T-DNA insertion mutant lines  
At4g16970 cdc7 SALK_130025, N683597 
At2g07340 pfd1 GABI_689A09, N2047565 
At3g22480 pfd2 SALK_041880C, N674646 
At5g49510 pfd3 GABI_863G01, N340700 
At5g49510 pfd3/vbp1 SALK_002489C, N681915 
At1g08780 pfd4 GK345E03, N433075 
At5g23290 pfd5 SALK_057848C, N671446 
At1g29990 pfd6 N16396 
At3g16640 tctp1 
SALK_000005C, N670971 and 
N860169 (SAIL) 
At5g62600 tnpo3 SALK_084257, N584257 
At5g26110 tp53rk 
SALK_071149, N571149 and N846003 
(SAIL) 
At1g12470 vps18 SALK_133060C, N654903 
 
  





Table 4.2-2: Sequences of primers used in this work 
 
Primer name Sequence (5'-3') Purpose 
LBb1.3 ATTTTGCCGATTTCGGAAC 
Left T-DNA border for 
SALK lines 
GabiLBTDNA_o8474 ATAATAACGCTGCGGACATCTACATTTT 
Left T-DNA border for 
GABI lines 
F2g07340genoGabi TGGTAAAATAATTTGGTGGTGTTAGC 
Forward genomic primer 





Reverse genomic primer on 





Forward genomic primer 





Reverse genomic primer on 





Forward genomic primer 





Reverse genomic primer on 





Forward genomic primer 




RP_SALK_002489 CCGTAGGAGATCTGGGATTTG   
Reverse genomic primer on 










Forward genomic primer 





Reverse genomic primer on 





Forward genomic primer 





Reverse genomic primer on 





Forward genomic primer 




RP_ SALK_084257 CAAGCCAGAGACCAGTGAAAC 
Reverse genomic primer on 





Forward genomic primer 




RP_ SALK_084257 CAAGCCAGAGACCAGTGAAAC 
Reverse genomic primer on 





Forward genomic primer 





Reverse genomic primer on 











4.2.3  Reagents and equipment 
Table 4.2-3. List laboratory reagents used in this work 
Reagent name Provider 
1.5 ml microcentrifuge ‘Eppendorf’ tubes StarLabs 
15 ml and 50 ml Falcon tubes VWR International Ltd 
15 ml Pipettes VWR International Ltd 
Propidium Iodine (PI) at working 
concentration of 10 µg/ml 
Invitrogen 
PCR Super Master Mix Biotool.com 
Microscope slides GE Healthcare 
 
  





4.2.4  Analysis of plant development on soil 
4.2.4.1  Leaf numbering 
As Arabidopsis leaves are growing in a specific clockwise or anti-clockwise, leaf 
numbering was applied based on a protocol published by (Farmer et al. (2013). First 
two leaves, called cotyledons, that remain in the same size throughout in the adult life 
are not considered in the numbering. Leaf numbering is starting with leaf number 1 as 
shown in Figure 4.2-1. 
 
 
Figure 4.2-1: Numbering of Arabidopsis leaves 
An Arabidopsis thaliana plant is shown 21 days post germination (dpg). Leaves of 
the plant are coming in a specific order, clockwise or anti-clockwise (in this image 
clockwise). They can be numbered in order of appearance as it is stated.  
Numbering is based on Farmer et al. (2013). The photo of the Arabidopsis plant was 
taken by me. 
  





4.2.4.2  Measuring the plant size 
Plants were grown on soil and photos were taken from above the growing plants 14 dpg 
every 2 days. Distorted photos have been corrected with Perspective Crop Tool from 
Adobe Photoshop CC software to make a same perspective analytical angle as indicated 
in Figure 4.2-2. Corrected angle photos were analysed using ImageJ software, Polygon 
selection tool. With this tool, triangles were drawn among the three longest leaves (leaf 
7,8 and 9) then area and perimeter data were analysed. Three longest leaves are usually 
the same (leaf 7,8 and 9) and easily detectable. I used only those pictures of plants, 
which were having these three leaves clearly visible to reduce noise in my data. 
 
 
Figure 4.2-2: Measuring the plant size 
Pictures that were taken with a different angle were corrected to have tall images 
normalised. (A) shows the original image. (B) Shows the cropping selection in 
Adobe Photoshop CC software, while (C) the results, fixed angle image. This image 
was later analysed using triangle methods in ImageJ software as shown in (D). 
 





4.2.4.3  Measuring the size of flower ramps 
The main flower ramps of the Arabidopsis plants were measured 5 weeks / 35 days post 
germination (dpg). The length of the main flower ramp has measured with a manual 




Figure 4.2-3: Measuring the development of flower ramp 
 (A) the length of the main flower ramp has been measured manually with a ruler. 
(B) the number of later branches has also been counted. 





4.2.4.4  Measuring the size of siliques and seeds 
The size of siliques and seeds was measured four weeks post germination. For 
performing the measurement, siliques were taken from the main flower ramp between 
10 and 20 cm from the base of the ramp (Figure 4.2-4, A). Pictures were taken using a 
dissecting microscope (Leica Microsystems MZ16 F stereo microscope), and photos 
were taken. Data was measured in ImageJ using straight line tool. Seeds were extracted 
from siliques from the main flower ramp between 10 and 12 cm and measured using two 
methods: (1) images were taken with Leica Microsystems MZ16 F stereo microscope, 
and ellipse shape superficies were measured in ImageJ with Oval Selection tool (Figure 
4.2-4, B); (2) images were captured with a microscope using the Zeiss Axioscope and 
an AxioCam MR5 camera (Figure 4.2-4, C).. Images and measurement lines were taken 
with related AxioVision software, and the data later analysed in Microsoft Excel. 
 
Figure 4.2-4: Measuring the size of siliques and seeds 
 (A) A main flower ramp from a plant at 28 dpg. Levels of siliques are numbered 
from the bottom to the top. (B) siliques between 10 and 20 cm from the base of the 
ramp and corresponding seeds between were measured with ImageJ software. (C) 
The size of seeds was also measured with Zeiss Axioscope and AxioVision software.  





4.2.5  Analysis of plant development on sterile media 
4.2.5.1  Analysis of leaf development 
Photos from Arabidopsis plants grown in Petri dishes on sterile medium were taken at 
different time points after germination. Photos were taken from above the growing 
plants. Development of the cotyledons and the first leaf (#1) were analysed. Analysis 
was made using ImageJ software by applying a circle around the cotyledon or leaf area 
and the perimeter data calculated as shown in Figure 4.2-5. 
 
 
Figure 4.2-5: Analysis of leaf development in ImageJ software. 
Black arrow pointing to a cotyledon that has been selected in ImageJ then circled 
with Oval Selection tool. The area was measured, and the perimeter calculated using 
Image J software. 
  





4.2.5.2  Analysis of root development  
Plates were positioned vertically, and the analyses were made on seedlings at different 
time points after germination every two days. I manually measured on each plate the 
length of the primary root (Figure 4.2-6, A) and number of lateral roots (Figure 4.2-6, 
B) using a ruler. 
 
 
Figure 4.2-6: Development of roots 
(A) Root length was measured manually using a general ruler and, while (B) the 
number of lateral roots has been counted. 
  





4.2.5.3  Analysis of leaf epidermal cells under confocal microscopy 
Seedlings were analysed 2 weeks / 14 days post germination (dpg). From each plant, 
the leaf number #5 was selected and cut. On the leaves specific areas under the half 
equatorial line were selected as shown in Figure 4.2-7, A. Leaf samples were incubated 
in propidium iodide (Invitrogen) for 2 minutes at 10 µg/mL in distilled water. Leaves 
were washed twice with water then put on microscope slides and analysed with a Nikon 
A1 inverted confocal with a spectral detector (Figure 4.2-7, B). Images were made with 
Nikon’s NIS Element software. Five images were taken at least from one leaf samples. 
In this specific part of the leaf, epidermal pavement cells grow into jigsaw shaped cells. 
Cell analyses were made with ImageJ software’s Wand tool (Figure 4.2-7, C), 
measuring the perimeter and area data. Specific settings for threshold colour (red) were 
used. 
 
Selection of leaves were always performed carefully as well as the cut for the jigsaw cells 
area. I was clearly paying attention to select only clearly visible cells and draw them 
precisely. In case the data is not correctly selected it can vary the result with high noise 
rate. I was doing all the selection of cells and all the analysis by myself to reduce the 
noise and create a consequent analysis. 
  





4.2.6  Data Analysis 
Recorded and measured data were analysed in Microsoft Excel. Basic statistical values 
were expressed as means, and their standard deviation and standard error were 
calculated. The levels of difference in standard deviation were calculated with F-test, 
then significance was calculated with two-tail Student’s T-test. 
 
 
Figure 4.2-7: Analysis of Epidermal Cells 
(A) Leaf number #5 was selected, and strips were cut diagonally (B) The leaf sectors 
were analysed, and pictures were taken using a Nikon A1 confocal inverted 
microscope. (C) Images were analysed with ImageJ’s Wand tool, applied tolerance 
level between 10 and 15. 
  





4.3  Results 
4.3.1  Targets for screening 
As stated in Chapter 2, I selected six different target genes plus the whole prefoldin 
group proteins in Arabidopsis to evaluate using a reverse genetic approach using T-
DNA insertion mutant lines and assess their role in cell size regulation in the plant. These 
are poorly studied proteins that have not been reported to regulate cell size in 
Arabidopsis thaliana yet. Proteins are listed in Table 4.3-1. Three of the genes have not 
been named yet and therefore used the name of the corresponding human ortholog for 
the Arabidopsis gene (cdc7, tp53rk and vps18). Vps18 gene has been selected but not 
tested systematically. As well as the pfd4 KO mutant has been selected, but not tested, 
while a homozygous were available in the two separate seed batches. I tested cdc7, 
mos14, pfd3, tctp1 and tp53rk mutants, plus the whole prefoldin complex excluding 
prefoldin 4: pfd1, pfd2, pfd3, pfd5 and pfd6.  
 
The knock-out seeds of these proteins were ordered from Nottingham Arabidopsis 
Stock Centre (NASC) and tested by growing the plants on the soil. Only checked 
homozygous knock-out (KO) mutants were tested. For a comparative growth see 
Figure 4.3-1. 
 
In the upcoming experiments shown below, Col-0 was used as a wild type, as well as a 
negative control. I used Col-0 for all of my experiments to see any change. In the 
prefoldin experiments pfd6 mutants were used as a positive control for size. 
  








Figure 4.3-1: Phenotypic characterisation of the Arabidopsis T-
DNA mutant lines 
Cdc7, mos14, pfd3, tctp1 and tp53rk mutants and the wild-type Col-0 grown on soil 
were tested. Pictures were taken 28 days post germination (dpg). During this 
screening pfd3 mutant showed a distinct phenotype (smaller plants) compared Col-
0 control plants, but we were unable to observe this phenotype in later experiments. 
This screening shows just an early comparison of different knock-out phenotypes. 
  















n/a At1g12470 Zinc ion binding protein VPS18  
PFD1 At2g07340 Prefoldin Subunit 1 PFD1 
PFD2 At3g22480 Prefoldin Subunit 2 PFD2 
PFD3 At5g49510 Prefoldin Subunit 3 VBP1  
PFD4 At1g08780 Prefoldin Subunit 4 PFD4 
PFD5 At5g23290 Prefoldin Subunit 5 PFD5 






Encodes a nuclear importer 
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the regulation of splicing of R 
genes by regulating the 
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4.3.2  Analysis of Plant Development 
I performed a systematic analysis of cdc7, mos14, pfd3, tctp1 and tp53rk T-DNA 
insertion KO mutant lines as well as the prefoldin group (pfd1, pfd2, pfd3, pfd5 and pfd6) 
TDNA KO mutant lines. 
 
Here in this section I show the analysis of plant, leaf and root sizes. 
 
4.3.2.1  Plant size 
First, I analysed and compared the plant size of the mutants to one of the wild-type Col-
0 plants at 25 dpg and 31 dpg. I found that there is no significant difference in plant size 
area or perimeter at these particulate time points as indicated in Figure 4.3-2. 
 
Moreover, I measured the area and perimeter of plants of the prefoldin complex. I found 
that pfd6 - the negative control of my experiments - is significantly smaller in all 
experiments. On another hand, pfd5 KO mutant was larger at 25 dpg, and pfd1 KO 
mutant was smaller at 31 dpg. (Figure 3.3-3). Pfd3 KO mutant showed consistently no 
difference to wild-type population. These results were different, comparing to Pfd3 and 
Pfd5 mutants that have been reported to show consistently smaller plants (Rodríguez-
Milla & Salinas, 2009). 
  








Sample Nrs 25 dpg 31 dpg 
Col-0 11 11 
cdc7 8 9 
mos14 9 11 
pfd3 11 9 
tctp1 11 7 
tp53rk 8 8 
Figure 4.3-2: Measuring the plant size 
Plants were grown on soil, and perimeter values were calculated at 25 and 31 dpg 
using the triangle measurement method. There were no significant differences. 
This experiment was repeated two individual times with no significant difference 








































































































Plant size - Triangles Perimeter
31 dpg








Sample Nrs 25 dpg 31 dpg 
Col-0 34 37 
pfd1 40 44 
pfd2 17 16 
pfd3 41 39 
pfd5 32 26 
pfd6 36 37 
Figure 4.3-3: Plant size of prefoldins 
Plants were grown on soil; the size was calculated using the triangle method at 25 
and 31 dpg. The pfd6 KO mutants were significantly smaller in all parameters tested 
while pfd5 KO mutants were larger (25 dpg) and pfd1 KO mutants were smaller (31 
dpg). The experiment was repeated two individual times with consistent results. 




































































































4.3.2.2  Leaf size - Cotyledones 
I analysed and compared the sizes of cotyledons 7 and 12 dpg (Figure 4.3-4) for cdc7, 
mos14, pofd3, tctp1 and tp53rk. I found that mos14 KO plants are significantly smaller 
and that pfd3 KO plants have significantly larger leaves than the wild-type Col-0 at 7 




Sample Nrs 7 dpg 12 dpg 
Col-0 31 27 
cdc7 22 29 
mos14 29 27 
pfd3 36 35 
tctp1 30 31 
tp53rk 27 28 
Figure 4.3-4: Comparing the size of cotyledons 
The area of the cotyledons was measured 7 dpg (left) and 12 dpg (right). The mos14 
KO mutants are significantly smaller (12 dpg), while pfd3 KO mutants are 
significantly larger at12 dpg. The mos14 and tctp1 KO mutants are significantly 
smaller (12 dpg). The experiments were repeated two times Independently with 
consistent results. 





















































Then, I analysed the size of cotyledons at 6,9 and 12 dpg for pfd1, pfd2, pfd3, pfd5 and 
pfd6. I found that cotyledons of pfd6 KO mutants – the negative control of my 
experiments, are significantly smaller in every experiment (Figure 4.3-5), while leaves 
of pfd3 KO mutants showed significantly larger leaves in half of the experiments (not 
shown on Figure 4.3-5). However, none of the experiments showed significantly larger 
cotyledons for Pfd5 mutants as it has been reported (Rodríguez-Milla & Salinas, 2009). 
In the experiment below, the cotyledons of pfd5 looks a little bit larger, but it is not 
significant. 
 
Sample Nrs 6 dpg 9 dpg 12 dpg 
Col-0 34 34 0 
pfd1 26 34 32 
pfd2 28 33 32 
pfd3 26 34 32 
pfd5 30 34 32 
pfd6 30 33 30 
Figure 4.3-5: Cotyledon size of prefoldin mutants 
Cotyledon leaf size was checked at 9 and 12 dpg. The negative control, pfd6 KO 
mutants were consistently smaller during the 12 days of growth.  
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4.3.2.3  Leaf #1 
I analysed and compared sizes of leaf number 1 at 12 dpg and 21 dpg for cdc7, mos14, 
pfd3, tctp1 and tp53rk (Figure 4.3-6). I found that tctp1 and mos14 KO plants have 
significantly smaller leaves at 12 dpg and 9 days later at 21 dpg, I found that mos14 KO 
plants have still significantly smaller leaves. 
 
   
Sample Nrs 12 dpg 21 dpg 
Col-0 24 16 
cdc7 23 18 
mos14 21 15 
pfd3 31 16 
tctp1 25 20 
tp53rk 26 15 
Figure 4.3-6: Size of leaf #1 
Area of leaf number #1 was measured at 12 (left) and 21 dpg (right). The tctp1 and 
mos14 KO mutants are significantly smaller at 12 dpg. The experiments were 
repeated independently two times with consistent results. 








































Area of leaf #1
21 dpg
* * * 





Leaf #1 was measured and counted 14 dpg for pfd1, pfd2, pfd3, pfd5 and pfd6. I found 
that pfd3 and pfd6 KO mutants are significantly smaller in leaf size comparing to the 












Figure 4.3-7: Size of leaf #1 of prefoldins 
The size of leaf #1 was checked at 14 dpg. The pfd3 KO mutants were significantly 
smaller than the wild-type Col-0.  




































4.3.2.4  Root sizes 
I analysed and compared the root size changes at 5, 7, 9, 11 and 13 dpg for cdc7, mos14, 
pfd3, tctp1 and tp53rk. I found that there was no significant difference in the length, the 
rate of root growth and number of lateral roots (Figure 4.3-8). However, in later 
experiments, pfd3 KO mutant showed shorter roots at a slower speed rate (Figure 
4.3-8). 
 
Morover, I analysed the length of root, the growth rate and the number of lateral roots 
for pfd1, pfd2, pfd3, pfd5 and pfd6 (Figure 4.3-9). Unlike in earlier analyses, I found that 
pfd3 KO mutants are significantly shorter and grew at a lower speed. The pfd6 KO 
mutants were significantly shorter and slower as well. The pfd1 KO mutants showed 
some significant differences in length at some stages (day 5), but this was not 
consistently observed. 
 
These results are different from what was described in the literature since my 
experiments did not show any alterations or lagging in size and growth rate for Pfd3 and 
Pfd5 T-DNA mutants (Rodríguez-Milla & Salinas, 2009). 
  









Figure 4.3-8: Measuring the root size 
Twenty individual mutant plants were grown next to each other in a petri dish. 
Sample numbers were between 12 and 20 for each data point. Root length (top 
chart), the speed of growth (middle chart) and a number of lateral roots (bottom 
chart) were measured. There was no significant difference between any mutant 










































Growth Speed of Roots 
2 days follow up





























Number of Lateral Roots
7 dpg 9 dpg 11 dpg 13 dpg









Figure 4.3-9: Root length, growth rate and number of lateral roots 
in prefoldin mutants 
The pfd3 and pfd6 KO mutants were significantly shorter and slower in growth. 
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4.3.2.5  Measuring the flower ramp 
I analysed the main flower ramps for pfd1, pfd2, pfd3, pfd5 and pfd6. I found that pfd1, 
pfd3 and pfd6 KO mutants have significantly (<0.05) shorter main flower ramps then 
Col-0. See Figure 4.3-10 for the details. 
 
 
Figure 4.3-10: Length of main flower ramps 
Pfd1, pfd3 and pfd6 KO mutants were significantly shorter flower ramps 42 dpg. 
* denotes significance level <0.05. 
  
Col-0 pfd1 pfd2 pfd3 pfd5 pfd6
Length 38,56 cm 33,31 cm 39,74 cm 36,25 cm 41,52 cm 28,45 cm















Length of main flower ramps
* * 
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4.3.2.6  Silique size 
I analysed the size of the siliques in the prefoldin mutants as well and found that all of 
the prefoldins have shorter silique, although only pfd3, pfd5 and pfd6 KO mutants have 
significantly shorter siliques (taken from the main flower ramp, between silique 10 and 
12 cm from the base of the ramp as shown in Figure 4.3-10. 
 
 
Figure 4.3-11: Length of siliques in prefoldin mutants 
Pfd3, pfd5 and pfd6 KO mutants have significantly shorter siliques. 
* denotes significance level <0.05. 
  
Col-0 pfd1 pfd2 pfd3 pfd5 pfd6
Average 15,65 mm 15,15 mm 13,96 mm 13,30 mm 13,14 mm 10,61 mm





















4.3.2.6.1  pfd3 mutant and silique size 
As pfd3 mutant showed significantly smaller or shorter phenotype in some dimension, I 
analysed and compared the size of the siliques. Plants were grown next to each other. 
From each plant, five siliques were harvested at the same distance 10 cm above the base 
of flower ramp as explained in material and methods. Interestingly, pfd3 KO mutants 
showed a clear phenotype distinct from the wild-type and the other mutant lines. In 
Figure 4.3-12, the results of 20 different individual experiments along with the summary 
statistics are shown. It can be clearly seen that the outcome results of individual 
experiments are highly variable, despite the plants were kept at the same light, 
temperature and watering conditions. The only reason behind could be the differences 
on soil material however I autoclaved the soil before the use. 
 
  
Figure 4.3-12: Comparing the size of siliques 
The results of 20 individual experiments are shown the right panel and summarised 
on the left. The number of samples was 100 siliques for both Col-0 and pfd3 KO 
mutants. The pfd3 KO mutants are significantly shorter.  

































































































































































I found that the length of siliques on pfd3 KO mutants are significantly shorter (p < 0.05) 
compared to the Col-0 plants a side to side comparison for three individual plant pots 




Figure 4.3-13: Comparison of siliques 
Siliques were harvested from the same level of the main flower ramp in Col-0 and 
pfd3 KO mutants. Mutants were grown next to Col-0 in the pot. The figure shows 
three individual pots for visual comparison. 
 
The pfd3 KO mutant showed an intriguing phenotype that can be explained as a 
“bumping” that was not observed in Col-0 plants. This phenomenon did not occur in 
the other KO mutants (Figure 4.3-14).  
 
We named this phenotype as “bumping” with my colleagues, while I did not find any 
relevant term in the current literature. I mean under this term that the seeds are clearly 
visible from the unopened silique, because of the larger seed size in the silique. 
  






Figure 4.3-14: The "bumping" silique phenotype of pfd3 
Bumps on siliques of the pfd3 KO mutant compared to the wild-type Col-0. 
  





4.3.3  Seed size 
4.3.3.1  Pfd3 mutant and seed size 
The phenotype was reproducible in many different independent experiments and was 
further investigated (Figure 4.3-15, top part). I measured individual seed sizes for the 
KO mutants and the control plants. I found that pfd3 KO mutant seeds are 8.85 % larger 




Figure 4.3-15: Measuring the size of seeds with ImageJ 
Pfd3 KO mutant seeds were larger in 2D oval shape measuring with 8.85% and 
13.5% in theoretical volume. The calculation based on 141 seed sample 
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Microscopic analysis of pfd3 KO mutants later confirmed these findings. The pfd3 are 
larger by 7.99% in 2D surface and 10.76% in 3D volume as shown in Figure 4.3-16. 
 
  
Figure 4.3-16: Microscopical measurements of seed size 
Pfd3 KO mutant seeds were larger in width (3.31%) and length (4.91%). As well as 
the derivative 2D surface with 7.99% and in 3D volume with 10.76%. The 
calculation based on 141 seed sample measurements from 7 individual plants for both 
pfd3 KO mutant and Col-0. 
  
Width Length Surface Volume
Col-0 100,00% 100,00% 100,00% 100,00%
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4.3.3.2  Pfd6 and seed size 
I checked the cell size of prefoldins mutants and found that in addition to the pfd3 KO 
mutants showed earlier, pfd6 KO mutants have significantly smaller dimensions in seed 
size as indicated in Figure 1.1-17. As I used pfd6 as a negative control during my 
experiments I was aware of the notion that these mutants should have a smaller 
phenotype in leaf and root sizes, however the smaller seed size was a novel result. 
 
 
Figure 4.3-17: Seed size in pfd6 KO mutants 
Seed size in pfd6 KO mutants is significantly smaller. These plants are 8.85% smaller 
in width, and 8.03% smaller in length compare to Col-0. This means the 2D surface 
is smaller about 16.24% percent and the theoretical volume is 23.53% compared to 
Col-0 plants. 
 
4.3.3.3  Other genes 
Tctp1 and tp53rk KO mutants were checked and analysed for seed size, but there was 
no significant difference in seed size comparing to the Col-0 plants. 
  
Width Length Surface Volume
Col-0 100,00% 100,00% 100,00% 100,00%
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4.3.4  Measuring the cell size: pfd3, pfd6 and tctp1 
While I have analysed nearly every developmental aspect of Arabidopsis’ organs in all 
prefoldin mutants, I completed the phenotypical characterisation by assessing if the KO 
mutation would affect the pavement epidermal cell size. These cells show jigsaw-like 
shapes in Arabidopsis. I analysed pfd3, pfd6 and tctp1 KO mutants’ cell size by 
measuring the area and perimeter data of epidermal cells of plants at growth saturation 
i.e. when starting flowering. The size of the epidermal cells was calculated from confocal 
microscopy pictures. I found that pfd3 and pfd6 KO mutants have significantly smaller 
cell size, while tctp1 KO mutants have about the same cell size than Col-0, however, 
with high variability (Figure 4.3-18). 
 
  
  Col-0 pfd3 pfd6 tctp1 
Area 6086.38 µm2 4038.40 µm2 4156.43 µm2 5034.20 µm2 
St. Diff. Area 3425.27 µm2 2132.37 µm2 1930.57 µm2 3520.86 µm2 
Perimeter 463.22 µm 383.48 µm 370.07 µm 394.17 µm 
St. Diff. Perimeter 195.21 µm 154.60 µm 132.67 µm 206.51 µm 
Sample Nr. 110 152 98 206 
Leaf Nr. 9 8 8 9 
Figure 4.3-18: Analysis of Cell size 
Leaves were harvested 6 weeks / 42 days post germination. I found that size of the 




































































Note for this experiment: I had time for one complete experiment only, while I got 
promising and significantly different data, I asked the help of my Italian supervisor Dr 
Azeddine Si-Ammour, who repeated this experiment for me. Here I showed data of his 
experiment. He grew the plants, he took the images, and I did only the analysis of cell 
size, using ImageJ software, where I got very similar results. 
 
In my experiment, I measured 4669.79 µm2 ( 2528.57 µm2) for pfd3 KO mutant 
epidermal cells, from 954 cell size samples (15 leaves), while here I calculated 4038.40 
µm2 ( 2132.37 µm2) based on 152 samples from 7 leaf samples. Based on these 
experiments I can say that pfd3 KO mutants are significantly smaller than wildtype, Col-
0 plants. 
  





4.4  Discussion 
In this chapter, I showed the results obtained using Arabidopsis thaliana and regarding 
cell size and growth measurements using T-DNA insertion mutants for the genes cdc7, 
mos14, pfd3, tctp1, tp53rk and the six gene members the prefoldin family. On one hand, 
I obtained interesting results for some mutants like pfd3. However, on the other hand, I 
showed that the phenotype associated with some mutants contradicts what was 
described in the literature. 
4.4.1  Prefoldin group 
The Prefoldin complex contains six proteins from pfd1 to pfd6. The complex is known 
to fold newly synthesised polypeptide chains, including actins and tubulins (Geissler et 
al., 1998; Vainberg et al., 1998) and play a fundamental role in the maintenance of 
cellular homeostasis (Martín-Benito et al., 2007; Siegert et al., 2000). In Arabidopsis, I 
tested the effects of pfd1, pfd2, pfd3, pfd5 and pfd6 knock-out T-DNA mutants. Pfd4 
gene was not tested and not shown, while I was not able to obtain homozygous plants 
for the mutation. 
4.4.1.1  Pfd3 and Pfd5 – Causing changes in plant and cell size 
As reported earlier, the prefoldin pfd3 and pfd5 mutants had alterations in the size and 
shape of cotyledon pavement cells (Rodríguez-Milla & Salinas, 2009). The growth rate 
of root development of these mutants was also slower under the same experimental 
conditions used in my study (Rodríguez-Milla & Salinas, 2009). I reported above that 
I found larger cotyledon leaves for the pfd3 mutant, as described by Rodríguez-Milla et 
al. (2009). However, I did not observe a slower rate of growth or alterations in root 
development and overall size changes (Rodríguez-Milla & Salinas, 2009). In contrary, 
I found that pfd3 mutants show significantly smaller cells, the opposite that has been 
reported by Rodríguez-Milla & Salinas (2009). Neither did I observe a significantly 
different phenotype for the pfd5 mutant from that reported by Rodríguez-Milla & 





Salinas (2009). Further experiments need to be done using different growth conditions 
to determine whether there are technical reasons for the differences. 
4.4.1.2  Pfd3 – Causes changes in seed size 
In addition to the phenotype described above for the prefoldin pfd5 mutant, I found that 
the pfd3 T-DNA mutant has significantly larger seed sizes. This phenotype has never 
been reported before. The seed size is an essential attribute for reproduction 
(Sundaresan, 2005). A seed consists of three distinct components: the embryo, the 
endosperm and a coat that covers the seed (Gasser et al., 1998; Grossniklaus et al., 
1998). Production of seeds is coordinated in a regulated manner, and it is triggered by 
fertilization (Alonso-Blanco et al., 1999; Gasser et al., 1998; Grossniklaus et al., 1998). 
Different methods have been used to look for genes that regulate seed size in plants. 
First is to discover these by a general screening or by quantitative trait loci (QTL) 
(Herridge et al., 2011). For example, Alonso-Blanco et al. (1999) identified six QTL 
that has an effect on seed size without significant effects on the plant (Alonso-Blanco et 
al., 1999). Seed size can be regulated via integument elongation by regulating ARF2 
(Auxin Response Factor 2) (Schruff, 2005) and TTG2 (Transparent Testa Galbra 2) 
(Johnson, 2002), or via control of early endosperm proliferation, involving MINI3 
(Miniseed3) (Luo et al., 2005) and Haiku 1-2 (Garcia, 2003). Knocking out genes 
encoding these four examples of seed size regulators caused a decrease in the size of the 
seeds. My results show that pfd3 T-DNA mutant has significantly larger seeds. This 
phenotype has been reported previously for da1 gene overexpression (Li et al., 2008). 
The da1 gene encodes a ubiquitin receptor and is thought to limit the final size of the 
seeds as well as plant organs (Li et al., 2008). A similar change in seed phenotype has 
been recently reported using the loss-of-function mutant of raptor1b, which functions 
in the TOR pathway (Salem et al., 2017). Producing larger seeds is potentially 
important for food products and further work is needed to understand the mechanisms 
that control seed size, particularly of agriculturally important plants. 
  





4.4.1.3  Pfd6 – Control for small plants 
Pfd6 is one of the four β-subunits of the prefoldin complex (Martín-Benito et al., 2007). 
It has been reported by Gu et al. (2008) that pfd6 mutants of Arabidopsis have a series of 
microtubule defects that affect cell division, cortical array organization and microtubule 
dynamics (Gu et al., 2008). They also showed that knockout plant have reduced levels 
of tubulins (Gu et al., 2008). In my experiments, pfd6 mutants were used as a positive 
control plant. I was able to reproduce all the reported details of pfd6 mutants, such as 
defects in cell division and alteration in microtubule organization that causes visible 
phenotypes (Gu et al., 2008). I showed that pfd6 mutants were significantly smaller, 
grew at a slower speed, have shorter roots and shorter main flower ramps. As pfd6 
mutants are still viable, it raises the question whether pfd6 is not essential for growth or 
that the mutant can be compensated, perhaps by other prefoldin proteins (Gu et al., 
2008). Another possibility could be the regulation of beta-tubulins via the chaperonin 
TCP1 (CCT), that also regulates microtubule formation in a prefoldin-independent 
manner (Castellano & Sablowski, 2008). 
  





4.4.2  Tctp1 – A mutant with known size control 
The experiments using the T-DNA insertion mutant tctp1 (At3g16640) did not result 
in any relevant phenotypes, despite the fact that all mutants I used were homozygous 
(as checked by PCR). These homozygous tctp1 mutants were the same as the wild-type 
population in every developmental aspect, whether of the roots or the leaves. 
Previously, tctp1 knock-out plants were retrieved via an embryo-rescue approach and 
showed a severe delay in development and critical growth defects with small organs and 
short plant stature (Brioudes et al., 2010). These mutants also flowered late and were 
sterile (Brioudes et al., 2010). Berkowitz et al. (2008) also described tctp1 mutants with 
an impaired vegetative devolvement and a leaf expansion that was slowed down due to 
reduced cell size. However, I run at least 3 complete independent experiments on 
different SALK mutants; I was unable to identify the embryo-lethal tctp1 T-DNA 
insertion mutant phenotype described by others in the literature (Berkowitz et al., 
2008). 
 
I focused my further study on leaf measurements, whereas Berkowitz at al. (2008) 
proposed that tctp1 mutation is embryo-lethal due to a defect in the male gametophyte 
(Berkowitz et al., 2008). Later, Brioudes et al. (2010) later showed a conflicting result 
stating that fertilization still occurs in embryo-rescue knock-out plants (Brioudes et al., 
2010). Recently Hafidh et al. (2016) repeated this experiment, and they described 
pollens of wild-type and tctp1 mutants that are not as different as described previously, 
while fertilization between the tctp1 mutant and wild-type still occur (Betsch et al., 
2017). Furthermore, Brioudes et al. (2010) showed that the TCTP protein in 
Arabidopsis controls cell proliferation (Brioudes et al., 2010). These findings were 
confirmed by other research groups working on tomato, tobacco and cabbage (Betsch 
et al., 2017; Bruckner et al., 2017; Cao et al., 2010; Gupta et al., 2013; Tao et al., 2015). 
The reasons behind the difference in phenotype observed between the tctp1 mutants 
used in all these studies and mine could be the nature of mutation used to knock-out the 
tctp1 or other technical differences in the conditions used during the experiment’s gene. 
Further work is necessary to understand and characterise this discrepancy. 
  






4.4.3  Mos14 – A mutant with smaller leaves 
MOS14 protein is an important receptor for nuclear-import of serine and arginine-rich 
splicing factors (Xu et al., 2011). Mos14 mutants have been described to cause defects 
in siRNA accumulation and transcriptional silencing (Zhang et al., 2013). I found that 
the size of the cotyledons and leaf #1 are significantly smaller (< 0.05) in mos14 T-DNA 
mutants compared to the Col-0 population. This is the first study reporting such leaf 
and cotyledon size phenotypes. The human ortholog, TNPO3, has been reported to act 
as a similar serine/arginine-rich splicing factor importer to the nucleus, including the 
alternative splicing factor 1/pre-mRNA-splicing factor SF2 and polyadenylation-
specific factor (CPSF6) (Lai et al., 2001; Lee et al., 2010). The reason behind the size 
difference in leaves could be the change in nuclear transport, as has been reported for 
the HASTY protein (Bollman, 2003). HASTY is also a transporter protein, and loss-of-
function mutation causes reduction of the size of roots and lateral organs in Arabidopsis 
(Bollman, 2003). 
  





4.4.4  Arabidopsis orthologs of CDC7 and TP53RK 
These genes are poorly characterized in Arabidopsis. The T-DNA mutants did not show 
any significant phenotype differences as compared with the Col-0 wild-type plant 
population. The Arabidopsis genes need to be characterised in more detail. Work is also 
necessary to determine what functions they have normally in the plant and whether 
these are similar or different from their roles in other organisms. 
 
4.4.5  Possible limitations of my methods 
The cell size measurements performed on the T-DNA insertion mutants were done with 
a PC by analysing pictures taken with a camera. It is therefore possible that this mode 
of operation introduced some biases and could be seen as a limitation for a proper 
interpretation of the results. Both plant size and perimeter or the area measurements 
were performed on macroscopic pictures taken above the plants. Although pictures 
were systematically taken using the same camera shooting angle I, however, introduced 
some modifications to correct the angles of different viewpoints as stated in Chapter 
4.2.4.2 . 
 
In the analysis of plants growing on sterile medium I was using young plants with a 
limited vertical dimension and it is unlikely that photos from the top have introduced 
biases. 
 
Using a PC, I restricted the analysis to the methods and protocols described in Section 
4.2.6 . However, some alterations could have been introduced if the leaf number was 
not selected carefully or the position of the cut area was not identified precisely. 
 
Furthermore, all the analyses were performed by me and the technical variability during 
handling of the material and the analysis of the results should be considered minimal. 
  





4.4.6  Possible alternative methods 
First of all, the ultimate experiment would be to perform a gene editing using 
CRISPR/Cas9 to trigger a mutagenesis in the gene of interest. This could have given 
me the chance to test the Pfd4 mutants of the Prefoldin complex, where I was not able 
to produce a homozygous mutant. 
 
Other alternate methods could be to use alternative measurements for cell size. Either 
other applications than ImageJ or to use more sophisticated microscopical techniques in 







Future Outlook  





5.1  Conclusions 
In this Thesis, I showed how to build a tool to create a comprehensive outlook of 
proteins that are regulating cell size. Cell size can be regulated in many ways as I have 
showed in the introduction part. There are three models that can be used: sizer, adder 
and timer (Tzur et al., 2009). In this thesis I was looking for cell size regulators that have 
an effect to the overall cell size without investigating the actual mechanisms behind the 
regulation. 
 
5.1.1  Summarizing the results 
In the Results chapters of my PhD Thesis, I described how I built two bioinformatics 
tools to predict proteins that control cell size. Then I performed experiments on 
Arabidopsis and Human T-Cells to determine whether some of the proteins predicted 
by my bioinformatics analyses affect cell size of those species. 
 
5.1.2  Bioinformatics analyses 
My first aim was to create a bioinformatics tool that can identify novel cell size orthologs 
in Homo sapiens and Arabidopsis. I successfully achieved this aim because I created a 
tool that collects the known cell size information then gives predictions for experimental 
testing. I made this tool publicly available ( ). With 
the help of this tool, I exported a pool of candidates described in detail in Chaper2, then 
I selected 17 of them to test experimentally after a 9-step narrowing process. The 9-step 
narrowing process is listed in Section 2.3.2  
  





5.1.3  Predicted candidates of the bioinformatic tool 
As I showed in Section from these 17 candidates, I selected 5 proteins plus the whole 
prefoldin complex. I tested these candidates experimentally, for the results see Table 
5.1-1. 
 
Table 5.1-1: Summary of the experimental tests 
In this table I show the results of the experimental tests in Arabidopsis and human T-
Cells. I tested all of the candidates listed in the table for Arabidopsis and all but two 
in human T-Cells. I did not list VPS18 and PFDN4 that I did not tested for various 
reasons in these organisms. 
 
A. thaliana Test / Result H. sapiens Test / Result 
At4g16970  Yes / Negative CDC7 Not tested 
At2g07340 Yes / Negative PFD1 Not tested 
At3g22480 Yes / Negative PFD2 Not tested 
At5g49510  Yes / Positive PFD3/VBP1  Yes / Negative 
At5g23290 Yes / Negative PFD5 Not successful 
At1g29990 Yes / Positive PFD6 Not successful 
Tctp Yes / Negative TCTP Yes / Positive 
Mos14 Yes / Negative TNPO3  Not tested 
At5g26110 Yes / Negative TP53RK Not successful 
 
5.1.4  Investigation of cell size regulators in human T-cells and Arabidopsis 
As shown in Table 5.1-1, I tested experimentally the 6 predicted candidate proteins 
based on my bioinformatics tool using human T-Cells. The experiments are based on 
reducing the induction of a given protein during the G0 to G1 transition using siRNA. 
Three of these experiments were successful for TCTP, VBP1 and PFDN6 proteins, 
while the PFDN2, PFDN5 and TP53RK protein results were unsuccessful, as I was not 
able to verify the reduction of the protein levels by Western Blotting. 





In Arabidopsis, I tested whether genetic knockouts of 10 candidates have effects on cell 
or plant size. I tested all of them as listed in the Table 5.1-1. Only two of them were 
known to affect cell size earlier: the Pfd6 and Tctp gene. The others have been never 
reported to affect or regulate cell or plant size. I tested the role in Arabidopsis cell size 
and organ growth for all of the 10 gene candidates using knock-out mutant lines. 
 
5.1.5  TCTP/TPT1 
Reducing the induction of one of TCTP caused a significant difference in cell size in 
human T-Cells. TCTP is a versatile protein that is involved in many fundamental 
biological processes and disorders either in human or other species (Bommer et al., 
2017). Possible it can be involved in cell size control in human, but interestingly it has 
been never reported earlier. If my results stand for TCTP in further repeated 
experiments it could make a higher impact as the protein is known to be involved in 
many cancer types (Telerman & Amson, 2009). Novel publications citing that TCTP 
is induces proliferation and cell growth in early stages of colorectal cancer (Xiao et al., 
2016). As well as some already cite TCTP as a therapeutic target in some cancer types 
such as melanoma (Boia-Ferreira et al., 2017). Despite my results showed significant 
difference there is a need for more experiments to test my findings and conclude 
whether TCTP protein is involved in cell size control. 
 
In Arabidopsis, the homozygous T-DNA insertion mutant tctp1 (Knock-out of gene 
At3g16640) did not result in any significant difference in phenotype compared to the 
wild-type - Col-0 plants. Previously, tctp1 showed a severe delay in development and 
critical growth defects with small organs and short plant stature (Brioudes et al., 2010). 
Moreover, Berkowitz et al. (2008) also described tctp1 mutants with an impaired 
vegetative devolvement and a leaf expansion that was slowed down due to reduced cell 
size. I was unable to see similar phenotypes despite I run at least 3 complete independent 
experiments on different SALK mutants. 
 





5.1.5.1  MCM7 
As I showed, I used MCM7 protein knock-downs as a technical control for cell cycle. I 
also checked the cell size of Mcm7 transfected cells. Importantly, transfecting siRNA to 
reduce the expression of Mcm7, caused a reduction of cell size in G1 and S-phases. It 
should be noted that gene knockouts of MCM genes are lethal and the effect of reducing 
Mcm7 expression on cell size has not been investigated previously. As this finding 
suggests that the MCM complex as a whole can reduce cell size, I tested MCM4 knock-
downs that showed a very similar reduction pattern of cell size distribution. MCM 
protein knock-downs known to be arrested in the G0 phase of the cell cycle (Orr et al., 
2010). It would be interesting to check whether the effect of other members of the 
MCM complex show a similar pattern. 
 
I did not investigate the effect of Mcm7 (At4g02060) knock-out in Arabidopsis, since a 
mutation in this gene is embryo lethal as it is known to be essential for early Arabidopsis 
development (Springer et al., 2000). Moreover, it is also known if we reduce MCM 
levels using endosperm-specific RNAi constructs it results in the up-regulation of DNA 
repair transcripts (Herridge et al., 2014). 
 
5.1.6  PFD6/PFDN6 
Pfd6 has been described to affect cell size and reduce plant size in Arabidopsis, while 
affecting the arrangement of microtubules (Gu et al., 2008). I was using pfd6 as a positive 
control of my experiments and my results corroborate the findings of Gu et al in 2008. 
 
In human T-Cells, I tested the knock-down effect of PFDN6, however there were no 
significant difference between the knock-down and control populations. The reason 
behind could be it does not fulfil any essential chaperonin function in human or other 
proteins surpasses the effect of the PFDN6 protein. 





5.1.7  VBP1/PFD3 
Based on the experiments performed in Arabidopsis, I gave suggestions toward that one 
of the prefoldin orthologs, namely Pfd3 is a cell size regulator. I have showed that Pfd3 
mutants have significantly smaller cell size. Moreover, Pfd3 knockout plants showed 
significantly larger seeds and longer siliques compared with the control Col-0 samples. 
This kind of phenotype has never been described before for pfd3 mutants. As my results 
show that pfd3 T-DNA mutant has significantly larger seeds. This larger seed 
phenotype has been reported previously for da1 gene overexpression (Li et al., 2008). 
Furthermore, a very similar change in seed phenotype has been recently reported using 
the loss-of-function mutant of raptor1b, which functions in the TOR pathway (Salem 
et al., 2017). Producing larger seeds is potentially important for food products and 
further work is needed to understand the mechanisms that control seed size, particularly 
of agriculturally important plants. 
 
In human T-Cells, I tested the knock-down effect of VBP1, however there were no 
significant difference between the knock-down and control population of cells. 
 
5.1.8  TNPO3/Mos14 
I also tested the Mos14 gene knock-out (KO) plants and checked whether they affect 
cell size or plant development in Arabidopsis. For Mos14 I found that the size of the 
cotyledons and leaf #1 are significantly smaller (< 0.05) than the Col-0 plants. This has 
never been reported. The reason behind the size difference in leaves could be the change 
in nuclear transport (Xu et al., 2011). It is know that Mos14 is needed for plant immunity 
through proper splicing of R genes (Tamura & Hara-Nishimura, 2014). Reduction of 
the size of roots and lateral organs in Arabidopsis has been reported to other transport 
molecules like HASTY (Bollman, 2003), that would explain the changes of size of 
Mos14 KO mutants. Despite I selected, I did not test the TNPO3 knock-downs in 
human T-Cells due to lack of time. 
 





5.1.9  Negative Results 
As I have stated above that, I experienced verified negative results in human T-Cells for 
VBP1 and PFDN6 protein siRNA knock-downs. While, in Arabidopsis I did not 
observe any significant difference in size or growth for Cdc7 (At4g16970) and tp53rk 
(At5g26110), as well as the other three members of the prefoldin complex that I tested 
pfd1 (At2g07340) pfd2 (At3g22480), and pfd5 (At5g23290) compare to the wild-type 
Col-0. 
 
5.1.10  Unsuccessful experiments 
On Table 5.1-1, it can be seen that some of my experiments did not work in human T-
Cells. The experiments for PFDN2 and PFDN5 siRNA transfected human T-Cells 
were unsuccessful. During my PhD studies, I tried to overcome this issue in several ways 
by changing the siRNA manufacturer. I tried either the siRNA provided by Dharmacon 
(Table 3.2-9) or the custom made siRNA from SigmaAldrich (Table 3.2-10), none of 
them produced a knock-down sufficient enough to reduce the protein level as tested by 
Western blot analyses. Moreover, I tried unsuccessfully to double the amount of the 
transfecting siRNA that did not shows well any reduction in the protein levels. I also 
had similar issues with TP53RK experiments in human T-Cells. 
 
  





5.1.11  The GOOT Tool 
As a follow-up of the orthology analysis of cell size regulators, I have created a 
generalised bioinformatic tool. This tool goes further and extends the tool that I created 
earlier to predict the conserved orthologous groups for any biological functions that are 
listed in the GO Slim database. I made this tool also publicly available at 
. I have shown a couple of examples which illustrate 
that it can indeed identify which conserved orthologous groups are responsible for a 
common GO function. For example, I showed that this tool is good to identify novel 
annotations for the GO term “GO:0051726 - regulation of cell cycle”. As well as I tested 
this tool for more GO term that I did not included in this thesis such as “GO:0006629 - 
lipid metabolic process” and “GO:0044281 - small molecule metabolic process”. 
 
Furthermore, I showed that this tool can help to extend the GO annotations inside the 
Gene Ontology Database, as it can highlight if a conserved function is missing from the 
annotations of proteins that are associated with an otherwise highly conserved 
functional orthologous group. Currently I’m testing this tool with more Gene Ontology 
term beyond GO-SLIM set. 
 
  





5.2  Future Outlook 
5.2.1  Bioinformatics 
5.2.1.1  Validation of my tools 
As I have shown in Chapter 2, I was able to predict candidate proteins with specific 
functions, most of which now need to be investigated further in large-scale wet-
laboratory experiments. Further, predictions using my tool have not been compared 
with those of other tools. A systematic comparison of the predictions obtained with my 
tool as compared with others is therefore required. 
 
5.2.1.1.1  Validating the Ortholog Finder Tool 
My tool is for predicting functional orthologs in human and Arabidopsis. As a first option 
I would employ a method to check the BLAST suite (Götz et al., 2008). I would enter 
a list of proteins from my initial size-control list in line with a set of current predictions 
in human to the BLAST2Go tool (Götz et al., 2008), then determine how many of them 
are predicted in common by both tools. The BLAST2Go suite is a good combination 
of various strategies since it contains general sequence management features and it has 
high-throughput capabilities (Götz et al., 2008). I favor a scenario in which the 
predictions made by my tool and those made by BLAST2GO would overlap but more 
candidates would be made available using my tool. I would also use a second method 
called RAST (Rapid Annotation of microbial genomes using Subsystems Technology) 
to test the quality of my predictions (Overbeek et al., 2014). The RAST method uses 
SEED, which contains consistent and accurate genome annotations and the annotations 
are scalable in more than 60,000 genomes. (Overbeek et al., 2014). 
  





5.2.1.1.2  Validating GOOT 
There are approaches to extend Gene Ontology based on homology as well as with 
phylogenetic annotation (Gaudet et al., 2011). I would test my predictions using the 
PAINT tool. I would pick 100 orthology groups, where there were 7 proteins in seven 
species, although all but one species has been annotated to a specific function. I would 
give 6 proteins - that have already been annotated as the sources and test the tool. If it 
gives back a prediction for the 7th organism, the protein that I have predicted in most of 
the cases (over 80%) it would be a good source for predicting protein candidates. 
 
5.2.1.2  Predictions for less characterized species 
The generalised OrthologFinder Tool can identify conserved proteins responsible for 
any GO-slim annotated biological functions. It will be interesting to see if the tool can 
be expanded to predict GO annotations for poorly characterised species, just by the 
presence of genes from these species in eggNOG groups. Sequencing of uncharacterized 
genomes is still a hot field in scientific research and as of 2013 more than 644 fully 
sequenced eukaryote genomes are in NCBI databases (Ellegren, 2014), while as of 2015 
more than 20,000 complete prokaryote genomes have been sequenced (Land et al., 
2015). Newly sequenced genomes contain uncharacterized proteins and while 
proteomics in non-model organisms has flourished in the recent years, researchers still 
try to add characterisation based on sequence homology (Armengaud et al., 2014). If 
we take a look at the goals and maintenance of the eggNOG database, they are regularly 
including data from non-model organisms and expanding the database with similar goals 
(Huerta-Cepas et al., 2016). As of version 4.5.1, the database contains 2,031 organisms 
with more than 190,000 orthologous groups (Figure 5.2-1). Based on eggNOG data my 
tool would be able to predict novel functional GeneOntology annotations for non-model 
organisms based on model organisms’ data. This could be used together with existing 
tools that try to predict GO annotations based on sequence similarity or other features 
(Mitchell et al., 2015). 
  








Figure 5.2-1: eggNOG database version 4.5.1 
The database contains 2,031 organisms, 352 viruses and more than 190,000 
orthologous groups. 
 
5.2.1.3  Experimental validation 
If time and money would permit me, I would test experimentally all of my 17 candidate 
proteins (described in Section 2.3.2 ). It would be good to see how many of them would 
have the predicted function either in Arabidopsis or human. I would like to run 
experiments with cells isolated from more human tissues to determine whether the 
protein has similar effects on the size of a wide variety of cells or just specific cell types. 
Further experiments could be done on mice in which conditional gene knock-out 
experiments (whole mouse or cell type-specific) could be performed. To test the effects 
of the predictions in less-curated species I would base my sources on known organisms 
and set of proteins, predict in less-curated but fully sequenced organisms, then test them 
experimentally. 
 





5.2.2  Arabidopsis 
Carrying out experiments on Arabidopsis is labour-intensive, and I was only able to test 
10 candidates during my PhD. If more technical resources were available, it would be 
good to test a much larger set of targets to determine which affect cell size as well as the 
size of seeds and other plant structures. Such experiments are important scientifically, 
but the results are also of potential interest for agriculturally important crops. 
 
An elegant way to show a complementation effect due to gene redundancy in the 
prefoldin gene family in Arabidopsis is to create double or triple mutants using all 
combinations of pfd1xpfd2, pfd1xpfd3 or pfd1xpfd2xpfd3. There are 2,400 gene knock-
out mutants with significant phenotypes in Arabidopsis (Lloyd & Meinke, 2012) and 
there are more than 27,000 genes in the genome (Swarbreck et al., 2008). While there 
could be several reasons to explain why only 10% of the gene knockouts cause a change 
in phenotypes my hypothesis is that Arabidopsis encodes some gene families with 
members having redundant functions. There are no seed repositories for double or triple 
mutants except for donations from special projects such as the MAPK initiative that 
deposited 275 double mutants to ABRC (Su & Krysan, 2016). Generating these double 
and triple mutants of the genes encoding prefoldins would require manual crosses but 
could potentially provide interesting results.  





5.2.3  Human 
As is the case for extending the coverage of Arabidopsis experiments, it would be possible 
to carry out high-throughput siRNA screens to identify other proteins that regulate the 
size of human T-Cells. Other experimental approaches are also possible. In recent years 
enormous efforts have been made to modify and manipulate the DNA of a given T-Cell 
genetically. These efforts were unsuccessful for a long time, but finally, Schuman et al. 
(2015) were able to successfully use CRISPR/Cas9 technology in human T-Cells 
(Schumann et al., 2015). They deleted the gene encoding the CXCR4 cell-surface 
receptor protein, which is a co-receptor for HIV, using electroporation of 
CRISPR/Cas9 ribonucleoproteins (Schumann et al., 2015). Unfortunately, this method 
was not available when I started my PhD in 2013. However, it opens the door for future 
generations in T-Cell related research into the requirement for genes predicted by my 
bioinformatics analyses to be involved in cell size control. I note that this approach is 
different from reducing expression with siRNA. Mcm7 would not be identified by a 
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6.2  List of Supplementary tables 
Table 6.2-1. List of terms listed in GO_SLIM database  
Table is correct as of 31st January, 2018. 
Term ID Term Name 
GO:0000003 reproduction 
GO:0000902 cell morphogenesis 
GO:0002376 immune system process 
GO:0003013 circulatory system process 
GO:0005975 carbohydrate metabolic process 
GO:0006091 generation of precursor metabolites and energy 
GO:0006259 DNA metabolic process 
GO:0006397 mRNA processing 
GO:0006399 tRNA metabolic process 
GO:0006412 translation 
GO:0006457 protein folding 
GO:0006461 protein complex assembly 
GO:0006464 cellular protein modification process 
GO:0006520 cellular amino acid metabolic process 
GO:0006605 protein targeting 
GO:0006629 lipid metabolic process 
GO:0006790 sulphur compound metabolic process 
GO:0006810 transport 
GO:0006913 nucleocytoplasmic transport 
GO:0006914 autophagy 
GO:0006950 response to stress 
GO:0007005 mitochondrion organization 
GO:0007009 plasma membrane organization 
GO:0007010 cytoskeleton organization 
GO:0007034 vacuolar transport 
GO:0007049 cell cycle 
GO:0007059 chromosome segregation 
GO:0007067 mitotic nuclear division 
GO:0007155 cell adhesion 
GO:0007165 signal transduction 
GO:0007267 cell-cell signaling 
GO:0007568 aging 
GO:0008150 biological process 
GO:0008219 cell death 





GO:0008283 cell proliferation 
GO:0009056 catabolic process 
GO:0009058 biosynthetic process 
GO:0009790 embryo development 
GO:0015979 photosynthesis 
GO:0016192 vesicle-mediated transport 
GO:0019748 secondary metabolic process 
GO:0021700 developmental maturation 
GO:0022607 cellular component assembly 
GO:0022618 ribonucleoprotein complex assembly 
GO:0030154 cell differentiation 
GO:0030198 extracellular matrix organization 
GO:0030705 cytoskeleton-dependent intracellular transport 
GO:0032196 transposition 
GO:0034330 cell junction organization 
GO:0034641 cellular nitrogen compound metabolic process 
GO:0034655 nucleobase-containing compound catabolic process 
GO:0040007 growth 
GO:0040011 locomotion 
GO:0042254 ribosome biogenesis 
GO:0042592 homeostatic process 
GO:0043473 pigmentation 
GO:0044281 small molecule metabolic process 
GO:0044403 symbiosis, encompassing mutualism through parasitism 
GO:0048646 anatomical structure formation involved in morphogenesis 
GO:0048856 anatomical structure development 
GO:0048870 cell motility 
GO:0050877 neurological system process 
GO:0051186 cofactor metabolic process 
GO:0051276 chromosome organization 
GO:0051301 cell division 
GO:0051604 protein maturation 
GO:0055085 transmembrane transport 
GO:0061024 membrane organization 
GO:0065003 macromolecular complex assembly 
GO:0071554 cell wall organization or biogenesis 
GO:0071941 nitrogen cycle metabolic process 
 
 
